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Enterohaemorrhagic Escherichia coli (EHEC) is a major foodborne pathogen which 
can cause bloody diarrhoea and potentially fatal haemolytic uremic syndrome (HUS). 
HUS is associated with the release of Shiga toxin (Stx) by EHEC, leading to the damage 
of globotriaosylceramide (Gb3) expressing cells located in the vascular system, 
kidneys and the central nervous system. In addition to release following bacterial cell 
lysis, Stxs can be secreted via outer membrane vesicles (OMVs). While OMVs are 
constitutively produced by Gram-negative bacteria, specific growth conditions can 
influence vesiculation.  
 
To successfully colonise, EHEC must survive the various hostile conditions present in 
the gastrointestinal tract. The production of OMVs can facilitate bacterial survival as 
OMVs are known to constitute a defence mechanism against harsh environmental 
conditions. Thus, in this investigation, the effect of various colonic environmental 
factors on EHEC OMV vesiculation was examined by quantifying OMV yield through 
different techniques. This study concluded that while simulated colonic 
environmental medium, which mimics various abiotic factors of the colonic milieu, 
and the presence of bile salts increased OMV vesiculation, no significant differences 
in OMV yields were detected when EHEC was grown in physiologically relevant levels 
of carbon dioxide and in the presence of host colonic T84 cells.  
 
In addition to their defensive role, OMVs can also contribute to pathogenesis by 
transferring virulence proteins into host cells. Since EHEC is not an invasive pathogen 
and the colonic epithelium does not express Gb3, OMVs may provide a mechanism 
which allows trafficking of Stx and other virulence factors across the colonic 
epithelium. Therefore, the ability of the colonic epithelium to internalise and 
translocate EHEC OMVs was investigated. This study determined that while OMVs 
are internalised and subsequently trafficked to late endosomal/lysosomal 
compartments in non-polarised Gb3-positive colonic-derived Caco-2 cells, OMVs are 
transported to the basolateral membrane and subsequently released by polarised 
 II 
Caco-2 cells. Nevertheless, using the more physiologically relevant Gb3-negative 
colonic-derived T84 cell line, little OMV internalisation was exhibited. To evaluate this 
discrepancy in a more biologically relevant context, EHEC OMV trafficking was 
evaluated in human colonic organoids which demonstrated OMV translocation 
across the polarised cell monolayer. The trafficking of EHEC OMVs was also 
elucidated to be similar in renal Vero cells as that in non-polarised Caco-2 cells. 
Furthermore, it was elucidated that upon OMV internalisation, encapsulated Stx2 
dissociates from OMVs and follows retrograde trafficking to the Golgi apparatus and 
the endoplasmic reticulum, eventually leading to cell death.  
 
In summary, this PhD study has shown that different conditions of the colonic milieu 
can affect EHEC OMV vesiculation in different ways. Moreover, the colonic 
epithelium can internalise and translocate EHEC OMVs, with cytotoxic effects in 
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1.1 Escherichia coli  
 
In 1885, Theodor Escherich isolated the bacterial species Bacterium coli commune 
from the faecal content of healthy infants and infants suffering from diarrhoeal 
disease (Escherich, 1885). In 1958, in honour to his work, Bacterium coli commune 
was renamed Escherichia coli (Judicial Commission of the International Committee 
on Bacteriological Nomenclature, 1958). Part of the Gammaproteobacteria class and 
the Enterobacteriaceae family, E. coli is a Gram-negative bacterium which colonises 
the large intestine of warm-blooded animals, including humans (Berg, 1996, Penders 
et al., 2006). 
 
The first E. coli strains to colonise the gastrointestinal tract of a new-born infant can 
be sourced from both the maternal faecal flora and the nursing maternity staff 
(Fryklund et al., 1992, Adlerberth and Wold, 2009). During an individual’s life, such 
colonising E. coli strains reside within the mucus layer which covers the host 
gastrointestinal epithelium. During adulthood, E. coli is one of the predominant 
facultative anaerobes, reaching a density of over 109 colony forming units per gram 
of faeces yet a gradual decrease in numbers follows during senior years (Smati et al., 
2015, Tenaillon et al., 2010). Residential gastrointestinal E. coli strains can partake in 
various roles including nutrient processing, colonisation resistance and contributing 
to the development and maintenance of the immune system (Deriu et al., 2013, 
Geva-Zatorsky et al., 2017, Maltby et al., 2013, Conway and Cohen, 2015). 
Nevertheless, the strains which colonise the gastrointestinal tract can change during 
a person’s lifetime (Conway and Cohen, 2015).  
 
E. coli can also be isolated from the natural environment, including soil, sand and 
sediment (Ishii and Sadowsky, 2008). Initially, the presence of E. coli in such 
environments were thought to be introduced through faecal contamination from 
animal-hosts, as studies had shown that E. coli could not survive outside of the host 
(Winfield and Groisman, 2003). However, subsequent studies have reported that E. 
coli can be an active member of microbial communities in the natural environment 
(Ishii et al., 2006). Currently, it is not clear whether such environmental strains are 
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from animal-origin which have adapted to the new environment or are from an 
ancestral lineage which evolved to reside in soil and sediment (Ishii and Sadowsky, 
2008, Jang et al., 2017).  
 
By far, E. coli is the most studied bacterial organism, making it a ‘model’ organism. 
Due to the high plasticity of the genome, E. coli has been exploited for biological 
engineering and molecular biological studies. Furthermore, various E. coli strains 
such as K-12, have been adapted to the laboratory environment, thus facilitating 
genetic manipulation and allowing the expression of recombinant therapeutic 
proteins (Heimesaat et al., 2013), including human insulin and monoclonal antibodies 
(Lih et al., 2010, Huang et al., 2012).  
 
As a species, E. coli is genotypically and phenotypically diverse due to the high 
plasticity of the E. coli genome. Genetic studies of representative E. coli strains have 
demonstrated that the core-genome of E. coli consists of less than 20% of genes in a 
‘typical’ genome, with the remaining genes constituting the flexible genome (Hao et 
al., 2012, Touchon et al., 2009, Lukjancenko et al., 2010). The plasticity of the genome 
allows different E. coli strains to acquire prophages, transposable elements and 
accessory genes which can give rise to pathogenic E. coli strains.  
 
Serotyping is often employed to identify different E. coli strains. The importance of 
strain identification is key to tracking and following pathogenic E. coli strains during 
outbreaks. Serotyping is a method based on the characterisation of different strains 
based on the O-antigen (lipopolysaccharide), H-antigen (flagella) and K-antigen 
(capsule; Orskov et al., 1977, Orskov F., 1984). To achieve this, strains are tested 
against various antibodies which work against specific antigens, with matching 
antibody-antigen complexes causing solute agglutination. Yet, the application of 
serotyping methods to classify and track of E. coli outbreaks is shifting to whole 
genome sequencing technology due to reduced cost and time, and the greater ability 
to track isolates allowing for efficient trace back investigation (Lindsey et al., 2016, 
Abdalhamid et al., 2019, Jenkins et al., 2019). 
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1.2 Pathogenic E. coli 
 
E. coli was first recognised as a pathogenic microorganism by John S. B. Bray in the 
1940s (Bray, 1945, Bray and Beavan, 1948). Following an outbreak of diarrhoea in 
infants, Bray and Beaven examined the faecal material of both healthy and ill infants. 
Antisera raised against isolates from both groups revealed that even though 
Bacterium coli commune was part of the normal faecal flora, it was also the causative 
agent to the diarrhoeal disease arising in infants (Bray, 1945, Bray and Beavan, 1948). 
 
Based on the location of the disease, pathogenic E. coli can be classified into two 
distinct groups: intestinal and extraintestinal E. coli. Furthermore, according to the 
defined set of virulence factors and the main site of infection, both groups can be 
further subdivided into pathotypes (Fig. 1.1). Currently, the pathotypes associated 
with extraintestinal disease are uropathogenic E. coli (UPEC), which infect the urinary 
tract; neonatal meningitis-associated E. coli (NMEC) which can infect the brain, and 
sepsis-associated E. coli (SEPEC) which is a group made up of strains that infect open 
wounds and cause sepsis.  
 
Within the intestinal pathogenic E. coli classification, pathotypes include Shiga toxin-
producing E. coli (STEC), enteropathogenic E. coli (EPEC), enterotoxigenic E. coli 
(ETEC), enteroinvasive E. coli (EIEC), enteroaggregative E. coli (EAEC) and diffusely 
adherent E. coli (DAEC; Guignot et al., 2009, Croxen and Finlay, 2010). The adherent 
invasive E. coli (AIEC) pathotype can also be included with the intestinal pathogenic 
E. coli classification, however, unlike the other members of the group, AIEC is 
associated with inflammatory bowel disease such as Crohn’s disease and ulcerative 
colitis rather than diarrhoeal disease (Palmela et al., 2018). Currently, such 
pathotypic grouping is under debate as pathogenic E. coli do not always obey the 
pathotype alignment due to genomic plasticity. Pathotypic combinations have arisen 
and caused outbreaks, such as the 2011 European outbreak caused by a Shiga toxin 
(Stx)-producing EAEC strain (Navarro-Garcia, 2014, Robins-Browne et al., 2016).  
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A STEC subgroup termed enterohaemorrhagic E. coli (EHEC) is distinguished by its 
ability to cause severe disease in humans, including haemorrhagic colitis (HC) and 
haemolytic uremic syndrome (HUS). Two primary virulence factors are associated 
with the ability of EHEC to cause disease; (i) the locus of enterocyte effacement (LEE) 
pathogenicity island which encodes for a type three secretion system (TTSS) and (ii) 
Shiga toxin (Stx) encoding prophages which enable the production of toxins such as 
Stx1 and Stx2. Nevertheless, LEE negative STEC strains have emerged in the last 
decade and have been associated with the development of severe disease such as 
HUS (Franz et al., 2015, Fruth et al., 2015, Herold et al., 2009a). Currently, the 
molecular mechanism by which such LEE-negative STEC strains adhere to the host 
intestinal epithelia is largely unknown.  
 
 





1.3 Enterohaemorrhagic E. coli  
 
1.3.1 Emergence and evolutionary origin  
 
The ability of EHEC to cause human disease was first associated in 1982 by Riley et 
al., following an outbreak of haemorrhagic colitis (HC) which affected 47 individuals 
in the states of Michigan and Oregon, USA (Riley et al., 1983). The source of this 
outbreak was identified to be from undercooked hamburgers contaminated with the 
then ‘rare’ EHEC serotype O157:H7. Prior to 1982, EHEC O157:H7 had only been 
isolated once from a patient who developed HC in 1975 (Riley et al., 1983). Following 
the first isolation of EHEC O157:H7, an E. coli strain with the serotype O26 was 
isolated from an infant suffering from a diarrheagenic disease. Investigations on this 
O26 strain deduced that some E. coli strains could produce a toxin which was termed 
verocytotoxin since it had cytotoxic effects on African green monkey kidney ‘Vero’ 
cells (Konowalchuk et al., 1977). Successively, it was discovered that this toxin was 
structurally similar to Stx synthesised by Shigella dysenteriae type 1 and that both 
toxins could elicit the same biological activity, thus verocytotoxin is also known as Stx 
(O'Brien et al., 1982, O'Brien and LaVeck, 1983). Furthermore, following 
investigations into sporadic cases of HUS, Karmali et al. demonstrated that the 
development of HUS was associated with EHEC infections, with further investigations 
linking Stx produced by EHEC to the development of HC and HUS (Karmali et al., 
1983b, Karmali et al., 1983a).  
 
In the UK, EHEC O157:H7 was first isolated in 1983 from faecal samples of three 
children during a HUS outbreak in the West Midlands involving 35 children (Taylor et 
al., 1986). Following this, the first documented community outbreak of HC caused by 
EHEC O157:H7 in the UK arose in 1985 in East Anglia, with 49 people falling ill, and 19 
individuals being admitted to hospital (Morgan et al., 1988).  
 
It is currently accepted that EHEC O157:H7 diverged from E. coli O55:H7, with current 
models suggesting that the first evolutionary step was the seroconversion from O55 
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to O157 (Feng et al., 1998). Subsequently, a split occurred in the O157 lineage which 
resulted in two populations, (i) a lineage which lost flagella (O157: H-) giving rise to 
ancestral lineages commonly known as ‘German clones’; and (ii) a lineage which lost 
the ability to ferment sorbitol, giving rise to the common ancestor of all EHEC 
O157:H7 strains. 
 
EHEC O157:H7 does not fall under a single phylogenetic group, instead there are 
three main lineages (I, II and I/II) and eight sub-lineages (Ia, Ib, Ic, IIa, IIb, IIc, I/IIa and 
I/IIb), all of which are genetically distinct (Dallman et al., 2015). Such variation may 
have arisen as a result of the geographical spread of an ancestral clone and 
subsequent regional expansion. Distinctions which have arisen between the lineages 
have come about due to differences in the insertion sites of Stx-encoding 
bacteriophages, the difference in Stx subtype being carried by strains and lineage-





In 2015, the World Health Organization (WHO) estimated that in 2010, more than 
600 million people fell ill due to foodborne disease (Codex Alimentarius Commission, 
2015, The World Health Organization and Food and Agriculture Organization, 2018). 
EHEC infection is a moderately rare cause of gastrointestinal illness, with estimates 
of 2.5 million acute illnesses developing (Majowicz et al., 2014). Indeed, the number 
of confirmed cases falls short of the estimated number of total cases, as patients will 
usually seek medical attention once the development of bloody diarrhoea occurs.  
 
Thus far, EHEC is the fourth most reported bacterial zoonotic pathogens in the 
European Union/European Economic Area (EU/EEA), following members of the 
Campylobacter species (spp.), Salmonella spp. and Yersinia spp. (European Food 
Safety Authority, 2018). Between 2014 and 2018, both the UK and Germany reported 
the highest number of EHEC cases within the EU/EEA, with a total of 4115 reported 
cases (46.7%) out of 8811 reported cases reported in the EU/EEA in 2018 (Fig. 1.2; 
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European Centre for Disease Prevention and Control, 2020). Beyond Europe, the 
highest rates of EHEC infections can be found in the USA, Canada, Australia, New 
Zealand, Argentina and Japan (Croxen et al., 2013).  
 
 
Figure 1.2: Proportion of total EHEC cases reported by countries in the EEA in 2018. Based on 
data from European Centre for Disease Prevention and Control, 2020.  
 
Data collected by Public Health England (PHE) has reported that more than 40% of 
EHEC incidents occur in children under the age of 15, with the highest incidence 
occurring in 1- to 4-year-olds (Byrne et al., 2015). Interestingly, other foodborne 
pathogens such as Campylobacter spp., do not follow this pattern. The suggested 
reasons for this unique occurrence include: (i) the low infectious dose of less than 
100 EHEC bacteria and (ii) infant behaviour which increases the chances of 
environmentally acquired EHEC infection.  
 
In the UK, the largest recorded outbreak of EHEC O157:H7 occurred in 1996, where 
512 cases were reported, along with 20 associated deaths (Cowden et al., 2001). 
Investigations into the source of the outbreak was traced to a local butcher selling 
contaminated meat products. 
 
Between 2009 and 2012, EHEC O157:H7 was attributed to 98.8% of all EHEC 
infections in England and Wales (Byrne et al., 2015), with only 89 cases of non-O157 
STEC being reported. Nevertheless, in 2018 a total of 1,219 cases of EHEC infection 
were reported in England and Wales, of which 607 (50%) were O157:H7 (Public 
Health England, 2020). This increase in infections by non-O157 EHEC strains is likely 








due to increased awareness of non-O157 serotypes after the 2011 outbreak caused 
by Stx-producing EAEC O104:H4, which affected over 4000 people and caused 855 
cases of HUS, thus representing the highest incidence of EHEC-related HUS reported 
thus far (World Health Organization, 2011, Wu et al., 2011, Karch et al., 2012). As 
such, from 2013 there has been an increased level of screening for non-O157 EHEC 
strains through molecular-based assays such as PCR and genomic sequencing (Byrne 
et al., 2014, Byrne et al., 2015, Public Health England, 2020, Greig et al., 2019). In 
2018, the five most common non-O157 serogroups detected in England were: O26, 
O91, O146, O128ab and O117 (Public Health England, 2020), with O26 representing 
the most commonly reported non-O157 STEC serogroup.  
 
Globally, whilst EHEC O157:H7 is the utmost recognised serotype to cause disease, 
over 150 non-O157 serotypes have been associated as causative agents of several 
outbreaks and sporadic cases of EHEC infection (Mellor et al., 2016, Fan et al., 2019). 
Lately, the number of non-O157 EHEC infection cases have increased globally, among 
which serotypes, O26, O45, O103, O111, O121, and O145, referred to as “the big six”, 
being major non-O157 STEC serotypes eliciting human disease (Karch et al., 2009, 
Scallan et al., 2011, Brooks et al., 2005). Disease which arises with an infection with 
one of these serotypes can range from mild non-bloody diarrhoea to HUS and death, 
with the young, the elderly and immunocompromised being most at risk (Brooks et 
al., 2005). The regions of which the rate of incidence for these non-O157 EHEC 
serotypes have increased includes the USA, Canada, Western Europe, Australia, 
Japan, and Argentina (Valilis et al., 2018).  
 
Both cattle and sheep can carry EHEC, with cattle representing the primary reservoir. 
In cattle, EHEC preferentially colonises the recto-anal junction, yet carriage remains 
asymptomatic (Cobbold et al., 2007, Naylor et al., 2003). In cattle, the intestinal 
vasculature lacks the Stx receptor glycolipid globotriaosylceramide (Gb3) thus 
explaining why asymptomatic carriage in cattle arises (Pruimboom-Brees et al., 
2000). Another reason for asymptomatic carriage is due to Gb3 isoforms present in 
bovine epithelial cells located in intestinal crypts, lacking association to lipid rafts, 
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resulting in inhibition of the cytotoxic activity of Stx in host cells (Falguieres et al., 
2001, Hoey et al., 2003).  
 
Global levels of EHEC O157:H7 carriage in dairy cattle varies with estimates of 0.2% 
to 48.8%. Furthermore, carriage levels increase in calves and during the summer 
months (Hussein and Sakuma, 2005, Elder et al., 2000). By far, beef has been 
identified as the most common food source for EHEC infection by the WHO (The 
World Health Organization and Food and Agriculture Organization, 2018). It is 
acknowledged that EHEC contamination of bovine food products arises when faecal 
shedding and spreading occurs in slaughterhouses (Omisakin et al., 2003). Most EHEC 
infections result from the consumption of undercooked meats, with a higher 
proportion being attributed to the summer months due to undercooked barbecued 
foods such as burgers (Chapman et al., 2000, Chapman et al., 2001, Tuttle et al., 1999, 
Barlow et al., 2006, Lansbury and Ludlam, 1997, Keenswijk et al., 2017).  
 
Direct contact with animals such as in a petting zoo is another route of EHEC 
transmission, particularly in children (Gould et al., 2009). In the UK, the largest 
petting zoo outbreak of EHEC O157:H7 occurred in 2009 (Public Health England, 
2011), when 93 individuals were infected after visiting Godstone petting farm. Of 
those infected, 82% were children under age 10 years, of which a total of 17 (18%) 
developed HUS (Public Health England, 2011). Other transmission routes include 
close contact with other infected patients such as in day-care centres and healthcare 
settings (Wheeler et al., 1999, Carter et al., 1987). 
 
A meta-analysis study which examined various case control and surveillance studies 
identified contact with animals or their habitat, and the consumption of raw meat as 
the main sources of EHEC infections (Kintz et al., 2017). In Kintz et al. (2017), 62.5% 
of studies associated the consumption of undercooked/raw meat as a significant 
source of EHEC infection and 70.4% of studies acknowledged contact with animals or 
their environment as a source of EHEC infection. Interestingly, this meta-analysis 
identified contact with animals as the major risk factor for EHEC infection in British 
investigations, with the consumption of raw meat as a lower associated risk factor to 
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contracting an EHEC infection. The risk factors associated with contracting an EHEC 
infection were also similar for European case studies, yet Northern American studies 
identified the consumption of raw meat as the main source of EHEC infection, with 
less than 42% of studies identifying animal contact as a source (Kintz et al., 2017).  
 
Another source of EHEC infection is through the consumption of contaminated 
bovine produce such as milk and other unpasteurised dairy products (Armstrong et 
al., 1996). The use of cattle faeces as a fertiliser can also lead to the contamination 
of other produce such as vegetables and unpasteurised fruit drinks (Cody et al., 1999, 
Ackers et al., 1998, Kintz et al., 2019, Gobin et al., 2018). In the USA, surveillance data 
from the Centers for Disease Control and Prevention for the period between 2000 
and 2009 identified leafy greens as the most frequently linked source to outbreaks of 
EHEC O157:H7 among fresh produce (Anderson et al., 2011). In the US, various 
multistate fresh produce associated outbreaks have occurred such as the 2006 
outbreak of EHEC O157:H7 which arose due to the consumption of contaminated 
spinach, consequently causing approximately 200 cases and three deaths (Grant et 
al., 2008, Wendel et al., 2009). The largest recorded outbreak caused by EHEC 
O157:H7 arose in Sakai city, Japan, in 1996 (Michino et al., 1999). During this 
outbreak, more than 7000 were infected, with over 98% of the infected being 
children. The source of the outbreak was identified to be white radish sprouts, 
contaminated with bovine faecal matter containing EHEC O157:H7 (Michino et al., 
1999). Overall, Japan recorded approximately 10,000 EHEC O157:H7 cases that year 
(Watanabe et al., 1999). The largest global outbreak of HUS occurred in 2011, with 
the source of the outbreak being traced to fenugreek seeds contaminated with Stx-
producing EAEC O104:H4 (King et al., 2012).   
 
 
1.3.3 Clinical disease   
 
It has been estimated that the EHEC infectious dose required to cause human illness 
is less than 100 organisms (Tuttle et al., 1999). Typical symptoms of an EHEC infection 
includes gastroenteritis and watery diarrhoea, with vomiting developing in some 
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cases (Holtz et al., 2009). In 60% to 90% of patients, 2 to 3 days after symptoms start 
to appear, diarrhoea becomes bloody, an indication of the development of HC (Holtz 
et al., 2009, Byrne et al., 2015). While most patients recover within 8 days, a subset 
of patients (5 to 15%), develop HUS which arises due to the action of Stx released by 
EHEC (Tarr et al., 2005, Trachtman et al., 2012, Byrne et al., 2015). Interestingly, the 
development of HC and HUS is strongly linked with EHEC strains which produce Stx2a 
over other Stx2 subtypes and Stx1 (Werber et al., 2003, Orth et al., 2007, Kawano et 
al., 2008). 
 
HUS is typically characterised by a triad of ailments: (i) the development of 
haemolytic anaemia, (ii) thrombocytopenia, and (iii) severe kidney injury which can 
result in renal failure (Trachtman et al., 2012). Furthermore, HUS may cause cardiac 
and neurological complications which can lead to coma, seizure and cortical blindness 
(Trachtman et al., 2012). In approximately 5% to 10% of cases, HUS is fatal, usually 
due to neurological complications (Trachtman et al., 2012). Other sequelae include 
hypertension, stroke, gallstone formation and diabetes mellitus (Byrne et al., 2015). 
Furthermore, rectal prolapse, massive lower gastrointestinal tract bleeding, toxic 
megacolon, colonic necrosis and perforation have been reported in children with 
HUS. EHEC induced HUS is the major cause of renal failure in children globally (Tarr 
et al., 2005). 
 
 
1.3.4 Treatment  
 
Antibiotic use during EHEC infection is generally not recommended as it may increase 
the incidence of HUS (Wong et al., 2000, Mor and Ashkenazi, 2014, Smith et al., 
2012). This occurs as EHEC exposure to certain antibiotics activates the SOS-response, 
prompting the activation of the stress-induced Stx-phage lytic cycle, which 
consequently triggers the expression and synthesis of Stx (Waldor and Friedman, 
2005). Various studies have shown an increased risk of developing HUS when patients 
are given antibiotics such as ciprofloxin, fluoroquinolones, trimethroprim-
sulfamethoxazole and furazolidone (Kimmitt et al., 2000, Zhang et al., 2000, 
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McGannon et al., 2010). A study, investigating a cohort of children under 10 years of 
age exhibiting diarrhoea due to infection with EHEC O157: H7, concluded that 
antibiotic treatment increases the risk of HUS (Wong et al., 2000). Nevertheless, a 
systematic review concluded that antibiotics such as fosfomycin, erythromycin and 
rifaximin, which target protein and cell wall synthesis, do not activate the SOS-
response, thus they have been recommended in EHEC infected patients (Agger et al., 
2015). In contrast, antibiotics which affect DNA synthesis such as b-lactams should 
be avoided (Agger et al., 2015). As of late, several EHEC strains, including some 
O157:H7 isolates can harbour antibiotic resistance genes, hence furthering the 
question on whether antibiotic use is appropriate (Um et al., 2018).  
 
Currently, hydration and supportive management are given to HUS patients. 
Administration of intravenous fluids has been shown to prevent electrolyte 
imbalance and reduce the risk of HUS-associated damage (Hickey et al., 2011). 
Platelet and erythrocyte transfusions may also be administered to counter the effects 
of thrombocytopenia and haemolytic anaemia, respectively (Tarr et al., 2005, Mody 
et al., 2015). In cases of renal failure, haemodialysis and peritoneal dialysis are usually 
administered (Rizzoni et al., 1988, Grisaru et al., 2011). Other ways to manage HUS 
include plasma infusion and exchange; and antihypertensive therapy (Rizzoni et al., 
1988, Slavicek et al., 1995, Allford et al., 2003, Van Dyck and Proesmans, 2004). 
Ultimately, such therapies are administered in order to avoid chronic renal damage 
which may require life-long dialysis or renal transplantation.  
 
Currently, a clinical trial is being undertaken to elucidate the benefits of the 
complement protein C5-targeting monoclonal antibody known as Eculizumab 
(ECULISHU, NCT02205541). Eculizumab has been shown to be an effective therapy, 
which helps patients recover from HUS-associated neurological complications 
(Lapeyraque et al., 2011). Eculizumab has been used in patients who developed HUS 
and acute kidney injury during the 2011 EHEC O104:H4 outbreak. However, 
retrospective studies concluded that Eculizumab did not provide greater benefit than 
supportive care or hydration therapy (Kielstein et al., 2012, Loos et al., 2012, Loos et 
al., 2017). Following this, smaller studies have concluded that early treatment should 
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be considered once patients are infected with EHEC, in order to avoid neurological 
complications from arising (Pape et al., 2015, Gitiaux et al., 2013). Another potential 
monoclonal antibody based therapeutic known as Urtoxazumab, targets Stx2 and is 
currently in randomised placebo-controlled studies (Lopez et al., 2010, Moxley et al., 
2017). Stx competitive inhibitors are also being examined and are currently waiting 
to be introduced into clinical trials (Bernedo-Navarro et al., 2014, Li et al., 2016).  
 
Currently, various vaccines are in development, with vaccines which elicit protection 
against the action Stx being developed for human administration and vaccines 
eliciting protection against EHEC colonisation being developed for administration in 
cattle. Vaccine candidates include attenuated bacterium based vaccines made up of 
EHEC mutant strains lacking virulence factors or attenuated bacteria from different 
species such as Salmonella Typhimurium, expressing recombinant EHEC-related 
virulence factors (Liu et al., 2009, Fujii et al., 2012, Oliveira et al., 2012); bacterial 
ghost-based vaccines which consist of EHEC cell envelope preparations lacking 
cytoplasmic contents (Cai et al., 2015); and DNA based vaccines which contain EHEC 
virulence genes (Bentancor et al., 2009, Riquelme-Neira et al., 2015). In addition, the 
use of outer membrane vesicles (OMVs) as a tool to develop EHEC vaccines has been 
explored (Rojas-Lopez et al., 2019). In Rojas-Lopez et al. (2019), inoculation of OMVs 
from E. coli K12 strains expressing EHEC lipid A deacylase into mice, resulted in 
antibodies being generated which recognises this antigen and consequently reduced 
EHEC colonisation.  
 
 
1.4 EHEC pathogenesis  
 
1.4.1 EHEC colonisation 
 
For disease to develop, EHEC colonisation of the gastrointestinal tract is essential. 
Colonoscopy examinations of EHEC infected individuals have shown the development 
of erythema, oedema, inflammation, bleeding and ulceration in the caecum and the 
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ascending colon (Griffin et al., 1990, Shigeno et al., 2002, Kelly et al., 1987). 
Histological examination of biopsies attained from EHEC infected individuals has 
revealed destruction of the surface epithelium and of the lamina propria (Griffin et 
al., 1990), indicating that the integrity of the epithelial barrier is compromised during 
EHEC infection. Due to the potential life-threatening sequalae of EHEC infection, 
human volunteer studies are unethical, therefore animal and in vitro models have 
been used instead.   
 
In gnotobiotic piglets, EHEC infection can cause watery and bloody diarrhoea (Tzipori 
et al., 1986, Francis et al., 1986, Moon et al., 1983), with EHEC colonisation and 
mucosal damage in the caecum and colon (Tzipori et al., 1989). Similar to humans, 
piglets develop renal endothelial damage and complications in the central nervous 
system develop due to the effects of Stx produced by colonising EHEC (Tzipori et al., 
1987, Gunzer et al., 2002, Pohlenz et al., 2005).  
 
Watery diarrhoea also develops in young New Zealand white (NZW) rabbits upon 
EHEC colonisation of the colon (Farmer et al., 1983, Pai et al., 1986, Ritchie et al., 
2003). Similar to the sequelae observed in humans, histological examination of the 
infected colon of NZW rabbits displays haemorrhage, inflammation and cellular 
apoptosis (Potter et al., 1985, Pai et al., 1986). The deletion of genes which encode 
for intimin and translocated intimin receptor (tir) needed for EHEC intimate adhesion 
with host cells (described in more detail in section 1.4.2.1), inhibited colonisation 
(Ritchie et al., 2003). No renal manifestations such as HUS arise upon EHEC 
colonisation in young NZW rabbits due to the lack of Gb3 in the kidneys (Zoja et al., 
1992). Yet, Stx2 has been implicated in increasing the severity and duration of 
intestinal disease in infant NZW rabbits (Ritchie et al., 2003). In contrast, Garcia et al. 
(2006) have demonstrated that infection of EHEC O157:H7 in Dutch Belted (DB) 
rabbit can cause diarrhoea and due to the action of Stx, renal vascular and glomerular 
lesions appear. Indeed, Gb3 homologs have been identified in the kidneys of DB 
rabbits, yet a study which examined EHEC infection in NZW and DB rabbits did not 
identify significant difference of disease outcome with renal pathology not being a 
major feature in DB rabbits (Panda et al., 2010). In addition, while suckling and young 
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rabbits are susceptible to oral administration of EHEC, older rabbits tend to be more 
resistant to EHEC (Keenan et al., 1986, Agin et al., 1996).   
 
In both piglet and rabbit models, EHEC adheres to the intestinal epithelium by 
forming characteristic attaching and effacing (A/E) lesions (Tzipori et al., 1995, Ritchie 
et al., 2003). A/E lesions were first described in piglets following infection with EPEC 
(Staley et al., 1969). As shown in Fig. 1.3, A/E lesions are characterised by the 
presence of intimately adherent bacteria, the loss (effacement) of microvilli and the 
formation of actin-rich pedestals beneath adherent bacterium (Knutton et al., 1989).  
 
The development of A/E lesions by EHEC and EPEC has been demonstrated in various 
cultured cell lines such as cervical HeLa cells and colonic Caco-2 cells (Fig. 1.3). 
Furthermore, to detect actin polymerisation, fluorescent actin staining was initially 
used to detect such lesions and quickly became employed as a standard diagnostic 










Figure 1.3: Transmission electron micrograph showing EHEC A/E lesion on host enterocyte. 
Arrow indicates A/E lesion (Wong et al., 2011). 
 
By using EPEC, the formation of A/E lesions were first demonstrated in human in vitro 
organ culture (IVOC) models (Knutton et al., 1987). Following this, similar studies also 
demonstrated that EHEC could form A/E lesions at the follicle associated epithelium 
(FAE) of Peyer’s patches in the terminal ileum but not at other regions of the small 
intestines and colon (Phillips et al., 2000). Further investigations elucidated that 
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priming EHEC on FAE aided colonic colonisation, yet bound EHEC exhibited a non-
intimate adherence phenotype inconsistent with A/E lesions (Chong et al., 2007). 
With little intimate adherence to the colon, these results did not explain why 
pathology was most pronounced in the colon and why animal studies revealed 
adherence to the large intestine. Interestingly, Lewis et al. (2015), discovered that 
EHEC could in fact colonise the human colon when oxygen levels were lowered in 
IVOC experiments. With this evidence, a model has been proposed where upon 
ingestion, EHEC colonises both the terminal ileum and the colon. 
 
 
1.4.2 Virulence factors of EHEC O157:H7 
 
The ability of EHEC to cause disease is attributed to its genetic makeup. EHEC 
O157:H7 contains three major genetic elements which are associated with the 
development of disease: (i) the locus of enterocyte effacement pathogenicity island 
(LEE PI), (ii) the stx genes found within Stx-encoding bacteriophages and (iii) the 
pO157 plasmid.  
 
 
1.4.2.1 The LEE pathogenicity island  
 
Initial adherence between EHEC and the intestinal epithelium arises through the 
action of various proteins. These include a type four pilus known as haemorrhagic 
coli pilus (Xicohtencatl-Cortes et al., 2007); and other fimbrial and afimbrial adhesins, 
such as the E. coli common pilus, long polar fimbriae, flagellin, E. coli secreted protein 
(Esp) A and outer membrane protein (Omp) A (Rendon et al., 2007, Farfan et al., 
2011, Erdem et al., 2007). There is evidence to suggest that the synthesis of these 
initial adherence proteins is downregulated upon the expression of LEE genes such 
as tir (Mahajan et al., 2009).  
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The ability of EHEC to intimately adhere to the intestinal epithelium and form A/E 
lesion is mainly mediated by genes within the LEE pathogenicity island (PI; Nguyen 
and Sperandio, 2012). PIs are large DNA regions of foreign origin which carry 
virulence genes and are made up of remnants of transposons and phage genes, 
flanked by tRNA genes and regions of direct repeats (Schmidt and Hensel, 2004). The 
LEE PI was first described in EPEC, and all the genes encoded in the EPEC LEE PI are 
also found within the EHEC LEE PI, with a sequence homogeny of 94% (McDaniel et 
al., 1995, Perna et al., 1998). Yet, the EHEC LEE PI is larger than that of EPEC due to 
remnants of a lysogenic bacteriophage being present (Perna et al., 1998). 
Additionally, the LEE PI is also found in Citrobacter rodentium, albeit with a higher 
difference with respect to EPEC and EHEC (Deng et al., 2001, Petty et al., 2010).  
 
The EHEC LEE PI is 35 kb in size and is made up of 41 genes which are arranged across 
five transcriptional units, ordered LEE1 to 5. Encoded within the LEE1 operon, the 
LEE-encoded regulator (Ler) is the global regulator for the transcription of LEE1 to 5 
(Elliott et al., 2000, Mellies et al., 1999). Ler activates the transcription of all the LEE 
operons by antagonising the repressing activity of histone-like nucleotide structuring 
protein. The regulators of Ler known as GrlA (activator) and GrlR (repressor) are 
encoded at the grlRA operon located between the rorf3 gene and the LEE2 operon in 
the LEE (Iyoda et al., 2006). GrlA binds to the LEE1 promoter and positively regulates 
Ler expression. Moreover, Ler can control the grlRA operon, thus forming a positive 
regulatory loop that ensures the appropriate level of Ler for LEE gene expression. 
Furthermore, other non-LEE encoded regulators of Ler exist, such as quorum sensing 
in E. coli (Qse) signalling proteins (described in more detail in section 1.7). The 
regulatory, structural and chaperone components of the type three secretion system 
(TTSS) are encoded in operons LEE1 to 3, with genes encoding for E. coli secreted 
proteins (Esps) making up the LEE4 operon. Genes involved in intimate adherence of 
EHEC such as tir and eae are located in the LEE5 operon (Wong et al., 2011, Elliott et 
al., 1998). 
 
The TTSS encoded in the LEE PI, is a syringe-shaped structure which protrudes from 
the bacterial surface into the eukaryotic cell, with a central channel allowing for 
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protein translocation (Gaytan et al., 2016, Slater et al., 2018). The TTSS is made up of 
three parts: (i) the cytoplasmic components, (ii) the basal body which consists of 
three membrane rings which cross the inner and outer bacterial membrane, and (iii) 
the extracellular translocon, entailing of the translocation pore, filament and needle 
(Slater et al., 2018).  
 
The LEE PI also contains the eae and tir genes which encode for intimin protein and 
the translocated intimin receptor (Tir), respectively. The mechanism by which EHEC 
implements intimate attachment was first discovered by studying how EPEC attaches 
onto HeLa cells (Rosenshine et al., 1992, Kenny et al., 1997, Rosenshine et al., 1996). 
Initial work elucidated that for intimate attachment, EPEC virulence protein intimin 
binds onto a 90 kDa protein (Hp90) expressed on the host surface membrane 
(Rosenshine et al., 1992, Rosenshine et al., 1996). Further investigations deduced 
that Hp90 was actually a protein injected by EPEC through the TTSS (Kenny et al., 
1997). This discovery was the first record of a bacterium injecting its own receptor 
into a host cell. Upon this finding, Hp90 was renamed translocated intimin receptor 
(Tir). Following Tir injection into the host cell, Tir integrates into the host membrane 
and binds to the EPEC outer membrane protein intimin thus achieving intimate 
attachment (Kenny et al., 1997). Further studies have deduced that EHEC achieves 
intimate attachment through a similar mechanism involving Tir translocation and 
intimin binding (Deibel et al., 1998). Binding of Tir to intimin achieves an intimate 
attachment to within 10nm of the host cell membrane for both EPEC and EHEC 
(Deibel et al., 1998, DeVinney et al., 1999, Frankel et al., 2001).  
 
The importance of intimin for in vitro intestinal colonisation has been confirmed in 
neonatal calves, infant rabbits and gnotobiotic piglet models (Kenny et al., 1997, 
Ritchie et al., 2003, Deibel et al., 1998, Dean-Nystrom et al., 1998, Donnenberg et al., 
1993, DeVinney et al., 1999, Ritchie and Waldor, 2005). In addition, IVOC experiments 
using human intestinal biopsies have demonstrated that intimin is essential for EHEC 
A/E lesion formation on human intestinal epithelium (Schüller et al., 2007). IVOC 
studies have identified A/E lesions upon EHEC colonisation, with such models 
regarded as the gold-standard in the study of EHEC adherence. This is because such 
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models contain all of the cell types which make up the intestinal lining and include 
mucus (Phillips et al., 2000, Chong et al., 2007, Schüller et al., 2007, Lewis et al., 
2015). 
 
A characteristic of A/E lesion is the effacement of microvilli around the site of 
bacterial adherence. It is speculated that the loss of microvilli contributes to the 
development of diarrhoea as the loss of cellular surface area reduces the amount of 
nutrients being internalised, consequently increasing the osmolarity of the gut lumen 
(Lai et al., 2011). The mechanism by which microvillus effacement occurs after EHEC 
adherence is not fully understood and requires further study.  
 
The mechanism to explain how the pedestal structures in A/E lesions form was first 
elucidated in EPEC. It was deduced that once the translocated Tir protein is 
phosphorylated by host tyrosine kinases, Nck adaptor proteins are recruited (Kenny, 
1999). Following this, Nck activates the Neural Wiskott-Aldrich syndrome protein (N-
WASP), consequently stimulating actin-related protein-2/3 (ARP 2/3), leading to actin 
reorganisation (Campellone et al., 2002). Unlike EPEC, EHEC Tir is not tyrosine-
phosphorylated and therefore does not recruit NcK for actin pedestal formation 
(Campellone et al., 2002). As shown in Fig 1.4, in order to recruit N-WASP, EHEC 
utilises the non-LEE encoded effector protein EspFu (also known as TccP), which links 
to Tir via the host protein insulin receptor tyrosine kinase substrate, also known as 
the insulin receptor tyrosine kinase substrate p53 (Campellone et al., 2004, 
Garmendia et al., 2004, Vingadassalom et al., 2009). Activation of EspFu recruits N-
WASP which subsequently activates ARP 2/3, consequently rearranging actin and 












Figure 1.4: A/E lesion formation by EHEC. (1) EHEC injects Tir and EspFu into the host through 
the TTSS. (2) Tir localises to the host membrane and binds to intimin to intimately attach EHEC to 
the cell. (3) Tir and EspFu recruits host factors to subvert host cytoskeleton and actin 
polymerisation. IRSp53 = the insulin receptor tyrosine kinase substrate p53, N-WASP = Neural 
Wiskott-Aldrich syndrome protein (Nguyen and Sperandio, 2012).  
 
Whether A/E lesions are associated with actin pedestals in vivo has been a matter of 
debate, since EHEC O157:H7 mutants which lack EspFu have shown impaired actin 
recruitment, yet intimate adherence and microvillus effacement occurs in IVOC 
infections (Garmendia et al., 2004). Furthermore, atypical EPEC which can cause 
diarrhoea can form A/E lesions despite the lack of actin recruitment (Bai et al., 2008), 
thus suggesting that actin recruitment is not needed for the formation of A/E lesions. 
Nevertheless, animal studies have concluded that actin pedestals stabilise adherence 
to the intestinal epithelium as the ability of EspFu EHEC deletion mutants to colonise 
and spread in gnotobiotic piglets and rabbits was reduced, compared to the wild type 
(Ritchie et al., 2008). 
 
It is estimated that EHEC secretes over 60 proteins though its TTSS into host cells 
(Tobe et al., 2006). Many of these effector proteins are encoded within the LEE PI, 
however some proteins are non-LEE encoded (termed Nle proteins). These proteins 
contribute to EHEC colonisation and subsequent development of disease as they 
mimic eukaryotic proteins and consequently subvert cellular function. The 
consequences of such effector proteins include the weakening of tight junctions due 
to the reallocation of occludin away from tight junctions by EspFu (Viswanathan et 
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al., 2004); the modulation of actin and tight junction through the action of EspM 
(Arbeloa et al., 2008, Simovitch et al., 2010); and the inhibition of cell apoptosis by 
NleH and NleD (Newton et al., 2010). For further information on the action of EHEC 
effector proteins in host cells the reviews by Wong et al., (2011) and Pinud et al., 
(2018) are recommended.  
 
 
1.4.2.2 Plasmid mediated virulence factors 
 
EHEC O157:H7 carries a non-conjugative plasmid referred to as pO157 (Burland et al., 
1998). This plasmid contains 100 open reading frames, encoding a type II secretion 
system and various virulence proteins such as pore-forming haemolysin, the zinc 
metalloprotease StcE, the adhesin ToxB, the catalase-peroxidase KatP and serine 
protease EspP which affects colonic epithelial ion and water transport (Schmidt et al., 




1.4.2.3 Shiga toxins 
 
The development of HUS is dependent on the release of Stxs. Stxs belong to the AB5 
toxin family, characterised by the presence of two components: (i) a single 30 kDa ‘A’ 
subunit eliciting the toxin catalytic ability, and (ii) five ‘B’ 7 kDa subunits, which 
mediate binding to host cells (Fraser et al., 2004, Stein et al., 1992, Ling et al., 1998). 
Other members of AB5 toxins include ricin toxin synthesised by the castor oil plant 
Ricinus communis, cholera toxin from Vibrio cholerae and heat labile enterotoxin (LT) 
from ETEC (Odumosu et al., 2010). 
 
Stxs were first described by Kiyochi Shiga, who isolated Stx from Shigella dysenteriae 
type 1 during a dysentery outbreak in 1897 (Shiga, 1898). EHEC can produce two 
structurally and antigenically distinct toxins; Stx1 and Stx2 (O'Brien and LaVeck, 1983, 
 23 
Strockbine et al., 1986, Melton-Celsa, 2014). Stx1 shares a 99% sequence homology 
to Stx synthesised by S. dysenteriae, whereas Stx2 shares a 56% sequence homology 
to Stx1 (Calderwood et al., 1987, Jackson et al., 1987, Takao et al., 1988, Strockbine 
et al., 1988). EHEC can carry either Stx1, Stx2 or both Stx1 and Stx2, yet Stx2 carriage 
is more commonly associated with the development of HUS upon EHEC infection 
(Werber et al., 2003, Orth et al., 2007, Kawano et al., 2008). In addition, several 
variants of Stx1 and Stx2 exists (Stx1a, c and d, and Stx2a to g; Pacheco and Sperandio, 
2012, Melton-Celsa, 2014), with the Stx2a subtype being highly associated with 
severe disease (Karch et al., 2006, Orth et al., 2007). In contrast, EHEC strains which 
synthesise Stx2b and Stx2e do not cause severe symptoms.  
 
 
1.4.2.3.1 Stx prophage 
 
Stx are encoded within lysogenic bacteriophages which are integrated into the EHEC 
chromosome (O'Brien et al., 1984, Schmidt, 2001). Upon entering a bacterial cell, 
lysogenic bacteriophages integrate their genomes into the bacterial chromosome, 
whereby the integrated genomes are known as prophages. When lysogenic 
bacteriophages are silent, prophage replicate along with the bacterial chromosome 
consequently passing the genetic material onto daughter cells (Penadés et al., 2015). 
Stx prophage genes remain silent, due to the action of the cI repressor which binds 
to operator sites (Neely and Friedman, 1998, Waldor and Friedman, 2005). 
 
In Stx2 prophage, upon the exposure of DNA-damaging agents such as hydrogen 
peroxide, UV radiation, mitomycin C and DNA damaging antibiotics, the bacterial 
SOS-response is triggered (Grif et al., 1998, Kimmitt et al., 2000, Osawa et al., 2000, 
Zhang et al., 2000, Aertsen et al., 2005, McGannon et al., 2010, Loś et al., 2010, Zhang 
et al., 2019). This occurs due to the expression and activation of RecA which 
consequently removes the cI repressor upon the initiation of the SOS-response 
(Mühldorfer et al., 1996, Aertsen et al., 2005). This process ultimately results in the 
transcription of Stx as well as phage genes which allow the synthesis of new phage 
particles (Fig 1.5). Upon phage mediated bacterial lysis, bacteriophage particles and 
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Stx are released. In contrast to regulation of Stx2 expression, Stx1 is mainly induced 
by low iron concentrations in the environment. Since this trigger does not initiate the 
expression of late phage lysis genes, bacterial lysis does not occur. Ultimately, Stx1 
accumulates in the periplasm and is released upon activation of the phage lytic cycle 
(Wagner et al., 2002). 
 
Interestingly, both Stx1 and Stx2 have been detected in outer membrane vesicles 
(OMVs), therefore demonstrating that an alternative pathway of Stx release exists, 










Figure 1.5: Regulation of the expression of Stx encoding genes in EHEC. Phage promoter 
transcription is restricted by (i) cI phage repressor activity at pL and pR, and (ii) transcriptional 
terminators. Upon prophage induction, (i) cleavage of cI permits transcription from pL and pR and 
(ii) synthesis of antiterminator proteins N and Q which facilitate transcription instigated at pR and 
pRʹ sites, respectively, by permitting terminator read-through. Both pR and pRʹ promoters, as well 
as the toxin-associated promoter (pStx; encoded in Stx1 prophage only) contribute to stx 
transcription. Phage lysis gene products set a limit on the duration of Stx production and encode 
for new phage particles which causes bacterial lysis and Stx release (Wagner et al., 2002). 
 
 
1.4.2.3.2 Mechanism of Stx cytotoxicity 
 
During HUS, Stx is transported around the body via the vascular system which 
ultimately leads to cell damage in the kidneys and central nervous system. Stx is 
internalised by host cells through the binding of the Stx ‘B’-subunit to glycolipid 
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globotriaosylceramide (Gb3; also known as CD77) which are associated to lipid rafts 
(Falguieres et al., 2006, Lingwood et al., 1987, Waddell et al., 1988, Waddell et al., 
1990). Gb3 is highly expressed in the microvasculature of the kidneys and of the brain 
(Trachtman et al., 2012, Chaisri et al., 2001, Obata et al., 2008, Hagel et al., 2015), 
however Gb3 is also expressed by neuronal cells and various renal cells such as 
podocytes and mesangial cells (Obata et al., 2008, Obrig, 2010). 
 
Interestingly, free Stx has not been detected in blood, but has been found to be 
associated to platelets, monocytes, erythrocytes and polymorphonuclear leukocytes 
(Te Loo et al., 2001, Stahl et al., 2009, Bitzan et al., 1994, van Setten et al., 1996, 
Brigotti et al., 2011). Binding of Stx to the Gb3 receptor expressed in blood cells and 
subsequent Stx internalisation initiates the release of microvesicles (MVs) which can 
contain Stx2 (Stahl et al., 2009, Arvidsson et al., 2015, Ståhl et al., 2011). Indeed, 
patients who have developed HUS have elevated levels of MVs derived from blood 
cell (Ståhl et al., 2015, Arvidsson et al., 2015). The examination of kidney biopsies 
taken from patients who developed HUS and of EHEC infected mice, have detected 
MVs containing Stx (Karpman et al., 2017). Furthermore, it has been demonstrated 
that MVs are internalised by various cells which express and lack Gb3 such as renal 
peritubular capillary endothelial cells and glomerular endothelial (Ståhl et al., 2015). 
Ultimately, cytotoxicity is only exhibited in cells expressing Gb3, with internalised 
MV-associated Stx2 following retrograde transport and inhibiting protein synthesis 
(Johansson et al., 2020).  
 
Neutrophils have also been identified to carry Stx, thus facilitating the distribution of 
Stx around the body (Brigotti et al., 2013). Indeed, Stx association with neutrophils in 
the blood circulation of patients suffering HUS has been detected (Brigotti et al., 
2006). Although neutrophils do not express Gb3, Stx can binds to Toll-like receptor 4 
(TLR4) through the A-subunit of the toxin, therefore allowing the transportation of 
Stx to Gb3 expressing cells (Brigotti et al., 2019). The affinity between Stx and TLR4 is 
lower than that between Gb3 and Stx, hence allowing Stx transferal to Gb3 expressing 
cells (te Loo et al., 2000). In monocytes, this similar binding does not trigger Stx 
internalisation but rather induces the release of pro-inflammatory cytokines which 
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can upregulate the expression of Gb3 in renal epithelial cells (Brigotti et al., 2013, 
Brigotti et al., 2018, Te Loo et al., 2001).  
 
Internalisation of soluble Stx by Gb3-positive target cells arises through clathrin-
dependent and clathrin-independent endocytosis, resulting in Stx internalisation into 
endosomal compartments (Lauvrak et al., 2004, Sandvig et al., 2008, Torgersen et al., 
2005). Nevertheless, the clathrin-dependent pathway is considered to be the most 
common mode of uptake (Bergan et al., 2012). Interestingly, if Gb3 receptors lack 
association with lipid rafts, internalised Stx is trafficked to lysosomal compartments 
and is consequently degraded without any cytotoxic effect (Falguieres et al., 2001). 
This is the reason for the resistance of bovine intestinal Gb3 expressing epithelial cells 
to Stx (Hoey et al., 2003). In Gb3 expressing cells, internalised Stx evades the late 
endocytic pathway and lysosomal degradation by following the retrograde sorting 
pathway by entering the trans-Golgi network (Fig. 1.6). 
 
During retrograde transport, the endoprotease furin, located in the trans-Golgi 
network, cleaves the Stx A-subunit into an enzymatically active A1-fragment (27.5 
kDa) and an A2-fragment (4.5 kDa) which are linked by a disulphide bond (Garred et 
al., 1995, Kurmanova et al., 2007). Reduction of the disulphide bond in the 
endoplasmic reticulum (ER) liberates the A1 fragment which is subsequently released 
into the cytoplasm via the ER-associated degradation pathway (Tam and Lingwood, 
2007, Yu and Haslam, 2005, LaPointe et al., 2005). Due to the absence of lysine 
residues, the A1-fragment avoids ubiquitination and degradation, consequently 
allowing the A1 fragment to exercise its N-glycosidase activity by depurinating a 
conserved adenine residue of 28S ribosomal RNA molecules. This action 
subsequently blocks binding of the elongation factor 2, thus inhibiting protein 
translation and triggering the ribotoxic stress response (Smith et al., 2003, Endo et 
al., 1988, Ogasawara et al., 1988).  
 
The ribotoxic stress response activates mitogen-activated protein kinase (MAPK) 
signalling pathways, which regulates cellular proliferation and apoptosis. Specifically, 
Stx triggers the p38 MAPK pathway, the c-Jun N-terminal pathway and the 
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extracellular signal-regulated kinase pathways, ultimately leading to cell apoptosis 
(Ikeda et al., 2000, Iordanov et al., 1997, Foster and Tesh, 2002, Smith et al., 2003). 
The ribotoxic stress response also leads to production of pro-inflammatory cytokines 
(Thorpe et al., 1999, Cameron et al., 2003, Cherla et al., 2006). Stx also induces 
apoptosis through the activation of caspase 8, subsequently causing the 











Figure 1.6: Intracellular trafficking of soluble Stx. Binding of soluble Stx to Gb3 induces the 
formation of endocytic invaginations. Stx then undergoes retrograde sorting in early endosomes, 
in which retrograde tubules are formed in a clathrin-dependent manner. Stx evades the late 
endocytic pathway and is transferred to the trans-Golgi network (TGN) and, into the ER. The 
active Stx subunit is translocated into the host cell cytosol via the ER-associated degradation 
machinery (Johannes and Romer, 2010). 
 
Despite similar molecular structure and function, the toxicity of Stx1 is more potent 
than that of Stx2 in African green monkey Vero cell models (Fuller et al., 2011, 
Strockbine et al., 1986, Kulkarni et al., 2010). This could be due to the higher binding 
affinity of Stx1 to Gb3 receptor than Stx2 (Nakajima et al., 2001). Nevertheless, 
intravenous administration of soluble Stx has demonstrated that Stx2 is 400 times 
more toxic than Stx1 in murine models (Tesh et al., 1993, Fuller et al., 2011). Similar 
results have also been attained using primate models (Siegler et al., 2003, Stearns-
Kurosawa et al., 2010). Furthermore, Basu et al. (2016), have reported that in mouse 
and human cells, the A1 subunit of Stx2 has a higher affinity for the target ribosomal 
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unit and a higher catalytic activity than Stx1 (Basu et al., 2016). Interestingly, EHEC 
strains which produce Stx2 have been more commonly associated with the 
development of HUS than strains which only produce Stx1 (Werber et al., 2003, Orth 
et al., 2007, Kawano et al., 2008). 
 
 
1.4.2.3.3 Stx translocation across human intestinal epithelium  
 
Upon the release of Stx from EHEC, the human intestinal epithelium represents the 
first point of contact between Stx and the host. As Gb3 is not expressed in human 
intestinal epithelium, it remains unknown how Stx crosses the colonic epithelium and 
enters the vasculature (Schuller et al., 2004). Conversely, the expression of Gb3 is 
associated with cancerous malignancies, with commonly used cell lines such as Caco-
2 and HCT-8 expressing Gb3 (Kovbasnjuk et al., 2005).  
 
Interestingly, studies have shown that colonic T84 cells lack Gb3 yet can internalise 
Stx1 and Stx2 (Schuller et al., 2004, Philpott et al., 1997). Upon internalisation, Stx is 
trafficked to the Golgi apparatus and then to the ER, similar to Stx trafficking in Gb3- 
expressing cells (Philpott et al., 1997, Schuller et al., 2004). Yet, it is speculated that 
Stx translocation from the ER to the cytosol is inhibited as there is no effect of Stx on 
protein synthesis or cell viability in T84 cells upon Stx internalisation (Schuller et al., 
2004). Furthermore, Stx translocation across polarised T84 monolayers has been 
demonstrated without any cytotoxic effect on T84 cells (Philpott et al., 1997, 
Maluykova et al., 2008, Tran et al., 2014, Tran et al., 2018). Macropinocytosis has 
been proposed to explain this phenomenon in T84 cells (Malyukova et al., 2009, 
Maluykova et al., 2008). Furthermore, studies have demonstrated that EHEC can 
stimulate macropinocytosis, with EspP being sufficient to cause actin rearrangement 
and Stx1 transcytosis (Lukyanenko et al., 2011, In et al., 2013). Yet different 
investigations have shown that incubation with macropinocytosis inhibitors do not 
decrease the level of Stx2 translocation across polarised T84 cell monolayers 
suggesting an alternative route of Stx internalisation by Gb3 negative cells (Tran et 
al., 2014).  
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Another proposed route to explain how Stx translocation across the epithelium 
occurs is via a paracellular pathway. Due to the actions of effector proteins (such as 
EspF and EspFu) EHEC infection leads to the disruption of tight junctions in T84 cells 
(Viswanathan et al., 2004, Philpott et al., 1997). However, no difference in Stx 
translocation has been observed when polarised T84 cells are exposed to soluble Stx 
with or without EHEC infection (Philpott et al., 1997). A prominent feature of EHEC 
infection is the infiltration of neutrophils at the site of infection (Slutsker et al., 1997, 
Bielaszewska and Karch, 2005). Furthermore, in vitro studies have demonstrated that 
neutrophil transmigration across polarised T84 cell monolayers can occur during 
EHEC infection (Hurley et al., 2001). As Hurley et al. (2001) demonstrated an increase 
in Stx1 translocation across epithelial barriers upon EHEC infection and neutrophil 
transmigration, it is postulated that neutrophil transmigration opens a path for free 
Stx to translocate into the vascular system.  
 
Currently, there is no consensus on the mechanism by which Stx crosses the intestinal 
epithelial barrier for subsequent spread in the host. Nevertheless, another proposed 
route that has recently gained attention, stems from findings of Stx released within 
EHEC outer membrane vesicles (OMVs; Kolling and Matthews, 1999). Thus, OMVs 




1.5 Outer membrane vesicles 
 
The secretion of membrane vesicles is conserved throughout all the domains of life 
(Deatherage and Cookson, 2012). In bacteria, both Gram-negative and Gram-positive 
bacteria are known to secrete vesicles. Due to the structural differences of the cell 
envelope between Gram-negative and Gram-positive bacteria, the nature of the 
vesicles between the two groups differs. For gram-positives, such vesicles have been 
dubbed “membrane vesicles”, whereas for gram-negatives the term “outer 
membrane vesicles” (OMVs) is used (Brown et al., 2015).  
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In 1965, secreted lipopolysaccharide complexes were first identified in cell-free 
supernatants after E. coli cultures were grown in lysine-limiting medium (Bishop and 
Work, 1965). Following this, such complexes were visualised by electron microscopy, 
both in free medium suspensions and associated with bacterial cells (Work et al., 
1966, Knox et al., 1966). Originally thought to be only produced under nutrient-
limiting conditions only, it is now accepted that many Gram-negative bacteria 
continuously produce such complexes which are now termed OMVs (Hoekstra et al., 
1976, Beveridge, 1999). OMVs were first isolated from humans in 1982 during the 
examination of cerebrospinal fluid of a child infected with Neisseria meningitidis and 
since then the role of OMVs in bacterial infection has been investigated (Stephens et 
al., 1982). 
 
OMVs are spherical bi-layered membrane structures, typically 50 to 250nm in 
diameter, and are made up of components from the outer membrane of the parental 
bacterium such as phospholipids, proteins and lipopolysaccharide (LPS; Mashburn-
Warren and Whiteley, 2006). OMVs are constitutively released by Gram-negatives, 
however, external stresses such as amino acid limitations, the presence of antibiotics 
and high temperatures can lead to higher OMV release (Sampath et al., 2018, 
Bauwens et al., 2017a, McBroom and Kuehn, 2007). Additionally, the components 
encapsulated within OMVs can change upon exposure to different environmental 
stimuli, thus allowing OMVs to participate in many roles which can aid in the survival 
of the parental bacterium (McBroom and Kuehn, 2007, Manning and Kuehn, 2011, 
Urashima et al., 2017, Lindholm et al., 2020, Augustyniak et al., 2018, Li et al., 1998, 
Ciofu et al., 2000, Schaar et al., 2014).  
 
In the past, there has been confusion in the literature, as some studies have used the 
term “OMVs” to refer to entities artificially formed by detergent treatment of 
bacterial cells (Ferrari et al., 2006, van de Waterbeemd et al., 2010). In this 
investigation, the term “OMVs” will be used only to refer to the naturally produced 




1.5.1 OMV biogenesis  
 
Since OMVs originate through a bulging out and pinching off process from the outer 
membrane (OM), it is understood that portions of the OM need to be released from 
the underlying peptidoglycan structure. Accordingly, to understand how OMVs form, 
the structure of the Gram-negative cell wall needs to be considered.  
 
The cell wall of Gram-negative bacteria consists of two membrane bilayers known as 
the cytoplasmic membrane and the outer membrane. The space between the two 
membrane bilayers is termed the periplasm which contains the peptidoglycan, 
several proteins, and various crosslinks which maintain the stability of the cell wall 
(Fig. 1.7). Such crosslinks include: (i) the covalent crosslinks between the OM-
anchored lipoprotein (Lpp) with the peptidoglycan; (ii) the non-covalent interaction 
between the outer membrane protein (Omp) A and the peptidoglycan; and (iii) the 
non-covalent interaction between the Tol-Pal complex (which spans from the OM 
across the periplasm to the cytoplasmic membrane) and the peptidoglycan (Braun 
and Bosch, 1972, Wang, 2002, Cascales et al., 2002, Braun and Sieglin, 1970, Koebnik, 
1995, Parsons et al., 2006).  
 
It is apparent that several mechanisms exist for the biogenesis of OMVs including: (i) 
the loss of covalent linkages between the OM and the peptidoglycan; (ii) alterations 
in the periplasmic space; and (iii) the supplementation of membrane curvature-
inducing molecules (Schwechheimer et al., 2014, Schwechheimer et al., 2015, 










Figure 1.7: The Gram-negative cell wall. The two bilayers (i) the cytoplasmic membrane and (ii) 
the outer membrane (OM), form a space known as the periplasm, where the peptidoglycan (PG) 
is situated. The PG is made up of alternating units of N-acetylglucosamine and N-acetylmuramic 
acid. Attached to the N-acetylmuramic acid is a peptide chain of three to five amino acids. Cross-
linking between amino acids in different linear amino sugar chains occurs. The OM is anchored 
by proteins which are embedded in both PG such as OmpA and Lpp and the cytoplasmic (inner) 
membrane by the Tol-Pal system made up of TolA, TolB, TolQ, TolR and Pal. Other proteins can 
also be found embedded on both cytoplasmic and outer membrane (Schwechheimer and Kuehn, 
2015).  
 
In the first proposed mechanism, the loss of the OM-anchoring proteins in the 
peptidoglycan leads to the formation of OMVs. The links between the OM and the 
peptidoglycan are dynamic, with an equilibrium of links forming and breaking (Braun 
and Bosch, 1972). Studies on E. coli and Salmonella Typhimurium mutants have 
shown that the loss of anchoring proteins such as Lpp, OmpA and the Tol-Pal system 
leads to increased OMV production (Bernadac et al., 1998, McBroom et al., 2006, 
Deatherage et al., 2009, Turner et al., 2015). Additionally, if robust crosslinks 
between the peptidoglycan and anchoring proteins do not form, due to altered 
equilibrium of peptidoglycan breakdown and synthesis, OMV production increases 
(Schwechheimer et al., 2014, Schwechheimer et al., 2015).  
 
In the second proposed model, fragments from the peptidoglycan, LPS and misfolded 
proteins have been shown to accumulate in nanoterritories found within the 
periplasm (McBroom and Kuehn, 2007, Schwechheimer et al., 2013, Schwechheimer 
 33 
et al., 2014). This in turn increases periplasmic turgor pressure on the OM causing 
the OM to bulge and pinch off, thus forming an OMV. 
 
The third model suggests that OMVs are induced by molecules which cause the 
membrane to become enriched with membrane curvature-inducing molecules such 
as Pseudomonas quinolone signal (PQS). Upon PQS association with the LPS at the 
lipid A region, PQS spreads within the outer leaflet of the OM. Consequently, this 
causes the membrane to bulge out leading to increased curvature and OMV 
formation (Schertzer and Whiteley, 2012). It is thought that the same mechanism is 
employed when bacteria are exposed to antibiotics causing membrane perturbations 
such as gentamicin and colistin, as studies show an increase in OMV production after 
antibiotic exposure (Manning and Kuehn, 2011).  
 
Even though these are currently accepted models, other alternative mechanisms may 
also be possible. Promotion of OMV production by the action of flagella rotating has 
been suggested as a novel mechanism (Aschtgen et al., 2016). Some bacteria such as 
Vibrio fischeri and Vibrio cholerae, have flagella which are surrounded by an OM-
derived sheath (Brennan et al., 2014). Blebs have frequently been observed on such 
flagella and studies have found that OMVs are released when flagella rotate. The 
molecular mechanism linking flagella rotation and OMV release remains to be 
elucidated, however given that other pathogens such as Helicobacter and Brucella 
also express such sheathed flagella, it is of interest to study whether similar 
mechanisms arise in different bacterial species (Fretin et al., 2005, Luke and Penn, 
1995).  
 
A caveat of most of the aforementioned methods is that they have so far only been 
described within specific bacterial species. Indeed, it may be possible that Gram-
negative bacteria may use more than one mechanism for OMV biogenesis, yet a 
potential conserved mechanism for OMV biogenesis has been proposed. Roier et al. 
(2016) has suggested that OMV synthesis is mediated by the maintenance of lipid 
asymmetry (MLA) pathway which is highly conserved among Gram-negative bacteria 
including E. coli, V. cholerae and Haemophilus influenza. This pathway has a role in 
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the retrograde trafficking of phospholipids from the outer leaflet of the OM to the 
inner membrane, thus maintaining OM asymmetry. The pathway involves an inner 
membrane ATP binding cassette transporter. Downregulation or mutations of genes 
which encode for this transporter lead to an accumulation of curvature-inducing 
phospholipids on the outer leaflet of the OM, ultimately leading to the bulging of the 
OM and its eventual budding, resulting in OMVs. Roier et al. (2016) has also 
demonstrated that genes involved in this pathway are downregulated upon low iron 
conditions, suggesting that the environment can influence OMV production (Roier et 
al., 2016). Furthermore, it has been determined that the bile salt sodium 
taurocholate can downregulate genes which regulate this pathway in Campylobacter 
jejuni, resulting in increased OMV production. This suggests that host gut signals can 
influence the expression of the MLA pathway, subsequently resulting in increased 
OMV synthesis. 
 
To date, it is still not clear what mechanism is utilised to ensure the packaging of 
proteins and genetic materials during OMV biogenesis, or whether they have been 
‘accidently’ packaged as a result of OMV synthesis. Since OMVs have been implicated 
with various roles which aid the survival of parental bacteria, active packaging may 
indeed occur in a yet unknown process.  
 
 
1.5.2 Biological functions of OMVs 
 
The molecular content of OMVs is diverse and is either encapsulated within the OMV 
lumen or incorporated in the OMV membrane bilayer. OMVs permit the secretion 
and delivery of bacterial cargo ensuring bacterial survival and long-distance 
distribution of bacterial products into the environment.  Generally, OMVs are known 
to be involved in various processes such as horizontal gene transfer, interspecies 
communication, interbacterial killing, nutrient acquisition, biofilm formation, 
protection against antimicrobial products and internal stresses, and the 
transportation of virulence factors into eukaryotic cells.  
 
 35 
1.5.2.1 Internal stress protection 
 
Bacterial treatment with denaturing agents or heat shock can lead to the 
accumulation of misfolded proteins in the periplasmic space. Although bacterial 
proteases help remove such misfolded proteins, and insoluble proteins maybe 
sequestered into periplasmic inclusion bodies, misfolded proteins can be exported 
via the vesiculation of the OM (McBroom and Kuehn, 2007). It is due to the 
accumulation of proteins in the periplasmic space that physical stress on the OM 
causes an outward force resulting in OMV release.  
 
 
1.5.2.2 Interspecies communication 
 
The ability of bacteria to sense the presence of other bacteria in the environment is 
mediated by quorum sensing. This allows bacterial populations to adjust their 
behaviour in reaction to cellular density (Papenfort and Bassler, 2016). P. aeruginosa 
has been the model organism to study quorum sensing, and studies have identified 
that 5% of the organism’s genome is directly regulated by quorum sensing (Hentzer 
et al., 2003, Schuster et al., 2003, Wagner et al., 2003, Déziel et al., 2005). The 
Pseudomonas Quinolone Signal (PQS) is one of the main signalling molecules involved 
in quorum sensing and has been detected in the membrane of OMVs produced by P. 
aeruginosa (Wagner et al., 2003). Since PQS molecules are hydrophobic, interaction 
with OMVs allows for distant transportation to other P. aeruginosa cells. In addition, 
as P. aeruginosa naturally exists in a polymicrobial environment, OMVs prevent the 
degradation of PQS by other bacteria, thus allowing for interspecies communication. 
Indeed, OMV formation in P. aeruginosa is dependent on PQS, thus demonstrating 
the importance of the interaction between PQS and OMVs in P. aeruginosa 
(Mashburn and Whiteley, 2005). Similar quorum sensing molecules have been 
identified in other bacteria such as in Vibrio harveyi which uses Cholera autoinducer-
1, which are encapsulated in OMV, subsequently allowing communication in aqueous 
environments (Brameyer et al., 2018). 
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1.5.2.3 Bacterial killing  
 
In nature, bacterial species compete against each other for nutrients and several 
species have developed ways to kill competing species via the production of OMVs 
containing anti-microbial effectors.  
 
A momentous study in 1998 showed that OMVs isolated from 15 different bacterial 
species including E. coli, Pseudomonas, Salmonella, Shigella and Klebsiella possessed 
interbacterial killing capabilities via the action of peptidoglycan hydrolases 
encapsulated within OMVs (Li et al., 1998). Incubation of OMVs with different 
bacterial species displayed killing, with OMVs isolated from P. aeruginosa exhibiting 
the deadliest activity probably due to the presence of murein hydrolase and PQS 
which has peptidoglycan degradation abilities and bactericidal activity, respectively 
(Li et al., 1998).  
 
In a different study, OMVs isolated from Lysobacter capsici were identified to carry 
bacteriolytic enzymes (Afoshin et al., 2020). Incubation of such OMVs with different 
bacterial species resulted in bacterial lysis. In order to have bacteriolytic effects, it is 
speculated that a fusion reaction between OMVs and the target bacterium is needed 
to deliver the bacteriolytic enzyme and cause lysis.  
 
The antimicrobial abilities of OMVs are also thought to contribute to nutrient 
acquisition as lysed bacteria provide an extra nutritional source and decrease 
competition for nutrients in the environment. Such activity has been associated with 
OMVs released by Myxococcus xanthus, which contain phosphatases, proteases and 
secondary metabolites with antibiotic activities. These OMVs are thought to fuse with 
the OM of E. coli, which results in lysis and the release of phosphate and other 
nutrients, thus promoting the growth of M. xanthus (Evans et al., 2012, Whitworth, 
2011). OMVs from the myxobacteria species Cystobacter velatus have also exhibited 
antimicrobial effects on E. coli due to the encapsulation of cystobactamid antibiotics 
(Schulz et al., 2018). Interestingly, since such bacteria are non-pathogenic 
environmental isolates, they have no endotoxin activity and low inflammatory 
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responses arise when added to human intestinal cells (Schulz et al., 2018). Therefore, 
the use of such OMVs provides a novel avenue for hypothetical substitute remedies 
for E. coli infections. 
 
 
1.5.2.4 Nutrient acquisition  
 
In addition to freeing nutrients via bacterial lysis, OMVs can also harbour enzymes 
which degrade molecular compounds in the surrounding environment for nutritional 
benefits. Hydrolytic and carbohydrate-binding proteins have been identified on 
OMVs isolated from the gut commensal bacteria Bacteroides fragilis and Bacteroides 
thetaiotaomicron, which mediates polysaccharide degradation. The resulting 
metabolites can be consumed by other bacterial species in the gut microbiota 
(Rakoff-Nahoum et al., 2014).  
 
A similar nutritional role has been demonstrated for OMVs produced by pathogenic 
Borrelia burgdorferi. Such OMVs carry enolase which catalyses the degradation of 
host matrix proteins and thereby provides a nutritional benefit for colonising B. 
burgdorferi (Toledo et al., 2012).  
 
Furthermore, OMVs from various species have been identified to be involved in iron 
acquisition. Iron limitation is a common external stressor for colonising pathogens, 
and iron depletion has been associated with increased OMV production in 
Helicobacter pylori, E. coli and V. cholerae (Roier et al., 2016, Keenan and Allardyce, 
2000). Indeed, siderophores, haem-scavenging proteins and haem acquisition 
systems have been identified in OMVs released by pathogens such as N. meningitidis 
and Porphyromonas gingivalis (Veith et al., 2014, Lappann et al., 2013). While these 
results suggest OMVs can capture iron, evidence on whether OMVs can be delivered 




1.5.2.5 Biofilm formation  
 
Biofilms are microbial growths which are bound by a multifaceted matrix consisting 
of exopolysaccharides, DNA and proteins. Biofilms can form on both biological and 
non-biological surfaces, allowing bacterial populations to resist and grow in stressful 
environments (Hall-Stoodley et al., 2004). Analysis of biofilms produced by P. 
aeruginosa and H. pylori have identified the presence of OMVs, suggesting OMVs 
contribute to the development and integrity of biofilms (Beveridge, 1999). 
 
Investigations using OMVs from H. pylori found that the addition of purified OMVs to 
growing biofilms conferred the production of thicker biofilms, thus providing 
resistance against external stresses (Yonezawa et al., 2009, Yonezawa et al., 2011). It 
is suggested that OMVs may act as a platform which allow exopolysaccharides, 
proteins and extracellular DNA to interact and adhere to surfaces thus enabling 
biofilms to form (Schooling and Beveridge, 2006). Indeed, studies have shown that 
weak biofilms are produced by bacterial strains which have a low OMV vesiculation 
rate (Yonezawa et al., 2009).  
 
 
1.5.2.6 Protection against lysis 
 
OMVs increase the survival of bacterial populations, as OMVs can act as decoy targets 
against antimicrobial peptides and bacteriophages (Manning and Kuehn, 2011). 
OMVs isolated from E. coli have demonstrated the ability to sequester membrane-
targeting antibiotics such as colistin and polymyxin B, resulting in OMV 
permeabilization and protection of growing E. coli populations and other bacterial 
species including P. aeruginosa (Kulkarni et al., 2015, Manning and Kuehn, 2011). 
EHEC OMVs have also been implicated with sequestering human antibacterial 
peptide cathelicidin LL-37, thus protecting EHEC populations from its lethal effects 
(Urashima et al., 2017).  
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OMVs can also contain antibiotic degrading enzymes which confer a further 
defensive strategy against antibiotics. Evidence of such enzymes first emerged from 
OMVs isolated from clinical isolates of P. aeruginosa containing β-lactamases (Ciofu 
et al., 2000). Notably, OMVs containing β-lactamases not only provide protection to 
the producing organism but also to nearby bacteria from a different species (Schaar 
et al., 2011, Schaar et al., 2014). Furthermore, OMVs produced by the gut commensal 
B. thetaiotaomicron, can contain β-lactamases which confers protection against third 
generation cephalosporins to other commensal and pathogenic bacteria such as 
Salmonella Typhimurium (Stentz et al., 2015).  
 
In addition to antimicrobials, it has been suggested that OMVs can also sequester and 
inactivate bacteriophage particles, preventing bacterial cell damage. This ability has 
been demonstrated by OMVs isolated from E. coli cultures which sequester T4 
bacteriophage thus inhibiting infection (Manning and Kuehn, 2011). Furthermore, 
OMVs isolated from Moraxella catarrhalis, Neisseria gonorrhoeae, P. gingivalis and 
Aggregatibacter actinomycetemcomitans have shown to aid bacterial serum 
resistance by sequestering components of the immune system such as antibodies 
and components of the complement system (Roszkowiak et al., 2019, Augustyniak et 
al., 2018, Lindholm et al., 2020, Pettit and Judd, 1992, Grenier and Bélanger, 1991). 
 
 
1.5.2.7 Horizontal gene transfer 
 
The main mechanisms for horizontal gene transfer among bacteria are 
transformation, conjugation and transduction (Thomas and Nielsen, 2005). Yet, 
studies have shown that OMVs often contain DNA and provide an addition 
mechanism to transfer genetic material. Nucleic acid may be bound to OMVs by 
electrostatic interaction with LPS or encapsulated within the vesicle lumen (Dorward 
and Garon, 1990). However, the mechanism by which DNA becomes associated with 
OMVs remains to be deduced.  
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Previous studies have demonstrated that horizontal transfer of antibiotic resistance 
genes can occur via OMVs. Experiments using OMVs from Acinetobacter baumannii 
containing the blaOXA-24 gene which encodes for β-lactamases conferred carbapenem 
resistance to susceptible strains of the same species (Rumbo et al., 2011). In a 
different study, incubation of OMVs derived from EHEC O157:H7 strains harbouring 
chromosomal and plasmid DNA with E. coli K12 led to vesicle-mediated transferal of 
virulence genes such as stx2 and hlyCA (which encodes for haemolysin), as well as 
antibiotic resistance (Yaron et al., 2000). In addition, the multidrug resistant E. coli 
O104:H4 strain which caused the large German outbreak in 2011, has been shown to 
transfer genes encoding extended spectrum β-lactamases to different 
Enterobacteriaceae species via OMVs (Bielaszewska et al., 2020). Remarkably, OMV-
mediated genetic transfer was increased under simulated intestinal conditions, 
suggesting that resistance transfer by OMVs is likely to occur in the human intestines.  
 
 
1.5.2.8 Transport of virulence factors 
 
In addition to traditional bacterial secretion systems (such as the TTSS in EHEC), 
OMVs can also mediate the release of bacterial virulence factors. This pathway 
ensures transportation of virulence factors over long distances and simultaneous 
protection from the host environment and the immune response. Upon interaction 
with target cells, OMV entry is mediated by endocytosis, but the specific mechanism 
of uptake is host and species-specific (O'Donoghue and Krachler, 2016).  
 
OMV internalisation can occur through lipid raft mediated endocytosis. Lipid rafts are 
eukaryotic cell membrane domains enriched with cholesterol and sphingolipids 
which form a compact region in the membrane and allows cell membrane 
invaginations to occur (Simons and Sampaio, 2011). This pathway is utilised by OMVs 
from H. pylori which contain various virulence factors such as the cytotoxin VacA 
(Ricci et al., 2005, Kaparakis et al., 2010). Upon OMV internalisation into host cells, 
VacA is released, inducing cell vacuolation and death (Parker et al., 2010, Olofsson et 
al., 2014). Similarly, OMVs from P. gingivalis also use lipid raft-associated endocytosis 
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to enter host cells and cause cell damage due to the action of released gingipains and 
fimbriae (Furuta et al., 2009).  
 
Lipid rafts may be associated with caveolae, which in turn allows caveolin-mediated 
endocytosis. Caveolae are made up of caveolin and dynamin proteins, and form 
‘cave-shaped’ invaginations on the cell membrane (Rewatkar et al., 2015). V. 
cholerae produces cholera toxin which can induce diarrhoea by activating adenylate 
cyclase which increases cyclic AMP (cAMP) and leads to water and chloride ion efflux 
into the intestinal lumen. Although cholera toxin can be secreted in its soluble form, 
the majority of the toxin is secreted within OMVs and enters host cells via caveolin-
mediated endocytosis (Chatterjee and Chaudhuri, 2011). OMVs produced by ETEC 
are also internalised by host cells through this pathway. ETEC produces heat-stable 
and heat-labile enterotoxin (LT) which affect colonocytes by inducing electrolyte and 
water loss leading to diarrhoea. Interestingly, LT can be localised within and on the 
surface of ETEC OMVs, and in turn mediates OMV uptake by binding to the 
ganglioside receptor GM1 (Kesty et al., 2004, Horstman and Kuehn, 2000). The 
pathogenic function of ETEC OMVs during infection is reinforced by their amplified 
production in vivo and their capability to induce immune responses against OMV-
associated LT and other virulence factors (Roy et al., 2011).  
 
Despite the structural difference, OMVs may directly fuse with the host cell 
membrane and release their content. OMVs from P. aeruginosa and A. 
actinomycetemcomitans use this method to enter cells and release cystic fibrosis 
transmembrane conductance regulator inhibitory factor (Cif) toxin and cytolethal 
distending toxin (CDT), respectively (Bomberger et al., 2009, Rompikuntal et al., 
2012). Cif toxin promotes the degradation of the cystic fibrosis transmembrane 
conductance regulator, subsequently diminishing mucociliary clearance and allowing 
infection establishment. Alternatively, CDT is a genotoxin which targets host DNA and 
induces G2 cell cycle arrest and apoptosis.  
 
In addition to the entry routes described above, the eukaryotic membrane may also 
contain receptors located on clathrin-coated pits (Vercauteren et al., 2010). 
 42 
Internalisation is triggered by ligand binding to the cell surface receptors, leading to 
invaginations at these pits and the formation of clathrin-coated vesicles (Rewatkar et 
al., 2015). Although, the receptors which trigger internalisation are not yet known, it 
is speculated that they differ between bacterial species. Interestingly, as well as 
through lipid-raft associated endocytosis, OMVs from H. pylori can also be 
internalised by clathrin-dependent endocytosis. H. pylori OMVs may utilise different 
endocytic routes due to different OMV compositions between strains and between 
different external pressures (Parker et al., 2010), yet OMV size may also influence the 
method of internalisation (Turner et al., 2018). OMVs produced by Brucella abortus 
contain various outer membrane proteins, with immunomodulatory effects and are 
internalised by host cells via clathrin-dependent endocytosis. Entry into human 
monocytes causes the downregulation of proinflammatory cytokine production and 
reduced expression of MHC- class II which results in bacterial immune evasion and 
the attenuation of T-helper cell-mediated immune responses against Brucella-
infected cells, therefore allowing bacterial persistence within the host (Pollak et al., 
2012). Notably, clathrin-dependent endocytosis is also employed for OMV-mediated 
transfer of EHEC virulence factors into host cells, described in more detail below 
(Bielaszewska et al., 2013, Bielaszewska et al., 2017).  
 
 
1.6 OMV production by EHEC 
 
EHEC OMV production was first demonstrated by electron microscopy in 1999 (Fig. 
1.8; Kolling and Matthews, 1999). Several OMV-associated virulence factors have 
been identified including Stx1, Stx2, haemolysin, cytolethal distending toxin V, 
Shigella enterotoxin, flagella and LPS, as well as genetic material encoding for Stx 
(Bielaszewska et al., 2013, Bielaszewska et al., 2017, Kim et al., 2010, Kolling and 
Matthews, 1999, Kunsmann et al., 2015). Stx1 and Stx2 are exclusively localised 
within the OMV lumen as verified by protease K treatment and electron microscopy 
(Kolling and Matthews, 1999, Bielaszewska et al., 2017).  
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Figure 1.8: Transmission electron micrograph of OMV production by EHEC O157:H7. (A) 
Ultrathin sections show vesicles blebbing from the bacterial outer membrane. The inset is an 
enlargement of the enclosed area, bar = 50 nm. (B) Negatively stained vesicle preparations. 
Arrowheads indicate individual vesicles, bar = 250 nm (Kolling and Matthews, 1999).  
 
The cytotoxic activity of OMV-associated Stxs has been confirmed using Gb3 
expressing Vero cells, with loss in cytotoxicity when cells are incubated with OMVs 
from isogenic Dstx mutants (Kim et al., 2010). Furthermore, mouse model studies 
have demonstrated that EHEC O157:H7 OMVs can cause HUS-like disease such as 
renal cell damage after intraperitoneal injection, showing their possible involvement 
in the development of severe disease in humans (Kim et al., 2011).   
 
Previous studies have demonstrated that OMVs from EHEC O157:H7 and Stx-
producing EAEC O104:H4 are internalised by clathrin-mediated endocytosis by Gb3-
positive human colonic Caco-2 cells and by microvasculature endothelial cells of the 
brain and of the kidneys (Kunsmann et al., 2015, Bielaszewska et al., 2017). While 
OMVs are trafficked along the endosomal-lysosomal pathway, Stx2 is released from 
OMVs due to a change to an acidic pH level in the early endosome. Similar to soluble 
Stx, once freed from OMVs, Stx is retrogradely trafficked via the Golgi apparatus and 
ER, consequently causing cell death (Bielaszewska et al., 2017).  
 
Whether OMV internalisation and similar trafficking occurs in the colon remains to 
be deduced as it is generally accepted that the human intestinal epithelium lacks Gb3. 
Therefore, the use of Gb3-positive cells is arguably an inappropriate model to study 
the fate of OMVs and their associated Stx in the human colon. Further studies are 
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needed to truly elucidate whether EHEC OMVs are internalised by the human colonic 
epithelium. Moreover, the intracellular trafficking and fundamental destination of 
EHEC OMVs needs to be clarified as it may be possible that OMVs translocate across 
the intestinal barrier, consequently allowing the trafficking of virulence factors such 
as Stx and contribute to EHEC disease.  
 
Various external cues can affect the vesiculation of EHEC OMVs such as exposure to 
antibiotics. As previously mentioned, antibiotic therapy during EHEC infection is not 
recommended due to the induction of Stx phage lytic cycles and enhanced HUS risk 
(Wong et al., 2000, Smith et al., 2012, Mor and Ashkenazi, 2014). Similarly, exposure 
to antibiotics which trigger an SOS-response (e.g., ciprofloxacin) increases OMV 
production and Stx2a content in EHEC O157:H7 (Bauwens et al., 2017a).  Moreover, 
environmental conditions in the gastrointestinal tract can also influence OMV 
production (discussed in more detail in section 1.7.8).  
 
 
1.7 The effect of the intestinal environment on EHEC virulence  
 
The human gastrointestinal tract encompasses several organs, including the 
oropharynx, the oesophagus, the stomach, the small intestine (duodenum, jejunum 
and ileum) and the large intestine (caecum, colon, rectum and anus; Gelberg, 2014). 
The intestinal lumen contains fluid, which is made up of various components secreted 
by cells which line the tract or by cells in accessory organs of the gastrointestinal 
system such as the gallbladder. The composition and environment of the gastric fluid 
varies during transit in the gastrointestinal tract. EHEC therefore needs to adapt to 
the various stresses (such as changes in pH, the presence of different bile salts and 
varying oxygen concentrations) encountered in the gastrointestinal tract in order to 
survive and colonise. To this aim, EHEC can sense various signals present in different 
regions of the gastrointestinal tract which can influence the expression of virulence 
genes and enable successful colonisation of EHEC.   
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1.7.1 Gastrointestinal pH levels 
 
Due to gastric acid secretion, the stomach is characterised by a low pH of 1.5 to a pH 
6.5 (Broesder et al., 2020). E. coli possesses five acid resistance (AR) pathways (AR1 
to AR5). The AR1 system uses the alternative σ factor and cAMP receptor protein 
(CRP), which provide an acid adaption and tolerance response, thus permitting the 
survival of EHEC in low pH (pH 2.5) that can be induced by growth in complex medium 
(Castanie-Cornet et al., 1999, Lin et al., 1995). The AR1 system is repressed by glucose 
due to the involvement of CRP. The mechanism by which these proteins instigate 
resistance is not fully known (Castanie-Cornet et al., 1999). The AR2 - AR5 systems 
are reliant on specific extracellular amino acid (glutamate, arginine, lysine and 
ornithine, respectively) and consist of an antiporter and a decarboxylase enzyme 
(Richard and Foster, 2004, Lund et al., 2014, Castanie-Cornet et al., 1999, Hersh et 
al., 1996, De Biase et al., 1999). These systems confer acid resistance by consuming 
intracellular protons through amino acid-dependent decarboxylation reactions, 
therefore neutralising internal bacterial pH (House et al., 2009). All systems can 
protect stationary phase cells from extreme acidity and prolong survival, however 
AR2 and AR3 have been reported to also function during the exponential phase 
(Castanie-Cornet et al., 1999, Richard and Foster, 2004). Recently, a new acid-
tolerant system has been described, known as the CpxRA acid-tolerant system. Upon 
the detection of acidic pH, this acid-tolerant system, activates the synthesis of 
unsaturated fatty acids. Augmented unsaturated fatty acid content in the cell 
membrane lipid, decreases membrane fluidity, therefore inhibiting the flow of 
protons into bacterial cells. This maintains optimum intracellular pH, thus allowing 
the normal growth of E. coli (Xu et al., 2020).  
 
EHEC also possesses two periplasmic heat shock proteins, HdeA and HdeB, which are 
activated and become molecular chaperones under acidic conditions (Gajiwala and 
Burley, 2000). These activated chaperones bind to a range of polypeptides and 
prevent aggregation thus protecting such proteins from acidic pH levels as low as 2.5 
(Benjamin and Datta, 1995, Lin et al., 1996).  
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Studies which have evaluated the gene expression profiles of EHEC O157:H7 strains 
after enduring acidic stress, revealed expression changes in genes involved in motility 
and the TTSS (House et al., 2009). In acid stressed EHEC, flagella synthesis genes are 
upregulated and is accompanied with increased motility levels (House et al., 2009). 
In contrast, genes associated with the TTSS are downregulated, indicating that 
through a sensory mechanism, EHEC does not colonise in the stomach but rather 
moves onto the neutral gastrointestinal tract (House et al., 2009). The 
downregulation of LEE genes under acidic pH is mediated by the increased expression 
of the regulator GadE (Kailasan Vanaja et al., 2009, Laaberki et al., 2006). GadE also 
activates the glutamate decarboxylate-dependent acid resistance system, thus it acts 
as link between acid resistance and virulence (Laaberki et al., 2006, Kailasan Vanaja 
et al., 2009). Regarding Stx expression, studies have shown that under acidic 
conditions, Stx expression is repressed (Yuk and Marshall, 2004).   
 
 
1.7.2 Bile salts 
 
After passage through the stomach, EHEC is exposed to the antimicrobial effects of 
bile salts in the small intestine. Bile is made in the liver, stored in the gallbladder and 
excreted into the intestinal lumen upon digestion (Hofmann, 1999). Bile salts are the 
most prevalent organic solutes in bile, with the primary bile salts cholate and 
chenodeoxycholate making up 80 - 90% of total bile salt content in the human small 
intestine (Chiang, 2013). In the gut, bile salts form micelles with fatty acids originating 
from dietary fats, thus allowing for their absorption (Gass et al., 2007). Most bile salts 
are reabsorbed by active mechanisms at the terminal ileum, yet a small amount of 
the salts may transit to the caecum and colon. Through faecal measurements and 
examinations of cadavers, it is estimated that bile salt concentrations in the colon are 
around 500µM to 3mM (Hamilton et al., 2007, Peleman et al., 2017). Yet due to 
biotransformation by the microbiota, the majority of the colonic bile salt pool 
consists of the secondary bile salts deoxycholic acid and lithocholic acid (Ridlon et al., 
2006). Bile salts can also act as antimicrobial agents as they can damage bacterial 
membranes, dissipating transmembrane electrical potential. This consequently 
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results in a reduction in internal pH, consequently inducing DNA damage and protein 
denaturation (Merritt and Donaldson, 2009, Prieto et al., 2004, Kurdi et al., 2006, 
Bustos et al., 2012, Rodriguez-Beltran et al., 2012).  
 
The ability for EHEC to resist the lethal activity of bile salts transpires by modifying 
the expression of porins and efflux pumps. Bile salts enter EHEC through the outer 
membrane porin F (OmpF). Yet, studies have demonstrated that upon bile salt 
exposure EHEC expression of OmpF is inhibited, thus reducing the outer membrane 
permeability to bile salts (Hamner et al., 2013). In addition, EHEC exposure to bile 
salts results in increased expression of the AcrAB efflux pump, which actively pumps 
out bile salts, thus providing resistance (Thanassi et al., 1997, Ma et al., 1995).   
 
Expression of EHEC virulence genes can be influenced by the concentration of bile 
salts. While bile salt concentrations similar to those in the small intestine reduce 
expression of the LEE genes (Hamner et al., 2013), expression of adhesive fimbriae 
involved in EHEC colonisation is enhanced in bile salts levels akin to those in the colon 
(Arenas-Hernandez et al., 2014). The concentration of bile salts in the small intestine 
also increases expression of genes associated with iron scavenging in EHEC O157:H7 
(Hamner et al., 2013), thus suggesting that bile salts may be an environmental signal 
which can influence EHEC to adapt to the iron-limiting conditions found in the 
intestine. Interestingly, small intestinal levels of bile salts do not influence the 
expression of Stx (Hamner et al., 2013).  
 
 
1.7.3 Short chained fatty acids  
 
Short chained fatty acids (SCFAs) are a metabolic product released by commensal 
bacteria in the colon (Louis and Flint, 2009, Louis and Flint, 2017). The main SCFA in 
the gastrointestinal tract include acetate, butyrate and propionate (den Besten et al., 
2013). Nevertheless, the concentrations and composition of SCFAs differ throughout 
the colon and can be influenced by diet, with concentrations generally increase 
during passage through the intestinal tract.  
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Interestingly, unlike ileal levels of SCFA, colonic levels of SCFAs have been shown to 
increase the expression of adherence-conferring outer-membrane lha protein, which 
contributes to EHEC adhesion (Herold et al., 2009b). Furthermore, murine studies 
have shown that when fed high fibre diets with high levels of the SCFA butyrate, EHEC 
colonisation increases up to 100-fold (Zumbrun et al., 2013). Indeed, it has been 
demonstrated that butyrate alone can upregulate LEE gene expression, thereby 
enhancing EHEC adherence (Nakanishi et al., 2009). In addition, studies have 
demonstrated that SCFA acetate, propionate and butyrate increases the expression 
of flagella-associated genes, yet butyrate can induce the expression of flagella and 
LEE genes (Tobe et al., 2011). Therefore, it is proposed that SCFA concentrations in 
the small intestine only upregulate flagellar synthesis, thus enhancing EHEC motility. 
Yet as SCFA levels rise in the colon, sufficient butyrate is produced therefore inducing 
LEE expression, resulting in colonic adherence. 
 
Currently, the effect of SCFAs on Stx expression is not known due to a lack of studies. 
Yet, SCFAs which are produced in the colon are absorbed and can be transported to 
the kidneys (Pluznick, 2016). Interestingly, butyrate increases Gb3 expression in 
human saphenous vein endothelial cells, consequently increasing the sensitivity and 
cytotoxicity of Stx (Keusch et al., 1996). It may be possible that the same arises in the 





In order to colonise the intestinal epithelium, EHEC needs to penetrate the overlaying 
mucus layer composed of glycosylated mucin proteins (Johansson et al., 2011). In the 
human intestine, MUC2 is the predominant mucin secreted by goblet cells (Hansson, 
2019). While the mucus layer in the small intestine is thin and allows nutrient 
absorption, the colonic epithelium is covered by a dense adherent inner mucus layer 
overlaid by a loose penetrable outer layer which is colonised by the microbiota 
(Johansson et al., 2011). Using human colonic biopsies and colonoids, studies have 
demonstrated that EHEC can reduce the inner mucus layer via the zinc 
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metalloprotease StcE and other mechanisms, thereby gaining access to the epithelial 
surface (Hews et al., 2017, In et al., 2016a) 
 
In the colon, mucus provides a major carbon source as it contains many sugars such, 
as fucose. Sugars can be harvested by members of the microbiota, such as B. 
thetaiotaomicron and made available for consumption by other bacterial species 
(Hooper et al., 1999). Interestingly, LEE expression can be regulated by fucose. Upon 
sensing fucose, the histidine sensor kinase FusK, phosphorylates FusR and binds to 
the Ler regulatory region, consequently inhibiting the expression of LEE genes 
(Pacheco et al., 2012). This contributes to the relocation of EHEC from the lumen to 
the epithelial surface, where sugars are predominantly associated to mucin. This in 
turn allows the expression of LEE genes, subsequently permitting adherence.  
Interestingly, studies have demonstrated that when other mucus-derived sugars 
including galacturonic acid, gluconic acid, glucuronic acid, pyruvate, sialic acid, or 
mannose are the sole carbon source, there is increased expression of TTSS genes in 
EHEC (Carlson-Banning and Sperandio, 2016). The mechanisms of how such sugars 
affect the expression of LEE-associated genes and contribute to colonic adhesion has 





Intestinal epithelial cells produce neurochemicals including catecholamine dopamine 
(Eisenhofer et al., 1997). From dopamine, different hormones can be formed 
including epinephrine and norepinephrine. These hormones augment EHEC growth 
in both in vitro and in vivo models (Lyte et al., 1996, Lyte et al., 1997, Lyte and Bailey, 
1997). The hormone signals are sensed by bacterial adrenergic receptors, quorum-
sensing E. coli regulator (Qse) C and QseE (Hughes et al., 2009, Njoroge and 
Sperandio, 2012, Reading et al., 2009). Autophosphorylation of QseC and QseE 
follows upon sensing epinephrine or norepinephrine. This in turn invokes the 
phosphorylation of their respective response regulators. QseB, KdpE and QseF are 
the associated response regulators of QseC (Hughes et al., 2009). Phosphorylation of 
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QseB invokes the expression of flagella genes which in turn provides greater motility 
in EHEC (Sperandio et al., 2002). The quorum sensing molecule autoinducer-3 has 
also been implicated in activating the QseBC two-complement system (Sperandio et 
al., 2003). Phosphorylated KdpE in conjunction with Cra induces the expression of 
LEE genes by directly binding to the Ler promoter. Cra is a global regulator of genes 
involved in carbon metabolism (gluconeogenesis), where affinity of Cra to the Ler 
promoter is catabolite dependent (Shimada et al., 2011). Thus, LEE expression is 
induced by KdpE and Cra in gluconeogenic environments such as those in the mucus 
layer, whereas in a glycolytic environment, LEE expression is not induced (Njoroge et 
al., 2012, Njoroge et al., 2013).  
 
Autophosphorylation of QseE invokes the phosphorylation of QseF, which in turn 
increases expression of Stx genes (Hughes et al., 2009). QseF can also inhibit the 
expression of fus genes which are involved in the sensing of fucose, therefore 
relieving the Ler regulatory region from fucose mediated inhibition of the LEE 





Using non-invasive methods, initial studies have detected gradual decreases in 
oxygen levels during transit in the gastrointestinal tract (Kalantar-Zadeh et al., 2018). 
Oxygen levels decrease as it diffuses into mucosal tissue and is used for respiration 
by host cells and bacteria. Using gas sensing electronic capsules, the oxygen-
equivalent gas profiles is estimated to be 65% in the stomach, lowering to 5% during 
transit in the small intestines, with levels decreasing to under 1% in the colon 
(Kalantar-Zadeh et al., 2018). In addition, a radial gradient from the gut lumen to the 
mucosal surface exists due to oxygen diffusing from the capillary vascular supply 
(Albenberg et al., 2014). This results in increased oxygen levels as proximity to the 
mucosal surface increases.  
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The ability to adapt to fluctuations in oxygen levels is important for E. coli colonisation 
of the intestine. This has been demonstrated in mouse models which have shown 
that functional aerobic and anaerobic respiration are required for successful 
colonisation by E. coli (Jones et al., 2007). Jones et al., (2007), demonstrated that 
mutant E. coli strains which lacked the ability to use either respiration pathways were 
out competed by wild type strains. To tolerate changes in oxygen levels, E. coli 
possesses two respiratory oxidases; cytochrome bo3 oxidase and cytochrome bd 
oxidase and can utilise a range of electronic terminators such as nitrate, 
trimethylamine-N-oxidase for anaerobic respiration and mixed acid fermentation 
(Gunsalus and Park, 1994, Stolper et al., 2010, Förster and Gescher, 2014, Chang et 
al., 2004). Switching of aerobiosis to anaerobiosis or microaerobiosis is governed by 
the regulators Fnr (anaerobiosis) and ArcA (microaerobiosis; Dibden and Green, 
2005, Alexeeva et al., 2003).  
 
In chemostatic growth conditions, oxygen limitation inhibits EHEC growth (James and 
Keevil, 1999), but enhances adherence to epithelial cells suggesting the induction of 
adhesin proteins (James and Keevil, 1999). In a different study, anaerobic growth in 
LB medium reduced expression of the EHEC TTSS and associated effector proteins 
(Ando et al., 2007). Interestingly, the addition of alternative terminal electron 
acceptors such as nitrate in anaerobic cultures restore the expression of the TTSS and 
allow the formation of A/E lesions on colonic-derived Caco-2 cells (Ando et al., 2007). 
Similarly, the same occurs when EHEC is grown in Dulbecco’s Modified Eagle Medium 
(Carlson-Banning and Sperandio, 2016). Interestingly, under anaerobic conditions the 
KdpE and FusR regulators represses the expression of the TTSS. Yet in aerobic 
conditions and in the presence of gluconeogenic sugars - similar to 
microenvironment near the colonic epithelium - Cra and KdpE upregulate LEE 
expression, therefore coordinating intimate adherence. Furthermore, in aerobic 
conditions, FusR does not repress LEE unless fucose or pyruvate are present (Carlson-
Banning and Sperandio, 2016).  
 
Previous studies have demonstrated that EHEC expression of the TTSS and ability to 
adhere to colonic epithelium is enhanced by microaerobic conditions (Schuller and 
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Phillips, 2010). It has been demonstrated that the oxygen-responsive small RNA DicF 
is involved in the regulation of the TTSS, where under oxygen-limited conditions, DicF 
increases TTSS expression (Melson and Kendall, 2019). This oxygen dependent 
regulation allows EHEC to control the expression of the TTSS with radial oxygen 
gradient in the intestine, with minimal LEE gene expression (and energy expense) in 
the anaerobic gut lumen. 
 
In contrast to TTSS, Stx production is enhanced in aerobic conditions versus 
microaerobic conditions (Tran et al., 2014). This may be due to the production of 
reactive oxygen species during aerobic respiration which results in induction of phage 
lytic cycle and subsequent Stx synthesis and release (González-Flecha and Demple, 





The gastrointestinal tract generates various membrane lipid metabolites including 
ethanolamine which is a breakdown product of phosphatidylethanolamine (Albright 
et al., 1973, Zhou et al., 2017). Ethanolamine can serve as a nitrogen source for EHEC 
in the human colon (Bertin et al., 2011). In addition, ethanolamine increases the 
expression of virulence regulators involved in LEE transcription, resulting in increased 
A/E lesion formation on host cells (Kendall et al., 2012, Luzader et al., 2013). 
Furthermore, ethanolamine can increase Stx expression. Enhanced transcript levels 
of QseA, QseE and QseC by EHEC upon ethanolamine exposure suggests the 
involvement of quorum sensing proteins (Kendall et al., 2012). 
 
 
1.7.8 Influence of intestinal conditions on EHEC OMV production 
 
In addition to influencing EHEC growth and virulence gene expression, environmental 
factors in the gastrointestinal tract can also influence OMV production and OMV-
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mediated Stx release. While Stx2 was predominantly released as soluble toxin under 
aerobic conditions, Stx2 release within OMVs predominated under anaerobic 
conditions. In contrast Stx1 release was mainly associated with OMVs under both 
conditions (Yokoyama et al., 2000).  
 
Another study demonstrated that exposure of EHEC O157:H7 to simulated colonic 
(SCEM) and simulated ileal environment medium resulted in a significant increase in 
OMV and OMV-associated Stx2a release compared to LB medium, with further 
increases observed under microaerobic versus aerobic conditions (Bauwens et al., 
2017b). In addition, EHEC OMV production was augmented by the presence of mucin 
glycoproteins and human α- defensin 5, a key antimicrobial peptide released in the 
small intestine. Bauwens et al. (2017b) also demonstrated that EHEC growth in acidic 




1.8 Summary  
 
EHEC virulence is mainly associated with the injection of effector proteins into the 
host cell via a TTSS, and the production of Stxs which targets and damages various 
renal and endothelial cells. Nevertheless, various EHEC virulence factors including Stx 
can be encapsulated by OMVs. Since OMVs permit the transportation of virulence 
factors over long distances and mediate the delivery of such virulence factors into 
host cells, EHEC OMVs may contribute to the development of systemic disease.  
 
 
1.9 Aims and objectives 
 
This PhD project aims to test the hypothesis that various human colonic conditions 
augment the production of EHEC OMVs, leading to their internalisation into the 
colonic epithelium and subsequent translocation across the epithelium. This 
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translocation consequently allows to the delivery of OMVs to the kidneys, causing 





1. To evaluate the effect the colonic environment has on EHEC growth and OMV 
production (Chapter 3). 
 
A protocol was first established to allow the successful isolation of EHEC OMVs. This 
protocol was then applied to evaluate the effect of EHEC growth phase on OMV 
production. Subsequently by identifying the optimal growth phase for OMV 
production, the influence of various colonic cues was evaluated including the 
presence of colonic cells, physiologically relevant osmolarity levels and bile salts.  
 
2. To determine the intracellular trafficking of EHEC OMVs by the human colonic 
epithelium and investigate the intracellular trafficking of OMV and OMV-
associated Stx by kidney cells (Chapter 4).   
 
Colonic derived Caco-2 cells and T84 cell lines, and human colonoid model were used 
to determine if EHEC OMVs can be internalised by the human colonic epithelium. 
Following this, the influence of cell polarisation on OMV intracellular trafficking and 
translocation was evaluated. Additionally, internalisation and intracellular trafficking 































































2.1 Bacterial strains and growth conditions 
 
The EHEC strains used in this study are presented in table 2.1. Work involving Stx-
producing EHEC strains was carried out at containment level (CL) 3, whereas work on 
Stx-negative EHEC strains was conducted at CL2. To start a culture, -80oC glycerol 
stocks of specific EHEC strains were collected and placed on dry ice. A sterile pipette 
tip was used to transfer the bacterial glycerol (Fisher scientific) stock onto a Luria-
Bertani (LB) Lennox Agar (Formedium, prepared according to manufacturers 
instructions) plate and then incubated overnight (18 hours) at 37°C. Subsequently, 
agar plates with grown EHEC colonies were stored at 4°C for up to 1 month. Bacteria 
were passaged no more than 2 times before reversion to glycerol stocks to prevent 
the accumulation of mutations.  
 
To begin EHEC growth for further experimentation, EHEC colonies were collected 
from an agar plate and grown overnight (18 hours) in 2mL of LB Lennox broth (Sigma 
prepared according to manufactures instructions) at 37oC, standing. 
 
For EHEC growth analysis and OMV isolation, bacterial overnight cultures were 
diluted at a ratio of 1:100 in either LB Lennox broth, tryptic soy broth (Sigma, 
prepared according to manufacturer’s instructions), Dulbecco’s Modified Eagle’s 
Medium with high glucose (DMEM; Sigma D5671), Dulbecco’s Modified Eagle’s 
Medium: Nutrient Mixture F-12 medium (DMEM/F-12; Sigma D4621) or simulated 
colonic environmental medium (SCEM; Polzin et al., 2013; composed of 6.25g/L BD 
Bacto tryptone (BD Biosciences), 0.88g/L NaCl (Sigma), 0.43g/L KH2PO4 (Fisher 
Scientific), 1.7 g/L NaHCO3 (Sigma), 2.7 g/L KHCO3 (Sigma), 2.6 g/L of D-glucose 
(Sigma), 4 g/L of bile salt no. 3 (Oxoid) and pH adjusted to pH 7. Upon preparation, 
SCEM was autoclaved and subsequently D-glucose was added after being filter 
sterilised). Bacterial cultures were grown in either 50mL falcon tubes shaking at 180 





Table 2.1: List of EHEC strains used in this study.  
 
 
2.2 Quantifying bacterial growth 
 
To quantify bacterial density, absorbance at 600 nm (OD600) was determined using a 
spectrophotometer. A mL of undiluted culture was used for OD600 measurements, 
however for OD600 readings above 0.8, a 1:5 or 1:10 dilution of culture in growth 
medium was prepared to accurately determine absorbance.  
 
To determine viable bacterial counts, EHEC cultures were serially diluted in 
phosphate-buffered saline (PBS; Oxoid) and 10μL of each dilution were spotted onto 
LB agar in triplicate (Miles and Misra method). Plates were incubated overnight at 
37oC, and colony forming units (cfu) per mL was determined the next day by counting 







Strain Serotype Description Reference 
EDL933 O157:H7 Wild type strain isolated from the 1982 US 
outbreak, Stx1 and Stx2 positive 
(Riley et al., 
1983) 
86-24 O157:H7 Wild type strain isolated from the 1986 US 
outbreak, Stx2 positive 
(Griffin et 
al., 1988) 









2.3 Cell culture 
 
2.3.1 Cryopreservation and resurrection of cell lines  
 
Long-term storage of eukaryotic cell lines was achieved by cryopreservation in liquid 
nitrogen (vapour phase, -190oC). To produce frozen stocks, cells were suspended at 
a density of 2 to 4 x106 cells in 1mL of culture medium containing dimethyl sulfoxide 
(DMSO, 5% v/v for T84 cells and 10% v/v for all other cells lines used in this study, 
Sigma) and aliquoted into cryotubes. To avoid the formation of ice crystal within the 
stocks, stocks were placed in a Mr Frosty FreezingTM Container (Thermo Fisher 
Scientific) holding isopropanol and subsequently frozen overnight at -80°C before 
being transferred to liquid nitrogen storage. 
 
To start a culture from frozen stocks, cells were thawed by part submersion of the 
cryotube in water (37oC). The suspension was transferred into 5mL of pre-warmed 
cell culture medium and centrifuged at 180 x g for 6 minutes. The supernatant was 
removed, and the cell pellet was resuspended in 7mL of warm cell culture medium. 
The whole suspension was then transferred into a 25cm2 (T25) culture flask (Sarstedt) 
and grown until confluent.  
 
 
2.3.2 Cell culture conditions and passaging 
 
Cell lines were cultured in T25 flasks at 37°C in a 5% CO2 atmosphere. The human 
colonic carcinoma Caco-2 cell line (ATCC HTB-37), the human cervix carcinoma HeLa 
cell line (ATCC CCL-23) and the African green monkey kidney Vero cell line (ATCC CCL-
81) were grown in DMEM containing high glucose levels, supplemented with 1x non-
essential amino acids (Sigma), 10% foetal bovine serum (FBS; Sigma) and 4mM L-
glutamine (Sigma). The human colonic carcinoma T84 cell line (ATCC CCL-248) was 
cultured in DMEM/F-12 medium (Sigma), supplemented with 10% FBS (Sigma) and 
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2.5mM L-glutamine (Sigma). Cells grown in T25 flasks were provided with 7mL culture 
medium. 
 
Cells were allowed to grow to full confluence prior to passage and/or seeding into 
wells for experimentation. Upon reaching confluence in T25 flasks, cell medium was 
removed, and the cells were washed with sterile PBS. For T84 cells, prior to 
trypsinisation, cells were briefly rinsed with 500µL of 0.25% trypsin-0.02% 
ethylenediaminetetraacetic acid (EDTA) solution (Sigma). Following this, 500µL of 
0.25% trypsin-EDTA solution was added to the monolayer and incubated at 37°C until 
cell detachment from the culture flask base. Cell aggregates were homogenised by 
repeated pipette aspiration in 4.5mL of cell culture medium. Once fully mixed, cell 
suspension was transferred into new culture flasks at a dilution ratio of 1:5 (T84 cells), 
1:10 (Caco-2, Hep-2 cells) or 1:20 (Vero cells). 
 
 
2.3.3 Seeding adhesion plates for OMV internalisation assay 
 
After trypsinisation and resuspension of cells, in order to distinguish dead cells, 50μL 
of the cell suspension was diluted with 50μL of 0.4% (v/v) trypan blue solution (Sigma) 
which would stain dead cells blue. The cell suspension was loaded into a Neubauer 
counting chamber (Hawksley; depth 0.1mm) and inspected using an inverted light 
microscope (Zeiss, Invertoscope ID03). To achieve the number of cells per mL, the 
average sum of the number of viable cells visible in two haemocytometer fields 
multiplied by 104 was calculated.  
 
Succeeding this, the following equation was used to calculate the volume of the cell 
suspension needed for seeding into cell culture wells:  
 
Total volume of the cell suspension needed for seeding = total number of cells 
required/cell concentration of cell suspension (cells per mL) 
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This volume was then diluted into the required volume of culture medium needed 
for seeding.  
 
Cells were seeded into 24-well plates (Sarstedt), containing sterile circular coverslips 
(13mm diameter, Academy Science Products) which allow for subsequent staining 
and microscopy analysis. A mL of cell suspension and medium was added per well, 
with seeding cell densities of 1.5 x 105/well for T84 and Vero cells, 1.2 x 105 cells/well 
for Caco-2 cells, and 1.0 x 105 cells/well for HEp-2 cells being added. Seeded plates 
were incubated at 37°C in a 5% CO2 atmosphere, with the culture medium being 
exchanged the day before use. 
 
 
2.3.4 Seeding cells on Transwell inserts 
 
Transwells were used in order to grow polarised epithelial cells thereby mimicking 
the intestinal epithelial layer. Caco-2 cells were grown on polyester Transwells with 
an insert membrane growth area of 1.12cm2 and pore sizes of 0.4µm (Corning 
Costar). Cells were seeded in the apical compartment at a seeding density of 5 x 104 
cells per well, with a total volume of 500µL of supplemented DMEM and cells in the 
inner chamber and 1500µL of DMEM in the outer chamber. One well per plate was 
not seeded with cells allowing a baseline control when measuring the transepithelial 
electrical resistance (TEER). 
 
After seeding, the medium was exchanged after four days of growth to prevent 
acidification by replacing 300µL in the inner chamber and 800µL in the outer 
chamber. Medium was then changed every other day using the same volumes. From 
day 10, TEER was measured by using an EVOM voltohmmeter with an STX2 chopstick 
electrode (WPI) to assess polarisation and barrier formation of Caco-2 cells. A steady 
TEER of 1500 Ω × cm2 for Caco-2 cells indicated full differentiation which was typically 
reached after 14 days of growth. 
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To avoid contamination, culture medium was supplemented with 1% (v/v) penicillin-
streptomycin (10,000 U/ml and 10mg/ml stock, respectively; Sigma). Antibiotics were 
removed the day before infection by replacing the medium with supplemented 
DMEM without antibiotics. 
 
 
2.4 Colonoid culture  
 
2.4.1 Dissociation of intestinal organoids and seeding on Transwell inserts 
 
Colonoid lines derived from histologically normal endoscopic biopsies of the 
transverse colon of a male patient (60-year-old) were established by S. Schüller. 
Colonoid cell lines at passage 5 were used to examine the interaction between EHEC 
OMVs and two-dimensional colonoid cultures.   
 
To establish two-dimensional colonoid cultures, polyester 6.5mm Transwell® 
(Corning) with an insert membrane growth area of 0.33cm2 and pore sizes of 0.4µm 
were first coated with 100µL of human collagen IV (at a final concentration of 
35µg/mL from a 1mg/mL stock; Sigma) and incubated for two days at 4oC. After 
removing the collagen solution, the filters were washed twice with complete medium 
without growth factor (CMGF-; DMEM/F-12 medium (Sigma) supplemented with 5mL 
1M HEPES at pH 8.0 (Sigma) and 5 mL GlutaMAX-I (Thermo Fisher Scientific) per 500 
mL bottle).  
 
Culture of two-dimensional colonoids was performed as described by In et al. 
(2016b). Briefly, colonoids grown on Matrigel were suspended in 600µL of Gentle Cell 
Dissociation Reagent (Stemcell Technologies) and the plate was placed on an orbital 
shaker at 200 rpm for 10 minutes at room temperature. Subsequently, the sample 
was mixed and collected into a tube after which two volumes of CMGF- was added. 
This was centrifuged at 240 x g for 10 minutes at 4oC.  
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With enough volume to add 100µL per filter insert, the cell pellet was resuspended 
in warm CMGF+ (made up of 11.2mL of CMGF-, 25mL of Wnt-3A-conditioned medium 
(made internally), 7.5mL of R-spondin 1-conditioned medium (made internally), 5mL 
of noggin-conditioned medium (made internally), 1mL B27 (100µL of N-Acetyl-L-
cysteine (500 mM stock solution in ddH20m; Sigma)), 50µL of human epidermal 
growth factor (50µg/mL stock solution in PBS/0.1% bovine serum albumin (BSA; 
Sigma), Sigma), 5µL of [Leu15]-gastrin (100µM stock solution in PBS/0.1% BSA; 
Sigma), 50µL of A 83-01 (500µM stock solution in DMSO; Sigma), 5µL of SB 202190 
(100 mM stock solution in DMSO; Sigma), 100µL of primocin (at 50 mg/mL; Fisher 
Scientific), supplemented with 10µM CHIR 99021 (Sigma) and 10µM Y-27632 (Sigma). 
 
Organoids from one Matrigel droplet allows for the seeding of two 6.5mm 
Transwell®. Prior to adding cell suspension into wells, 600µL of CMGF+ was added 
into the outer chamber and then 100µL of cell suspension was added per filter insert. 
The plates were then incubated at 37oC in air supplemented with 5% CO2. Two days 
after seeding, CMGF+ was replaced. Medium was then exchanged every 2 - 3 days 
until confluence was reached. TEER was measured (as described in section 2.3.3) to 
assess polarisation and barrier formation, with a steady TEER of 300 Ω × cm2 
indicating growth and polarisation. After two weeks, to differentiate organoid 
monolayers, CMGF+ lacking Wnt-3A-conditioned medium, R-spondin 1 conditioned 




2.5 Outer membrane vesicle isolation 
 
EHEC overnight cultures (prepared as indicated in section 2.1) were inoculated at a 
1:100 dilution into media in either Falcon tubes or T75 flasks. Once grown in the 
desired conditions, a total of 1.1mL of the bacterial culture samples per flask/Falcon 
tube was collected for OD600 absorbance measurements and viable cell count 
determination by using the Miles and Misra technique (as indicated in section 2.2). 
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To purify OMVs, bacterial cultures were spun at 4000 x g for 15 minutes at 4oC in 
25mL aliquots in 50mL Falcon tubes. The obtained supernatant containing OMVs was 
then filter-sterilised using polypropylene filters with pore sizes of 0.45μm (Fisher 
Scientific). The sterile supernatant was then concentrated using cellulose membranes 
centrifugal units, with a molecular weight cut-off (MWCO) of 100 kDa (Merck 
Millipore) by spinning the samples at 6000 x g at 4oC. Once the whole supernatant 
was concentrated to 1mL, 15mL of PBS was added to the concentrated sample and 
spun at 6000 x g at 4oC until the sample was concentrated to a final volume of 1mL. 
OMVs were subsequently pelleted by ultracentrifugation (Beckman Coulter sealing 
tubes, Beckman LE-80 Ultracentrifuge) at 130,000 x g for 2 hours at 4oC, with the 
pellet being re-suspended in 500μL PBS. To confirm sterility, 10μL of OMV 
preparation samples were spotted onto LB agar plates and incubated overnight at 
37oC.  
 
To quantify OMV yields by Bradford protein assay and Sodium dodecyl sulphate 
polyacrylamide gel electrophoresis (SDS-PAGE), Amicon Ultra 0.5 centrifugal devices 
with cellulose membrane filter with a 100 kDa MWCO (Merck Millipore) were used 
to concentrate samples. In order to activate the filter devices, 500μL of d.H2O was 
added into the filter device and spun in a microcentrifuge at 14,000 x g until a volume 
of 20μL was reached. OMV samples were then loaded and spun at the same speed 
until concentrated to a final volume of 30μL. 
 
 
2.6 Bradford protein assay 
 
Protein content of OMV samples was determined using the Bio-Rad protein assay 
which is based on the Bradford dye-binding method. Briefly, 10μL of bovine serum 
albumin (BSA; Sigma) protein standards (0μg/mL to 500μg/mL) and OMV diluted 
samples (1:5) were prepared and aliquoted into microtiter plate wells. Samples and 
standards were mixed with 190μL of Bio-Rad protein assay dye reagent solution 
(prepared by a 1:4 dilution in dH2O) and incubated for 5 minutes at room 
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2.7 Sodium dodecyl sulphate polyacrylamide gel electrophoresis  
 
OMV-associated proteins were separated by Sodium dodecyl sulphate 
polyacrylamide gel electrophoresis (SDS-PAGE) using a Mini-PROTEAN Tetra System 
device (Bio-rad). The running gel (12.5%) was made of 2.5mL of 4x running gel buffer 
(1.5M Tris (Fisher Scientific), 0.4% (w/v) SDS (Fisher Scientific) adjusted to pH 8.8 with 
concentrated hydrochloric acid (HCl)), 4mL of Acrylamide/Bis-acrylamide (30% 
solution; Sigma), 3.5mL of d.H2O, 50μL of 10% Ammonium persulfate (APS; Sigma) 
and 10μL of Tetramethylethylenediamine (TEMED; Sigma). This was overlaid by a 3% 
stacking gel prepared from 1.25mL of 4x stacking gel buffer (0.5M Tris, 0.4% (w/v) 
SDS adjusted to pH 6.8 with concentrated HCl), 500μL of Acrylamide/Bis-acrylamide 
(30% solution), 3.2mL of d.H20, 50μL of 10% APS and 5μL of TEMED. Well combs were 
inserted before polymerisation of the stacking gel. Once polymerised, gels were 
stored at 4oC for up to a month.  
 
To separate proteins, polyacrylamide gels were first inserted into the running tank 
filled with 1x Running buffer (diluted from a 10x Running Buffer (0.25M Tris, 2M 
Glycine at 144.0 g/L and 1% (w/v) SDS, at pH 8.3)). The combs were then removed, 
and the wells rinsed with 1x Running buffer. A total of 10μL of sample was mixed with 
2.5μL of 5x Reducing sample buffer (RSB; 2.5mL Glycerol (Sigma), 0.5g SDS (Fisher 
Scientific), 625μL of Tris (Fisher Scientific), 0.39g of Dithiothreitol (ForMedium Ltd.), 
5mL Bromophenol blue (Sigma) and 1.9mL of d.H20) and denatured by boiling the 
sample on a heating block for 5 minutes. When OMVs were isolated from EHEC 
cultures grown with human cells, DMEM, DMEM/F-12 medium and SCEM, OMV 
samples were diluted 1:10 in PBS prior to boiling. Boiled samples were loaded into 
each well, along with 5μL of pre-stained protein marker (Blue Prestained Protein 
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Standard, Broad Range 11-190 kDa, NEB). Gels were run at 200V, 20W, 100 mA for 
50 minutes using a Mini-PROTEAN Tetra Cell device (Bio-Rad).  
 
At the end of the run, gels were removed from the glass plates and stained with 
GelCode TM Blue Safe Protein Stain (Thermo Fisher Scientific) according to the 
manufacturer’s instructions. Gels were imaged using a FluorChemE system 
(proteinsimple).  
 
For OmpA and OmpF/C densitometric quantification, ImageJ software was used 
(https://imagej.nih.gov/ij/; Java-based image processing program developed at the 
National Institutes of Health).  
 
 
2.8 Western blot  
 
In order to transfer separated proteins from a polyacrylamide gel onto Polyvinylidene 
difluoride membranes (VWR; GE Healthcare), membranes were first submerged in 
100% methanol for 10 seconds and then submerged in blotting buffer (200mM 
Glycine, 25mM Tris at pH 8.8) for 15 minutes on a rocking platform. After protein 
separation, polyacrylamide gels were washed in d.H20 for 5 minutes and then 
submerged in blotting buffer for 15 minutes on a rocking platform. Proteins were 
subsequently transferred onto the methanol treated membrane by wet blotting at 
100V constant for 60 minutes in blotting buffer.  
 
After protein transfer, membranes were blocked in 5% (w/v) skimmed milk powder 
in Tris buffered saline containing 0.05% (v/v) Tween-20 (TBST; 5M NaCl (Thermo 
Fisher Scientific), 1M Tris (Thermo Fisher Scientific), pH adjusted at 8.0 with HCl and 
0.5 mL/L Tween-20 (Thermo Fisher Scientific)), at room temperature for 60 minutes 
on a rocking platform. After washing in TBST for 10 minutes, membranes were 
incubated with primary antibody which were diluted in TBST overnight at 4°C (Table 
2.2).  
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After washing in TBST, blots were incubated with species specific horseradish 
peroxidase-conjugated anti-IgG (1:200,000 dilution in TBST, Sigma) for 60 minutes. 
This was followed by a 30-minute wash in TBST to remove non-bound antibodies. The 
membranes were developed using peroxide solution (Thermo Fisher Scientific) and 
Luminol enhancer solution (Thermo Fisher Scientific), prepared at a 1:1 ratio and 
imaged with a FluorChem E Imager (ProteinSimple). 
 
Antibody Species Dilution Source 
Anti-OmpA Rabbit 1:2000 Antibody Research Corporation 
Anti-Stx2 204 Rabbit 1:1000 A. Kane, Tufts Medical Centre 
Table 2.2: Primary antibodies used for Western blotting in this study. 
 
 
2.9 Dynamic Light Scattering analysis 
 
OMV size distribution was determined by using a Zatasizer Nano-ZS (Malvern 
Instruments, UK). After resuspending OMV pellets post-ultracentrifugation, to avoid 
artefacts due to multi-scattering, OMV samples were diluted 1:500 in 1mL of PBS. To 
measure samples, a standard operating procedure was set to using a laser 
wavelength of 659nm so to measure samples with a refractive index of 1.450 and an 




2.10 NanoParticle Tracking Analysis 
 
OMV size and particle concentration were acquired by using a LM 12 viewing unit of 
a NanoSight LM10 instrument and its corresponding NanoParticle Tracking and 
Analysis (NTA) software system. This system provides a way to measure particle size 
in liquids by relating such particles to their Brownian motion. To analyse OMV sizes 
and concentrations, OMV suspensions were diluted in PBS to a concentration which 
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would allow optimum analysis by the software. Optical camera level and gain settings 
were manually set and were maintained for all analyses.  
 
Each sample was evaluated three times for 60 seconds at room temperature. Frame 




2.11 EHEC growth analysis 
 
EHEC growth was assessed in LB medium and SCEM with and without bile salts over 
a 24-hour period. Overnight EHEC cultures (prepared as indicated in section 2.1) were 
inoculated at 1:100 into LB medium or SCEM with or without bile salts and grown at 
37oC, shaking at 180 rpm. OD600 was measured hourly for the first 6 hours in LB and 
SCEM cultures and then at 24 hours (as indicated in section 2.1.1). Furthermore, at 
every second hour, viable bacteria counts were made for SCEM cultures containing 




2.12 Examining the effect of carbon dioxide on OMV production and 
composition 
 
To study the effect of CO2 on EHEC OMV production and composition, overnight EHEC 
cultures (prepared as indicated in section 2.1) were inoculated at 1:100 into LB 
medium. EHEC cultures were grown in T75 flasks on a rocking platform, max speed 
at 37oC for 24 hours in normal atmospheric conditions (air) or 5% CO2/air (cell culture 
incubator).   
 
At the end of the incubation, the media was collected and then treated for OMV 
isolation (as indicated in section 2.5). OMV yields were quantified by Bradford assay 
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and SDS-PAGE (as indicated in section 2.6 and 2.7, respectively). Furthermore, EHEC 
growth was assessed by viable bacterial counts and OD600 measurements (as 
indicated in section 2.2).  
 
 
2.13 Examining the effect of the presence of human cells on OMV production 
and composition 
 
To study the effect of human host cells on EHEC OMV production and composition, 
monolayers of cervical-derived HeLa cells or colonic-derived T84 cells were grown in 
T75 flasks and then infected with EHEC strains. 
 
Four T75 flasks were seeded with cells and grown until confluence was reached. 
Growth medium was exchanged when required. Bacterial overnight cultures were 
prepared as indicated in section 2.1. On the day of infection, cell culture media was 
exchanged with 25mL of non-supplemented media (DMEM for HeLa cells and 
DMEM/F-12 medium for T84 cells) and two flasks were inoculated with 250μL of 
bacterial overnight culture (prepared as indicated in section 2.1). To examine 
whether human host cell derived contaminants would be present using the OMV 
purification protocol, the remaining two flasks were not infected and only incubated 
with non-supplemented medium. Furthermore, to examine the effect of the cell 
media on OMV production, overnight EHEC cultures (prepared as indicated in section 
2.1) were inoculated at 1:100 into two T75 flasks containing non-supplemented 
medium. All six flasks were then incubated in 5% CO2 atmosphere at 37oC for 24 hours 
on a rocking platform at maximum speed. At the end of the incubation, the media 
was collected and then treated for OMV isolation (as indicated in section 2.5). OMV 
yields were quantified by Bradford assay and SDS-PAGE (as indicated in section 2.6 
and 2.7, respectively). Furthermore, EHEC growth was assessed by viable bacterial 




2.14 Examining the effect of bile salts on OMV integrity 
 
To examine the effect of bile salts on OMV integrity, OMVs from bacterial cultures 
grown in SCEM lacking bile salts were incubated in SCEM media with and without bile 
salts for 18 hours in a shaking incubator at 180rpm. OMVs were separated from free 
proteins by using cellulose membrane centrifugal filter devices (100 kDa MWCO, 
Merck Millipore), spun at 14,000 x g in a microcentrifuge. Both the concentrated 
sample and flow through were collected.  
 
To determine if proteins were present in the flow through, trichloroacetic acid (TCA, 
Sigma) precipitation was carried out. Flow-through samples and 100% TCA (w/v) in 
d.H2O were cooled on ice for 15 minutes. Subsequently, both the sample and 100% 
TCA were mixed to make up a final concentration of 10% TCA. Samples were 
incubated for 30 minutes on ice, then spun at 21,000 x g in a microcentrifuge for 15 
minutes at 4oC. The supernatant was discarded carefully without disturbing the pellet 
and the pellet was re-suspended in 18µL of 1x RSB (from 5x RSB diluted in d.H2O). If 
samples appeared yellow, 2μL of 2M of Tris was added to the sample in order to 
neutralise pH. Both the concentrate and flow through samples were separated by 
SDS-PAGE and analysed by Western blot (as indicated in section 2.7 and 2.8). 
 
 
2.15 Lipophilic tracer staining of OMV 
 
To stain OMVs with the lipophilic tracer Dil or DiO (Molecular probes), lipophilic 
tracer was added to the desired OMV aliquot at a 1:100 dilution and incubated for 30 
minutes at 37oC in the dark. To remove unbound dye, cellulose membrane centrifugal 
filter devices with 30 kDa MWCO (Merck Millipore) were used. In order to activate 
the filter devices, 500μL of d.H2O was added into the filter device and spun in a 
microcentrifuge at 14,000 x g until a volume of 20μL was reached. The stained OMV 
sample was then added to the filter device and spun at the same speed until 
concentrated to a volume of 20μL. To wash the sample, 500μL of PBS was added to 
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the filter, and the sample was concentrated to a final volume 20μL. This was repeated 
three times. The sample was then collected by inverting the filter device into a clean 
sterile Eppendorf microcentrifuge tube and spinning at 1000 x g for 2 minutes. 
 
 
2.16 Stx2 and OMV internalisation assays in eukaryotic cells 
 
To examine the internalisation of Stx2, eukaryotic cells were grown in 24 well plates. 
Confluent cell monolayers replenished with supplemented cell medium eighteen 
hours prior to Stx2 incubation. On the day of Stx2 incubation, medium was removed 
and replenished with a total of 250μL of non-supplemented medium containing 
1.25µg of pure Stx2 was added to cells grown in 24-well plates. After six hours, a 
further 250µL of non-supplemented medium was added per well for incubations 
lasting 24 hours.  Incubations were made in 5% CO2 atmosphere at 37oC. 
 
To examine the internalisation of OMVs in non-polarised cells, eukaryotic cells were 
grown in 24 well plates, yet cells were grown in transwell plate inserts to study OMV 
internalisation in polarised cells. Confluent cell monolayers were replenished with 
supplemented cell culture medium eighteen hours before OMV incubation with 
eukaryotic cell monolayers. On the day of OMV inoculation, cell culture medium was 
removed and replaced with non-supplemented cell culture medium.   
 
In order to examine whether OMVs could be internalised by host eukaryotic cells, 
OMVs were isolated from EHEC LB cultures grown at 37oC with 5% CO2 
supplementation in normal atmospheric conditions. To examine internalisation, 
initial experiments utilised lipophilic dyed (DiO- or DiI-) OMVs. Following this, non-
dyed OMVs were used to investigate OMV intracellular trafficking and OMV 
translocation across eukaryotic cells. 
 
A total of 250µL of non-supplemented medium containing 10µg of OMVs (as 
determined by protein content) was added to cells grown in 24-well plates or 1.12cm2 
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transwell plates inserts. After six hours, a further 250µL of non-supplemented 
medium was added per well for incubations lasting 24 hours. Incubations were made 
in 5% CO2 atmosphere at 37oC.  
 
To examine whether OMVs would affect the barrier integrity of the polarised cell 
monolayers, TEER readings were measured prior to OMV incubation to confirm 
membrane integrity. Medium from both the apical and basolateral side of the 
polarised monolayer was replaced with fresh non-supplemented medium with the 
apical medium containing OMVs isolated from EHEC strain 85-170. Immediately after 
OMV addition, TEER readings were measured, corresponding to the first time point 
(t = 0). TEER measurements were made hourly for the first 5 hours and then at 24 
hours, with measurements being converted to a percentage change in TEER values 
compared to the TEER value measured at t = 0. Furthermore, TEER values were 
normalised by subtracting the value of empty wells only containing cell medium from 
the TEER values gained at each time point. After five hours, a further 250µL of non-
supplemented cell culture medium was added to wells which would be incubated 
with OMVs for 24 hours. 
 
When examining the interaction between OMVs and colonoid two-dimensional 
monolayers grown on 0.33cm2 transwell plate inserts, eighteen hours before OMV 
inoculation, medium was replaced with fresh CMGF+ lacking Wnt-3A-conditioned 
medium, R-spondin 1 conditioned medium, SB 202190 and primocin. On the day of 
the inoculation, medium from Transwells was removed and replaced with 50µL of 
non-supplemented DMEM/F-12 medium containing 2.5µg of OMVs (as determined 
by protein content). Incubations were made in 5% CO2 atmosphere at 37oC. TEER 
measurements were made at the beginning of the experiment (t = 0) and then at 5 
and 24 hours post-OMV inoculation. TEER measurements were converted to a 
percentage change in TEER values compared to the TEER value measured at t = 0. 
Furthermore, TEER values were normalised by subtracting the value of empty wells 
only containing cell medium from the TEER values gained at each time point. After 
five hours, a further 50µL of non-supplemented DMEM/F-12 medium was added to 
wells.  
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2.17 Immunofluorescence staining and image analysis 
 
After completing an experiment, monolayers were washed in PBS and fixed with 
either 3.7% formaldehyde (FA) in PBS for 15 minutes, ice-cold methanol for 10 
minutes on ice or ice-cold acetone-methanol (1:1) for 10 minutes on ice. After 
washing, fixed samples were permeabilised and non-specific binding sites were 
blocked with 0.1% Triton-X-100 (Sigma) and 0.5% BSA (Sigma) in PBS for 20 minutes 
at room temperature.  
 
Samples were incubated with primary antibodies diluted in PBS containing 0.5% BSA 
for 1 hour at room temperature (table 2.3). The samples were then washed in PBS 
for 10 minutes on a rocking platform, and subsequently incubated with species 
specific antibodies labelled with either Alexa Fluor 488, 568 or 647 (Life Technologies, 
1:400) diluted in PBS containing 0.5% BSA for 30 minutes at room temperature in the 
dark. When desired, 4’,6-diamidino-2-phenylindole (DAPI; 1:5000; Roche) and 
fluorescein isothiocyanate (FITC)-conjugated phalloidin (1:200; Sigma) were added 
during the final antibody incubation to detect for DNA and filamentous actin, 
respectively. Following the final antibody incubation, samples were washed in PBS 
for 30 minutes on a rocking platform and mounted on glass microscopy slides (R & L 
Slaughter) in Vectashield mountant (Vector Laboratories) to reduce photo-bleaching. 
Slides were stored at 4°C in the dark.  
 
Samples were imaged using either a standard widefield fluorescence microscope 
(Zeiss Axio imager M2 or Leica DM6000 B microscope) or confocal microscope (Zeiss 
LSM800), using fixed exposure settings. Images were performed with up to four 
excitation wavelengths including 405nm (blue, DAPI), 488nm (green, FITC and Alexa-
488 immunostaining), 561nm (red, Alexa-568 immunostaining) and 650nm (far red, 
Alexa-647 immunostaining). Imaging parameters are summarised in table 2.4 and 
2.5. Furthermore, optimal pixel sizes were utilised when confocal microscopy was 
used.   
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Table 2.3: Primary antibodies used for immunofluorescence staining in this study. 
 
To quantify colocalization between signals of interest, images were assessed using 
the JaCoP plugin (Bolte and Cordelières, 2006) in ImageJ (National Institute of 
Health). Single cells were selected and analysed to determine the Manders 
colocalization coefficients. Prior to measurements, threshold values for M1 and M2 
















Mouse 1:150 Abcam 3.7 % FA 
Anti-58K Golgi protein 
antibody (Golgi 
apparatus) 








specific LPS antibody 
(OMVs) 





Anti-Stx2 204 Rabbit 1:1000 A. Kane, Tufts 
Medical Centre 
3.7% FA or 100% 
methanol 
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Microscope Magnification NA Immersion Actual pixel size, x/y 
(nm) 
Zeiss Axio 
 Imager M2 
10x 0.3 Air 645 
20x 0.5 Air 323 
40x 0.75 Water 161 
63x 1.4 Oil 102 
100x 1.3 Oil 110 
Leica Ariol 6000B 40x 0.75 Air 185 
63x 1.3 Oil 118 
Table 2.4: Widefield microscope specifications and the pixel sizes of images taken for this study.  
 
Table 2.5: Confocal microscope specifications and the pixel sizes of images taken for this study.  
 
 
2.18 Transmission electron microscopy 
 
After ultracentrifugation, OMV pellets were resuspended in 250µL of PBS. Following 
this, 5µL was applied onto carbon coated Formvar copper grids (Agar Scientific) for 2 
minutes. The samples were negatively stained by washed the grid six times with 2% 
(w/v) uranyle acetate (BDH) solution in water for 2 minutes. Excess stain was 
removed, and the grid were air-dried. The samples were examined and imaged by 
Kathyrn Cross (Electron Microscopy Facility, Institute of Food Research) using a 




Microscope Magnification NA Immersion Actual pixel size, x/y 
(nm) 
Zeiss LSM 800 40x 1.1 Water 106 
63x 1.2 Water 76 
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2.19 Statistical analysis 
 
GraphPad Prism Version 6 software was used for statistical analysis for this project. 
For the comparison of two groups, results were analysed using parametric student T-
test. For the comparison of three or more groups, parametric analysis of variance 
(ANOVA) with Tukey’s post-hoc multiple comparison test was used. Results are 
expressed as means +/- standard deviation (SD). A P value of < 0.05 was considered 
significant, with degrees of statistical significance presented as: * = P < 0.05; ** = P < 































3 Chapter Three: The influence of the colonic 














































3.1 Introduction  
 
Prior to colonic colonisation, EHEC is exposed to various environmental stressors in 
the gastrointestinal tract. Examples of abiotic stresses include changes in pH, limited 
iron levels and the presence of bile salts (Fallingborg, 1999, Hofmann, 2009, Lacy et 
al., 2011). Biotic stressors are instigated by cells which line the gastrointestinal tract, 
releasing neurochemicals and various antimicrobial compounds such as nitric oxide, 
defensins and antimicrobial peptides (Sharma et al., 2007, Muniz et al., 2012). 
Furthermore, EHEC competes for essential compounds as nutritional molecules are 
consumed by the microbiota (Blachier et al., 2009, Rowland et al., 2018). These 
different stressors can influence the expression of different virulence genes, 
consequently coordinating the successive colonisation of EHEC in the host. 
Furthermore, EHEC has adapted various methods to resist against such host stressors 
such as altering outer membrane lipid composition to resist changes in pH, and 
increased expression of efflux pumps to dispose of intracellular bile salts (Thanassi et 
al., 1997, Yuk and Marshall, 2004). 
 
Conversely, OMVs have also been shown to perform various roles which can aid 
bacterial survival and contribute to bacterial pathogenesis. A role OMVs have been 
implicated with, includes the transferral of virulence factors such as toxins to target 
host cells (Ricci et al., 2005, Parker et al., 2010, Chatterjee and Chaudhuri, 2011, 
Horstman and Kuehn, 2000, Kesty et al., 2004, Bomberger et al., 2009, Bielaszewska 
et al., 2013, Bielaszewska et al., 2017). The secretion of such virulence factors in 
OMVs ensures their transportation over long distances whilst they are protected 
from external environments to host cells. Another role which OMVs are involve in 
includes the clearing of misfolded and denatured proteins from the periplasmic space 
when bacteria are exposed to high temperatures (McBroom and Kuehn, 2007). OMVs 
can also defend bacteria from antimicrobial compounds through sequestration and 
degradation of such components as enzymes such as cephalosporinases can be 
encapsulated in OMVs (McBroom and Kuehn, 2007, Ciofu et al., 2000, Kim et al., 
2018, Liao et al., 2015, Stentz et al., 2015, Kim et al., 2020, Kulkarni et al., 2015). 
Accordingly, increased OMV production has been observed in bacteria when exposed 
 78 
to stressful conditions, including high temperatures, acidic pH, exposure to 
antimicrobial agents, reduced iron levels, and oxidative stress (Manning and Kuehn, 
2011, McBroom and Kuehn, 2007, Roier et al., 2016, Bauwens et al., 2017b, 
Lekmeechai et al., 2018).  
  
To evaluate OMV production in response to different environmental conditions, 
previous studies have isolated OMVs from bacterial cultures grown under respective 
conditions by removing intact bacteria from the culture through centrifugation and 
sterile filtration (Bauwens et al., 2017b, Bauwens et al., 2017a, Manning and Kuehn, 
2011, MacDonald and Kuehn, 2013, Horstman and Kuehn, 2000). Following this, the 
sterile supernatant undergoes ultrafiltration, typically using a membrane with a 100 
kDa molecular weight cut-off (MWCO; Chutkan et al., 2013). To achieve this, studies 
have utilised different ultrafiltration arrangements such as: (i) ultrafiltration driven 
by pumping the solution through a membrane, (ii) tangential flow (crossflow) 
filtration concentrator, and (iii) centrifugal ultrafiltration units (Klimentová and Stulík, 
2015, Stentz et al., 2015, Bauwens et al., 2017b, Jones et al., 2020).  
 
Subsequent quantification of OMVs can be performed through different methods. 
Since proteins are one of the major constituents of OMVs, protein-based techniques 
such as Bradford protein assays have been used to quantify OMV yield (Bradford, 
1976, Klimentová and Stulík, 2015). Alternatively, previous studies have quantified E. 
coli OMV yields by densitometric measurements of the ubiquitously located outer 
membrane proteins (Omp) F/C and A, after proteins separation by SDS-PAGE 
(McBroom and Kuehn, 2007, Manning and Kuehn, 2011, Horstman and Kuehn, 2000, 
Lee et al., 2007, Schwechheimer et al., 2014, Bonnington and Kuehn, 2016).   
 
OMVs can also be enumerated by nanoparticle tracking analysis (NTA), with the size 
and concentration of OMVs being determined (Saveyn et al., 2010, Hong et al., 2019, 
Gerritzen et al., 2017, Vestad et al., 2017). NTA determines the Brownian motion of 
particles in a solution by a camera which records the scattered light produced by the 
particles when a laser bean illuminates the sample. Dynamic light scattering (DLS) 
may also be used to determine the size distribution of OMVs (Stetefeld et al., 2016). 
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To achieve measurements by DLS, the Brownian motion of particles in the suspension 
is measured by quantifying the rate at which the intensity of scattered light fluctuates 
due to diffusing particles. DLS software determines the diffusion coefficient of OMVs 
resulting in the particle sizes being determined (Hallett et al., 1991, Kim et al., 2018, 
Kulkarni et al., 2015). Electron microscopy is another technique which has been used 
to visualise and determine OMV sizes (Kolling and Matthews, 1999, Parker et al., 
2010, Bielaszewska et al., 2013).  
 
When quantifying OMV yield, it is vital to normalise results due to differences in 
bacterial growth under different conditions. Previous studies have used various 
methods to normalise data such as OD600, total cfu, cfu/mL or bacterial pellet weight 
(Bauwens et al., 2017b, Deatherage et al., 2009, McBroom et al., 2006, Wessel et al., 
2013, Schwechheimer et al., 2015, Schwechheimer et al., 2014). In this investigation, 
OMV production was normalised by OD600 rather than viable bacterial counts (cfu) to 
account for OMVs produced by bacteria which have died prior to OMV isolation.  
 
As OMVs are known to protect bacteria from external stresses, this study aimed to 
assess the influence of the colonic milieu on EHEC OMV production. Since the colonic 
milieu has various components which can stress EHEC, it is hypothesised that colonic 
conditions investigated in this study increase OMV production. This was elucidated 
by addressing the following objectives: 
 
1. Establishing a protocol for EHEC OMV isolation and subsequent analysis of 
quantity, size and protein composition.  
2. Characterising the effect of growth phase and different media composition 
on OMV production. 
3. Determining the influence of 5% carbon dioxide, colonic host cells, simulated 







3.2.1 Establishing a protocol for OMV isolation from EHEC cultures 
 
To develop a standard protocol for EHEC OMV isolation, Stx-negative EHEC strains 
TUV 93-0 and 85-170 were grown in LB medium shaking at 37oC for 24 hours. After 
centrifugation, the supernatant was sterilised by using filter units with 0.45µm pore 
sizes to ensure the collection of larger OMVs. The filtered supernatant was then 
concentrated by ultrafiltration using centrifugal units made up of cellulose 
membranes with a 100 kDa MWCO. 
 
Since previous studies have isolated OMVs through crossflow tangential filtration 
without an ultracentrifugation (UC) step, it was examined whether UC was necessary 
for this study after samples undergo ultrafiltration using centrifugal units (Stentz et 
al., 2015, Jones et al., 2020). To elucidate this, half of the sample was subjected to 
UC and the protein profiles were examined by SDS-PAGE. As shown in Fig. 3.1, UC 
samples showed two protein bands with a molecular size of approximately 32 kDa, 
which correspond to the E. coli outer membrane proteins (Omp) F/C and A, generally 
used for E. coli OMV quantification (McBroom and Kuehn, 2007, Manning and Kuehn, 
2011, Horstman and Kuehn, 2000, Lee et al., 2007, Schwechheimer et al., 2014, 
Bonnington and Kuehn, 2016). However, these bands were obscured by 
contaminating protein bands in samples not subjected to UC, hence indicating the 
requirement of an UC step. To verify the absence of viable EHEC, OMV samples were 
plated onto LB agar plates, which resulted in no growth. 
 
OMV samples were subsequently labelled with lipophilic dyes DiO and DiI, which 
integrate into the phospholipid membrane of OMVs. As shown in Fig. 3.2, the images 
produced by florescence microscopy revealed florescent spherical entities, 
suggesting the presence of small phospholipid bodies. OMV samples were also 
subjected to transmission electron microscopy which demonstrated the presence of 















Figure 3.1: Ultracentrifugation is required for EHEC OMV isolation. Overnight cultures of EHEC 
strain TUV 93-0 and 85-170 were inoculated in LB medium (1:100) and grown shaking at 37oC for 
24 hours. OMVs were subsequently concentrated from supernatants and subjected to UC (+) or 
left untreated (-). Proteins were separated by SDS-PAGE. OmpF/C and OmpA are highlighted. Gel 




Figure 3.2: Fluorescence micrograph of OMVs isolated from EHEC 85-170 grown in LB medium 
for 24 hours labelled with DiI or DiO lipophilic dye. Isolated OMVs were labelled with dye DiI 
(red) or DiO (green). Shown are representative images from three independent experiments. 
Images were produced at a resolution as close to the optimal resolution permitted by the system. 
Images were attained by using a Zeiss Axio imager M2 widefield microscopy fitted with a 40x 
water emersion objective (EC Plan-Neofluar 40x, NA = 0.75, Zeiss). Scale bars = 10µm. 
DiI DiO 
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Figure 3.3: Transmission electron micrograph of OMVs isolated from EHEC 85-170 grown in LB 
medium for 24 hours. Shown are representative images of two independent experiments. Arrows 
indicate OMVs. Scale bar = 100nm. 
 
Previous studies have demonstrated that medium components can be detected in 
OMV sample preparations, which can affect subsequent analysis (Cecil et al., 2016). 
To exclude the presence of LB medium contaminants in OMV preparations, cultures 
of EHEC strain 85-170 grown in LB and sterile LB medium were treated for OMV 
purification using the established protocol. Samples were subsequently examined 
using SDS-PAGE and assessed by dynamic light scattering (DLS) which would detect 
nanoparticle contaminants. 
 
The resulting polyacrylamide gel revealed that the OMV preparation from cultured 
EHEC 85-170 demonstrated a similar protein profile to that shown in Fig. 3.4A. In 
contrast, no proteins were present in the samples obtained from sterile LB medium 
(Fig. 3.4A). In addition, DLS analysis did not detect any nanoparticles in the OMV 
preparation from the sterile medium sample, whereas nanoparticles (OMVs) with a 
size range of above 43.82nm and under 825nm were identified in samples from EHEC 
cultures (Fig. 3.4B). In conclusion, both these techniques confirm that LB medium 
contaminants are not present in EHEC OMV preparations. Therefore, it was decided 

























Figure 3.4: EHEC OMV preparations do not contain contaminants from LB medium. Overnight 
cultures of EHEC strain 85-170 were inoculated in LB medium (1:100) and grown shaking at 37oC 
for 24 hours. EHEC culture and the same volume of sterile LB medium were treated for OMV 
isolation. (A) Neat and diluted (1:10) samples were separated by SDS-PAGE. Gel image is 
representative of two independent experiments. (B) Dynamic light scattering confirms the 
absence of nanoparticles in LB samples. The size distribution of EHEC 85-170 as means ± SD of 











































































Figure 3.5: Flow chart of the protocol used to isolate EHEC OMVs in this investigation. MWCO = 
molecular weight cut-off. Created by BioRender.com 
 
 
3.2.2 OMV yield increases during EHEC growth 
 
Previous studies have demonstrated that OMV production is dependent on bacterial 
growth phase, with the highest OMV yield being attained from stationary phase 
cultures in various bacterial species including non-pathogenic E. coli (Gerritzen et al., 
2017, Bauman and Kuehn, 2006, Manabe et al., 2013, McCaig et al., 2013, Tashiro et 
al., 2010). To determine the growth kinetics of EHEC strains TUV 93-0 and 85-170 in 
LB medium, overnight cultures of bacteria were inoculated at a 1:100 dilution in LB 
medium and grown shaking at 37oC. Growth was then evaluated by measuring the 
optical density at 600nm (OD600) over 24-hour growth periods.  
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As shown in Fig. 3.6, both EHEC strains exhibit similar growth curves. After a 1-hour 
lag phase, both strains entered the exponential (log) growth phase. After 4 hours, 
bacterial growth slowed and the curve plateaued after 8 hours, indicating the 
approach of the stationary phase. Only a slight increase in OD600 was observed after 












Figure 3.6: Growth curve of EHEC TUV 93-0 and 85-170 over a 24-hour growth period in LB 
medium. Overnight EHEC cultures were inoculated in LB medium (1:100) and grown shaking at 
37oC. Data is shown as means ± SD of three independent experiments performed in duplicate.  
 
To determine the effect of growth phase on OMV production, 4-, 7- and 24-hour time 
points were selected to represent the log, late log and stationary phase of EHEC 
growth, respectively. EHEC LB cultures were incubated for the respective time 
periods and OMVs were isolated according to the established protocol. OMV yields 
were quantified by Bradford protein assay and densitometric measurements of 
OmpA and OmpF/C after SDS-PAGE, hereafter termed as the Omp density area. All 
data was normalised to the OD600 of the harvested cultures to account for differences 
in bacterial numbers at different growth phases (Fig. 3.7). For both strains the lowest 
OD600 were attained from 4-hour cultures, with significantly higher OD600 being 
attained with longer incubation periods (Fig. 3.7; P < 0.001). However, the OD600 
measurement of harvested cultures were significantly lower compared to those 
shown in Fig. 3.6 (Fig S1A, P < 0.001 and P < 0.0001 after 7- and 24-hour culture 


















periods for EHEC strain TUV 93-0, and P < 0.01 at 4 hours and P < 0.001 at longer 
incubation periods for EHEC strain 85-170).  
 
 
Figure 3.7: Higher OD600 values are obtained from EHEC cultures when grown for longer time 
periods. Overnight cultures of EHEC strains TUV 93-0 and 85-170 were inoculated in LB medium 
(1:100) and grown shaking at 37oC for 4, 7 and 24 hours. Data is shown as means ± SD of three 
independent experiments, performed in duplicates. *** = P < 0.001.  
 
Data attained from Bradford protein assay showed that relative OMV protein content 
of both strains increased over time, with the highest yield being obtained from both 
strains after a 24-hour growth period (Fig. 3.8A), yet differences were only significant 
for EHEC strain 85-170 between 4-hour and 24-hour cultures (P < 0.05). On average, 
according to Bradford protein assay, OMV yields exhibited an 8-fold and 2.8-fold 
increase between 4- and 24-hour cultures for EHEC strains TUV 93-0 and 85-170, 
respectively. In addition, yields obtained from 24-hour cultures of EHEC strain 85-170 
were significantly higher than those attained from 24-hour cultures of EHEC TUV 93-
0 (P < 0.05). 
 
SDS-PAGE indicated similar protein profiles of the isolated OMVs at the different time 
points (Fig. 3.8B). Additionally, increases in Omp band intensities for both EHEC 
strains were noted over time. This was confirmed by densitometric analysis of Omp 
proteins, with maximal OMV production at stationary phase (Fig. 3.8C). Using 
densitometric values, OMV yields exhibited a 4-fold and 6.5-fold increase between 4- 
and 24-hour cultures for EHEC strains TUV 93-0 and 85-170, respectively. 




















Furthermore, for both EHEC strains statistical tests confirmed significant differences 
between yields obtained between 4- and 24- hour cultures (P < 0.001 for EHEC strain 
TUV 93-0, P < 0.0001 for EHEC strain 85-170), and 7- and 24-hour cultures of the same 
strain (P < 0.01 for EHEC strain TUV 93-0, P < 0.0001 for EHEC strain 86-170). In 
addition, significantly higher OMVs yields were attained from EHEC 85-170 cultures 
compared to TUV 93-0 cultures after 7- (P < 0.01) and 24-hour (P < 0.0001) incubation 
periods. 
 
Overall, both quantitative methods indicated that 24-hour stationary EHEC cultures 
produced the highest OMV yield, thus 24-hour growth cultures will be used for future 
experiments. 
 
Having established optimal parameters for OMV isolation from Stx-negative EHEC 
strains, OMVs were subsequently isolated from the Stx-producing EHEC strain 
EDL933. Due to safety regulations in the containment level (CL) 3 laboratory, EHEC 
growth through of shaking cultures in Falcon tubes was not permitted. Instead, 
bacteria were grown in T75 cell culture flasks on a rocking platform at 37oC. As well 
as measuring OD600 measurements, viable cell counts were quantified using the Miles 
and Misra method i.e., a 100µL aliquot of the culture was serially diluted and three 
10µL spots per dilution were plated out on LB agar.   
 
After 24 hours growth periods, EDL933 cultures reached an OD of 3.16 ± 0.18 and a 
viable cell count of 5.68 x 108 cfu/mL ± 2.37 x 108 was attained. OMVs were quantified 
by using Bradford protein assay and Omp densitometric analysis (table 3.1). Overall, 
both quantitative methods detected significantly higher OMV values than that of 
EHEC strain TUV 93-0 and 85-170 grown in shaking Falcon tubes, yet this could be 
due to cultures being grown in T75 flasks rather than in Falcon tubes. Furthermore, 
the OMV protein pattern (Fig. 3.9) was similar to those of strains TUV 93-0 and 85-














Figure 3.8: EHEC OMV production is dependent on growth phase. OMVs were isolated from 4-, 
7- and 24- hour cultures of Stx-negative EHEC strains TUV 93-0 and 85-170. A) OMV quantification 
by Bradford protein assay. B) SDS-PAGE of OMV samples. C) Densitometric analysis of Omp 
proteins. Data was normalised to the OD600 of processed bacterial cultures. Data is shown as 
means ± SD of three independent experiments, performed in duplicates. * = P < 0.05, ** = P < 
0.01, *** = P < 0.001, **** = P < 0.0001. 
































































































Table 3.1: OMV production by stationary phase cultures of Stx-positive EHEC strain EDL933 
grown in LB medium. OMVs were isolated from 24-hour EHEC cultures and quantified by 
Bradford protein assay and Omp densitometry. Data was normalised using OD600 of processed 
bacterial cultures. Data is shown as means ± SD of two independent experiments performed in 
triplicate. 
 
Figure 3.9: Protein composition of OMVs isolated from stationary phase LB cultures of EHEC 




3.2.3 EHEC OMV production can be affected by different culture media 
 
Previous studies have shown that bacterial growth in different media can affect OMV 
yield and composition (Choi et al., 2014, Brameyer et al., 2018, Vasilyeva et al., 2009). 
Here, the effect of a different media (Tryptic soy broth (TSB) and DMEM/F-12 
medium) on OMV production was assessed. In addition, EHEC growth was quantified 
by OD600 and viable cell counts (cfu/mL).  
 
Mode of quantification Values 
Bradford protein assay (µg/mL) 365.9 ± 211  
Omp density area 40564 ± 2427 
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After a 24-hour growth period, similar viable cell counts were attained when EHEC 
strains were grown in TSB versus LB medium (Fig 3.10A). Additionally, similar OD600 
values were obtained from EHEC strains grown in TSB compared to LB medium (Fig 
3.10B). 
 






Figure 3.10: No significant difference in EHEC growth arises between TSB and LB cultures. 
Overnight cultures of EHEC strains TUV 93-0 and 85-170 were inoculated in either LB or TSB media 
(1:100) and grown shaking at 37oC for 24 hours. Growth was assessed by (A) viable cell counts 
and (B) OD600 measurements. Data is shown as means ± SD of at least two independent 
experiments performed in triplicates. 
 
For both EHEC strains, Bradford protein assay demonstrated a significantly higher 
yield when OMVs were isolated from EHEC TSB cultures than in EHEC LB cultures (Fig. 
3.11A, P < 0.0001). No significant differences were detected between EHEC strains 
when grown in the same medium. As shown on Fig. 3.11B, dissimilar OMV protein 
patterns were displayed when EHEC was cultured in different media. Omp 
densitometric analysis indicated that compared to LB, OMV production in TSB 
medium increased by 1.6 and 3 times for EHEC strains 85-170 and TUV 93-0, 







































































Figure 3.11: Compared to LB cultures, OMV production is higher when EHEC is cultured in TSB. 
OMVs were isolated from cultures of TUV 93-0 and 85-170 grown in either LB or TSB media for 
24 hours. A) OMV quantification by Bradford protein assay. B) SDS-PAGE of OMV samples isolated 
EHEC 85-170. C) Densitometric analysis of Omp proteins. Data was normalised to the OD600 of 
processed bacterial cultures. Data is shown as means ± SD of at least three independent 
experiments, performed in duplicates. * = P < 0.05, **** = P < 0.0001. 
 
To determine the effect of DMEM/F-12 medium on EHEC OMV production, Stx-
positive EHEC strains EDL933 and 86-24 were used. For both strains, OMVs were 
isolated from LB or DMEM/F-12 cultures which were grown in T75 flasks at 37oC for 
24 hours. Bacterial growth was also assessed by determining cell density and 
measuring OD600. As shown in Fig. 3.12, similar viable cell counts (A) and OD600 values 
(B) were obtained for both EHEC strains between the two conditions examined. In 
addition, no significant difference in growth was detected between the two strains. 
























































Isolated OMVs were separated on a polyacrylamide gel and protein profiles showed 
differences between strains and between conditions (Fig. 3.13A). Omp densitometric 
analysis indicated that both EHEC strains produced similar OMV yields as statistical 
tests failed to detect significant differences, even though strain 86-24 produced a 2.2- 
and 1.6-fold higher OMV yield than EHEC EDL933 when grown in LB and DMEM/F-12 
media, respectively (Fig. 3.13B). Furthermore, even though the data suggests 
DMEM/F-12 cultures produced higher OMV yields than LB cultures, the differences 
did not reach statistical significance.  
 
Previous studies have shown that EHEC OMVs isolated from Stx-producing strains 
contain Stx2 (Kolling and Matthews, 1999). To confirm the presence of Stx2 in OMVs 
isolated from EHEC strains EDL933 and 86-24, Western blots using a polyclonal Stx2-
specific antiserum were performed. While the antibody detected purified Stx, a weak 
signal was detected in OMV samples, with the signal migrating at a slightly higher 
molecular weight compared to purified Stx2 (Fig. 3.14B). Equal loading of OMV 
samples was confirmed by probing the blot with anti-OmpA (Fig. 3.14A).  
 
To determine if the faint signal was specific for Stx2, OMVs were purified from wild-
type EDL933 and an isogenic Stx2 mutant. OMV protein profiles from both strains 
were similar (Fig. 3.15A) and equal loading was confirmed by probing for OmpA (Fig. 
3.15B). However, blotting the membrane with anti-Stx2 produced signals for both the 
wild type and Stx-negative strain, indicating that the detected signals were not 
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Figure 3.12: Between DMEM/F-12 and LB cultures, EHEC growth is not significantly different. 
Overnight cultures of EHEC strains EDL933 and 86-24 were inoculated in LB or DMEM/F-12 media 
(1:100) and grown shaking at 37oC for 24 hours. Growth was assessed by (A) viable cell counts 
and (B) OD600 measurements. Data is shown as means ± SD of at least two independent 












Figure 3.13: EHEC OMV production is not significantly different between LB and DMEM/F-12 
cultures. OMVs were isolated from EHEC cultures of strains EDL933 and 86-24 grown in LB or 
DMEM/F-12 media. A) SDS-PAGE of EHEC OMV samples. B) Densitometric measurements of 
Omps. Data was normalised using OD600 of processed bacterial cultures. Data is shown as means 
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Figure 3.14: Western blot of OMVs isolated from strains EDL933 and 86-24 grown in either LB 
or DMEM/F-12 media. OMV isolated proteins were separated by SDS-PAGE, blotted onto 
Polyvinylidene difluoride membranes and subsequently probed with (A) anti-OmpA or (B) anti-











Figure 3.15: Cross reaction of anti-Stx2 with non-specific proteins occurs. OMVs isolated from 
LB cultures of wild-type (wt) EDL933 and an isogenic Stx mutant (Δstx) were separated by SDS-




3.2.4 Carbon dioxide does not significantly affect EHEC OMV production 
 
Various gases are present in the human gastrointestinal lumen including carbon 
dioxide (CO2; Lacy et al., 2011, Levitt and Bond, 1970). CO2 enters the gastrointestinal 
tract due to swallowing of atmospheric gas, bacterial fermentation of carbohydrates 
and colonocyte release of bicarbonate so to neutralise hydrochloric acid (Lacy et al., 
 95 
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2011). Using electronic gas sensing capsules, colonic CO2 levels have been estimated 
to be 5-30% (Kalantar-Zadeh et al., 2018). Therefore, the effect of 5% CO2 on EHEC 
OMV production was evaluated. In these experiments, EHEC cultures were grown 
rocking in T75 flasks in a 37oC incubator gassed with 5% CO2 (5% CO2/air; cell culture 
incubator), or under normal atmospheric conditions (air). 
 
As shown in Fig. 3.16A, EHEC growth in 5% CO2/ air versus air resulted in a significantly 
higher viable cell count in EHEC strains TUV 93-0 and 85-170 with a 10.4- and 13.7-
fold increase, respectively (P < 0.05). This was reflected in significantly higher OD600 
values attained from both EHEC strains when grown in 5% CO2/ air than growth in air 









Figure 3.16: EHEC growth significantly increases when supplemented with 5% CO2/air. 
Overnight cultures of EHEC strains TUV 93-0 and 85-170 were inoculated in LB (1:100) and grown 
rocking at 37oC for 24 hours in 5% CO2/air or air atmosphere. Growth was assessed by (A) viable 
cell counts and (B) OD600 measurements. Data is shown as means ± SD of three independent 
experiments performed in triplicates. * = P < 0.05. 
 
OMV protein profiles were similar when cultures were grown under both conditions 
(Fig. 3.17B). Bradford protein assay and Omp densitometric analysis indicated that 
no significant difference in OMV yields is obtained from cultures grown in 5% CO2/air 
versus air (Fig. 3.17A and Fig 3.17C, respectively). Furthermore, even though results 
indicated that under both atmospheric conditions EHEC 85-170 produced higher 
OMV yields than EHEC strain TUV 93-0, statistical tests failed to detect any significant 
differences.  







































































































Figure 3.17: EHEC OMV production is not significantly affected when cultures are supplemented 
with 5% CO2/air. OMVs were isolated from cultures of TUV 93-0 and 85-170 grown in LB for 24 
hours in air atmosphere or 5% CO2/air. A) OMV quantification by Bradford protein assay. B) SDS-
PAGE of EHEC OMV samples. C) Densitometric analysis of Omp proteins. Data was normalised 
using OD600 of processed bacterial cultures. Data is shown as means ± SD of three independent 
experiments, performed in triplicates.  
 

































































Using dynamic light scattering (DLS) technology, the size distribution of OMVs was 
determined (Fig. 3.18A). By averaging the most common OMV size, it was elucidated 
that the size of OMVs produced by EHEC 85-170 cultures in air were significantly 
larger than OMVs isolated from EHEC TUV 93-0 cultures in air (Fig. 3.18B, P < 0.05). 
Statistical tests did not detect significant differences between OMVs isolated from 
similar cultures when grown in 5% CO2/air. Furthermore, similar sizes were attained 
from cultures of the same strains when grown in different atmospheric conditions.   
 
Taken together, these results suggests that 5% CO2/air enhanced EHEC growth but 





















Figure 3.18: Dynamic light scattering data from EHEC OMVs isolated from stationary phase LB 
cultures grown in air atmosphere or 5% CO2/air. A) Representative size distribution of EHEC 
OMVs. Data is the result from one independent experiment. B) Mean of the most frequent EHEC 
OMV size during stationary phase in LB grown in air or 5% CO2/air. Data is shown as means ± SD 
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3.2.5 The presence of human cells does not significantly affect OMV yield  
 
During passage and colonisation in the gastrointestinal tract, EHEC is exposed to 
colonic host cells and their secreted products such as antimicrobial peptides. Thus, it 
was of interest to evaluate the effect the presence of human cells on EHEC OMV 
production.  
 
To achieve eukaryotic cell growth, cell culture media is usually supplemented with 
foetal bovine serum (FBS), which provides various growth factors and nutrients. To 
evaluate whether the addition of FBS would affect OMV preparations, EHEC strain 
85-170 was cultured in T75 culture flasks containing either LB medium, non-
supplemented or supplemented DMEM. In addition, since this investigation will 
assess the effect human cell lines have on OMV production, these tests were 
undertaken in 5% CO2/air which is needed to maintain eukaryotic cells.  
 
As shown by SDS-PAGE (Fig. 3.19), the Omp bands were obscured by contaminating 
protein bands in samples isolated from supplemented DMEM cultures. In addition, a 
major band around 58 kDa in size showed up in OMV preparations from 
supplemented DMEM, which probably represents contaminating bovine serum 
albumin. Consequently, the contaminants obscured Omp densitometric analysis thus 
preventing accurate OMV quantification. Nevertheless, clear Omp bands were 
attained from cultures grown in non-supplemented DMEM. Furthermore, the 
presence of protein contaminants affected OMV quantification by Bradford protein 
assay as significantly higher protein yields were gained from OMV samples from 
supplemented medium (Fig. 3.20, P < 0.0001). Therefore, to evaluate the effect of 
human cells on EHEC OMV production, incubations were performed in non-













Figure 3.19: Protein composition of OMVs isolated from EHEC cultures grown in LB, non-
supplemented DMEM or supplemented DMEM. OMVs were isolated from overnight cultures of 
EHEC strain 85-170 which were inoculated in either LB, non-supplemented (D -) or supplemented 
(D +) DMEM (1:100) and grown at 37oC rocking for 24-hours in 5% CO2/air. Diluted samples (1:10) 




Figure 3.20: Protein concentration of OMV yields isolated from EHEC grown in LB, non-
supplemented DMEM (D -) or supplemented DMEM (D +). Data is shown as means ± SD of two 
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To optimise the assay, the effect of fast-growing cervical cancer cell line HeLa was 
used. EHEC 85-170 was grown in T75 flasks containing non-supplemented DMEM 
with or without confluent HeLa cell monolayers for 24 hours at 37oC in 5% CO2/air. 
Quantification of viable cell counts showed no significant differences between 
cultures grown with and without the presence of HeLa cells (Fig. 3.21A). This was also 









Figure 3.21: EHEC growth is not significantly affected by the presence of HeLa cell monolayers. 
Overnight cultures of EHEC strain 85-170 were inoculated in non-supplemented DMEM (1:100) 
with (H +) or without (H -) HeLa cell monolayers and grown rocking at 37oC for 24 hours in 5% 
CO2/ air. Growth was assessed by (A) viable cell counts and (B) OD600 measurements. Data is 
shown as means ± SD of two independent experiments performed in triplicates. 
 
EHEC cultures and medium from non-infected HeLa cells (control) were subjected to 
OMV isolation. As proteins were also present in control medium from HeLa cells (Fig. 
3.22A), Bradford protein assay could not be used for OMV quantification in these 
experiments. Comparative analysis of the polyacrylamide gel showed distinct protein 
profiles of vesicles isolated from EHEC and HeLa cells monocultures and a 
combination of the two in EHEC-HeLa cell co-cultures (Fig. 3.22B). Notably, most 
proteins of HeLa cell origin exhibited a molecular weight above 58 kDa, thus did not 
affect OMV quantification by Omp densitometric analysis. As shown in Fig. 3.22C, no 
significant differences were detected between OMV yield between EHEC cultures 
with and without the presence of HeLa cells when Omp densitometric analysis was 
used.  
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Figure 3.22: No significant difference in OMV yield is attained between EHEC 85-170 cultures 
with and without HeLa cell monolayers. OMVs were isolated from cultures of EHEC 85-170 
grown in non-supplemented DMEM with (H +) or without (H -) HeLa cell monolayers in 5% CO2/ 
air for 24 hours. HeLa cells were also cultured on their own and treated for OMV isolation to serve 
as controls. A) Protein content of samples were quantified by Bradford protein assay and is shown 
as total protein content. B) Protein composition of vesicles released by EHEC and HeLa cells. 
Samples were also diluted 1:10. C) Densitometric analysis of Omp proteins. Data was normalised 
using OD600 of processed bacterial cultures. Data is shown as means ± SD of three independent 
experiments. 
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Following this, the effect of colonic T84 cells on OMV production by EHEC strains TUV 
93-0 and 85-170 was examined. Human T84 colonic carcinoma cells were chosen as 
they resemble colonic crypt cells and like the human colonic epithelium, do not 
express the Stx receptor known as Gb3 (Devriese et al., 2017, Schuller et al., 2004). 
Incubations were performed as described above (EHEC and T84 cells alone and in co-
culture).  
 
After a 24-hour growth period, no significant differences were detected between 
viable bacterial counts for both EHEC strains 85-170 and TUV 93-0, when grown in 
the presence of T84 cells versus the absence of T84 cells (Fig. 3.23A). Similarly, this 
was reflected with the measured OD600 values for both EHEC strains (Fig. 3.23B) 







Figure 3.23: EHEC growth is not significantly affected by the presence of T84 cell monolayers. 
Overnight cultures of EHEC strains TUV 93-0 and 85-170 were inoculated in non-supplemented 
DMEM/F-12 medium (1:100) with (+ T) or without (- T) T84 cell monolayers and grown rocking at 
37oC for 24 hours in 5% CO2/ air. Growth was assessed by (A) viable cell counts and (B) OD600 
measurements. Data is shown as means ± SD of three independent experiments performed in 
duplicate. 
 
EHEC cultures and medium from non-infected T84 cells (control) were subjected to 
OMV isolation. As proteins were also present in control medium from T84 cells (Fig. 
3.24A), Bradford protein assay could not be used for OMV quantification. Similar to 
the results described for HeLa cells, protein separation by SDS-PAGE showed specific 
protein patterns for vesicles isolated from T84 cells and EHEC, with a combination of 
the two observed in preparations from the co-cultures (Fig. 3.24B and C, 







































respectively). Notably, very little T84 cell-derived protein were present at the 
molecular weight range of OmpA and Omp F/A (circa 32 kDa), therefore Omp 
densitometry could be used to quantify EHEC OMV production in the presence and 
absence of T84 cells.  
 
Generally, densitometric quantification showed a 28% reduction for both strains 
when grown in the presence of T84 cells but this did not reach statistical significance 
(Fig 3.24D). Furthermore, no significant differences were detected between EHEC 
strains grown under similar conditions.  
 
In summary, these results indicate no significant difference in EHEC growth or OMV 

















































































































Figure 3.24: No significant differences in OMV yield is attained between EHEC cultures with or 
without T84 cells monolayers. OMVs were isolated from EHEC cultures of TUV 93-0 and 85-170 
grown in non-supplemented DMEM/F-12 medium with (+ T) or without (- T) T84 cell monolayers 
in 5% CO2/air for 24 hours, rocking at 37oC. T84 cells were cultured on their own and treated for 
OMV isolation to serve as controls. A) Protein content of samples were quantified by Bradford 
protein assay and is shown as total protein content. Protein composition from isolated T84 cell 
derived vesicles and OMV samples from EHEC strains (B) TUV 93-0 and (C) 85-170. Samples were 
also diluted 1:10. D) Densitometric analysis of Omp proteins. Data was normalised using OD600 of 
processed bacterial cultures. Data is shown as means ± SD of three independent experiments, 
performed in duplicates. * = P < 0.05, *** = P < 0.001. 
 
 
3.2.6 Bile salts significantly increase OMV production  
 
Simulated colonic environmental medium (SCEM) reproduces several parameters 
within the human colon including neutral pH, osmolarity and the presence of 
secondary bile salts, and thus represents an optimal medium to investigate the 
effects of the colonic milieu on EHEC OMV production (Beumer et al., 1992). 
However, previous studies have reported that bile salts have outer membrane-
damaging effects on bacteria, thus causing bacterial cell lysis and the release of 
cytoplasmic proteins (Merritt and Donaldson, 2009). Consequently, EHEC lysis by 
SCEM could lead to artificial vesicle formation from fragmented membranes and 
cause OMV sample contamination (Turnbull et al., 2016, Devos et al., 2017). To 
determine whether the concentration of bile salts in SCEM (4.73mM) leads to 
bacterial lysis, EHEC strains TUV 93-0 and 85-170 were grown shaking at 37oC in SCEM 

























with or without bile salts for 24 hours. Growth was determined by OD600 and viable 
cell counts. As shown in Fig. 3.25A and B, both EHEC strains demonstrated similar 
OD600 measurements and viable cell counts throughout the growth period in both 
media, thus indicating that bile salt concentrations used in SCEM does not induce 

























Figure 3.25: Growth curves of EHEC TUV 93-0 and 85-170 over a 24-hour growth period in SCEM 
with or without bile salts. Overnight cultures of bacteria were inoculated in SCEM (1:100) with 
(+) or without (-) bile salts and grown shaking at 37oC for 24 hours. Bacterial growth was 
determined by (A) OD600 and (B) colony forming units per mL (cfu/mL). Data is shown as means ± 

































TUV 93-0 in SCEM +
85-170 in SCEM +
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85-170 in SCEM -
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To exclude the presence of SCEM-derived contaminants in OMV preparations, 24-
hour EHEC cultures in SCEM and sterile SCEM were subjected to OMV purification.  
Sample were subsequently examined for contaminants by SDS-PAGE and DLS. As 
shown in Fig. 3.26A, no proteins were present in OMV preparations from sterile 
SCEM, yet a protein pattern was produced from the treated SCEM culture. Similarly, 
DLS analysis did not detect any nanoparticles in SCEM-derived samples (Fig. 3.26B). 





















Figure 3.26: EHEC OMV preparations do not contain contaminants from SCEM. Overnight 
cultures of EHEC strain 85-170 were inoculated in SCEM (1:100) and grown shaking at 37oC for 24 
hours. EHEC culture and the same volume of sterile SCEM were treated for OMV isolation. A) 
Neat samples were separated by SDS-PAGE. Gel image is representative of two independent 
experiments. B) Dynamic light scattering confirms the absence of particles in sterile SCEM 
samples. Furthermore, the size distribution of EHEC 85-170 is shown as means ± SD of two 




























































































To assess the impact of SCEM and bile salts on EHEC OMV production, EHEC strains 
85-170 and TUV 93-0 were grown for 18 hours in LB and SCEM with and without bile 
salts, and cultures were subsequently treated for OMV isolation. Furthermore, 
bacterial growth was monitored by OD600 measurements and viable cell counts. A 
shorter incubation period was chosen as the high viscosity of OMV samples isolated 
from 24-hour SCEM cultures was observed in initial experiments.  
 
Interestingly, for both EHEC strains, viable cell counts significantly decreased when 
grown in SCEM containing bile salts compared to LB medium (Fig. 3.27A, P < 0.001 
for EHEC strain TUV 93-0 and P < 0.01 for EHEC strain 85-170). A reduction in viable 
cell counts also occurred between SCEM cultures without bile and LB, yet this was 
only significant for EHEC strain TUV 93-0 (P < 0.05). While the reduction in bacterial 
numbers in SCEM without bile salts versus LB was also reflected by decreased OD600 
values, bacterial densities of SCEM cultures with bile salts were not significantly 
different from those of LB cultures (Fig 3.27B). Curiously, OD600 measurements and 
viable cell counts were lower than those obtained for previous growth curves in SCEM 
(Fig. 3.25A and B, respectively). However, due to no 18-hour data points in the growth 























Figure 3.27: Viable cell counts decrease when EHEC is grown in the presence of bile salts in EHEC 
cultures used for OMV isolation, yet OD600 is not significantly affected. Overnight cultures of 
EHEC strains TUV 93-0 and 85-170 were inoculated in LB or SCEM with (+) or without (-) bile salts 
(1:100) and grown shaking at 37oC for 18 hours. Growth was assessed by (A) viable cell counts 
and (B) OD600 measurements. Data is shown as means ± SD of six independent experiments 
performed in triplicates. * = P < 0.05, ** = P < 0.01, *** = P < 0.001. 
 
Analysis of OMV samples by Bradford protein assay demonstrated that similar values 
were attained from EHEC strains TUV 93-0 and 85-170 under all culture media (Fig. 
3.28A).  
 
The protein profiles of OMVs isolated from EHEC strain TUV 93-0 grown in LB and all 
SCEM cultures were similar except for the diffuse smear in the higher molecular 
weight region present in OMVs isolated for EHEC strain TUV 93-0. For EHEC 85-170, 
OMV protein profiles appeared similar between LB and SCEM without bile salt 











































culture, with additional band appearing in cultures grown in SCEM with bile salts (Fig. 
3.28B and C, respectively). Furthermore, a 1 in 10 dilution of the OMV samples from 
SCEM cultures for both EHEC strains was needed in order to clearly visualise protein 
profile, suggesting a higher OMV yield in SCEM cultures versus to LB cultures.  
 
Omp densitometry indicated that both EHEC strains produced the lowest OMV yield 
when cultured in LB medium, with a 6-fold increase in OMV yield in SCEM cultures 
without bile salts and a further 2.8-fold increase being produced in SCEM cultures 
containing bile salts (Fig. 3.28D). Significant differences were detected between 
SCEM cultures containing bile salts and both SCEM cultures lacking bile salts (P < 0.01) 
and LB cultures (P < 0.001) for both EHEC strains. No significant differences were 













































































Figure 3.28: EHEC OMV production increases when cultured in the presence of bile salts. 
Overnight cultures of EHEC strain TUV 93-0 and 85-170 were inoculated in LB medium or SCEM 
with (+) or without (-) bile salts (1:100) and grown shaking at 37oC for 18 hours. The cultures were 
then treated for OMV purification. A) Isolated OMVs were quantified by Bradford protein assay. 
Protein composition of isolated EHEC OMVs from (B) TUV 93-0 or (C) 85-170 cultures. D) 
Densitometric Omp analysis. Data was normalised using OD600 of processed bacterial cultures. 
Data is shown as means ± SD of five independent experiments. ** = P < 0.01, *** = P < 0.001.  
 
OMV sizes were also analysed using the Nanoparticle tracking analysis (NTA) system, 
which produced OMV size distribution curves (representative curves shown in Fig. 
3.29). By analysing the mean of the most common OMV size (Fig. 3.30), both strains 
produced significantly smaller OMVs when cultured in SCEM lacking bile salts 
compared to culture in LB (P < 0.01 for EHEC strain TUV 93-0 and P < 0.001 and EHEC 
85-170) or SCEM with bile salts (P < 0.01 for EHEC strain TUV 93-0 and P < 0.05 for 
EHEC strain 85-170). Furthermore, results suggested OMV sizes were larger in LB 
cultures of EHEC TUV 93-0 and 85-170 (P < 0.01).  
 
The NTA system also allowed for the quantification of OMV particles. Generally, 
higher OMV yields were obtained from EHEC strains grown in SCEM with bile salts 
compared to when EHEC was grown in the other two media (Fig. 3.31), however this 
did not reach significance.  
 
Overall, this data suggests that growth in SCEM containing bile salts EHEC viability 
significantly reduces but OMV production is significantly enhanced.  
 


































Figure 3.29: Size distribution of EHEC OMVs isolated during stationary phase in LB and SCEM 
with (+) and without (-) bile salts. OMVs from EHEC TUV 93-0 and 85-170 cultures were examined 
by Nanoparticle tracking analysis using the Nanosight LM10 instrument. Data is shown as a result 
from an independent experiment.  

























































































































































Figure 3.30: EHEC OMV sizes during stationary phase cultures in LB and SCEM with (+) and 
without (-) bile salts. OMVs from EHEC TUV 93-0 and 85-170 cultures were examined by 
Nanoparticle tracking analysis using the Nanosight LM10 instrument. Data is shown as the mean 
of the most frequent OMV size ± SD of at three independent experiments. * = P < 0.05, ** = P < 




Figure 3.31: EHEC OMV concentrations obtained from LB cultures and SCEM cultures with (+) 
and without (-) bile salts. OMVs from EHEC TUV 93-0 and 85-170 cultures were examined by 
Nanoparticle tracking analysis using the Nanosight LM10 instrument. Data was normalised using 

























































3.2.7 Bile salts do not affect OMV integrity  
 
Bile salts can dissolve membrane lipids and cause integral membranes to disassociate 
(Merritt and Donaldson, 2009). To investigate whether bile salt concentrations in 
SCEM could dissolve OMVs, OMVs isolated from EHEC strains 85-170 and TUV 93-0 
cultures in SCEM without bile salts were incubated in SCEM with or without bile salts, 
shaking at 180 rpm for 18 hours at 37oC. OMVs were then recovered by ultrafiltration 
using spin columns with a 100 kDa MWCO. Non-OMV-associated proteins in the flow-
through were precipitated with trichloroacetic acid. Both ultrafiltrate and flow-
through were analysed by SDS-PAGE. As shown in Fig 3.32, bile salts do not cause 
protein release from OMVs, since the protein profiles between OMV samples 
incubated with or without bile salts were similar. Moreover, minimal protein content 
was present in the flow-through. Probing of Western blots with anti-OmpA only 
detected the protein in the ultrafiltrates containing OMVs and not in the flow 
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Figure 3.32: Bile salts do not affect OMV integrity. OMVs isolated from EHEC TUV 93-0 and 85-
170 grown in SCEM for 18-hours without bile salts were incubated for 18 hours in SCEM with (+) 
or without (-) bile salts, shaking at 37oC. Subsequently, OMVs were isolated by ultrafiltration 
(100K MWCO) and proteins in the flow through were concentrated by trichloroacetic acid 
precipitation. Original OMV samples without treatment were included as positive controls 
(OMVs). The concentrated sample and flow throughs were analysed by SDS-PAGE and Western 








3.3 Discussion  
 
OMVs are constitutively shed by Gram-negative bacteria and production is 
considered to be essential for bacterial survival. The coordinated modulation of OMV 
synthesis enables bacteria to counter the lethal effects of harsh environments. 
Therefore, the impact on EHEC OMV production by different physiologically relevant 
conditions encountered in the gastrointestinal tract was investigated such as 5% CO2 
levels, human colonic cells and bile salts.  
 
 
3.3.1 OMV purification and quantification 
 
In order to study how different colonic settings affect EHEC OMV production, a 
workflow to isolate OMVs was optimised. After cultures were grown in the desired 
conditions, low speed centrifugation and supernatant filtration using filter units with 
pore sizes of 0.45µm was applied to separate bacteria from the supernatant. In this 
study, cellulose membrane filters were used for ultrafiltration as it is suggested that 
polyethersulphone filters have a high adsorption of proteins and macromolecules 
(Klimentová and Stulík, 2015). Previous OMV studies have isolated OMVs through 
tangential flow filtration without the need of ultracentrifugation (Stentz et al., 2015, 
Jones et al., 2020). In this study, it was established that ultracentrifugation was 
needed to isolate OMVs and accurately quantify OMV yield when ultrafiltration 
columns were used as the Omp bands needed to carry out densitometry were 
obscured in samples which lacked ultracentrifugation. OMV isolation was verified 
through (i) the presence of Omps which produced distinctive bands at the 32 kDa 
region when OMV proteins were separated via SDS-PAGE; (ii) fluorescence labelling 
of OMVs and visualisation through fluorescence microscopy; and (iii) transmission 
election microscopy (TEM). Using TEM, OMVs isolated from LB cultures ranged from 
20nm to 120nm in diameter. The size of OMVs isolated from similar growth phase LB 
cultures ranged from 43nm to 615nm when DLS was applied; and 70nm to 510nm 
when NTA was utilised. Indeed, these sizes fall into published OMV sizes which range 
from 20nm to 300nm in diameter (Schwechheimer and Kuehn, 2015).  
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Previous studies have used different techniques to quantify E. coli OMV yields, 
including Bradford protein assay and densitometric analysis of Omps (Klimentová and 
Stulík, 2015, Manning and Kuehn, 2011, Schwechheimer et al., 2014). In this 
investigation both aforementioned quantification methods were used, yet in this 
study Omp densitometry is considered to be more accurate over Bradford protein 
assay, as contaminating proteins such as flagella, fimbria, pili and large protein 
complexes can also be isolated along with OMVs after ultracentrifugation, as shown 
in Bauman and Kuehn (2006). In order to avoid such contaminants, additional 
purification steps have been used by other studies such as density gradient 
centrifugation (DGC) and size exclusion chromatography (Bauman and Kuehn, 2006, 
Bitar et al., 2019, Cecil et al., 2016). DGC is based on the lipid content of particles, 
and due to the lipid content of OMVs differing to that of contaminating proteins, 
OMVs will separate from contaminants (Horstman and Kuehn, 2000, Bauman and 
Kuehn, 2006). Another caveat of using Bradford protein assay to quantify OMV yield 
is that an increase in total protein content cannot always be interpreted as the 
isolation of more OMVs, as OMV protein content may differ between different 
growth conditions. In contrast, OMV quantification through densitometric analysis of 
Omps is not affected by larger-sized contaminating protein aggregates and is only 
dependent on ubiquitously present Omps (McBroom and Kuehn, 2007, Manning and 
Kuehn, 2011), therefore it is likely to provide a more accurate methods of measuring 
EHEC OMV yield. 
 
Other studies have quantified OMVs using lipid-based techniques. This includes using 
the lipophilic dye FM4-64, which fluoresces upon integration with the phospholipid 
membrane of OMVs (Manning and Kuehn, 2011, MacDonald and Kuehn, 2013, 
Schwechheimer et al., 2014). The fluorescence intensities which are produced 
correlate to the number of OMVs, thus producing a quantifiable measurement. 
Another way to measure OMV yield is by recording the absorbance of phospholipids 
from OMV samples which have been processed with chloroform extraction (Stewart, 
1980, Schertzer et al., 2010, Wessel et al., 2013). This method relies on the formation 
of complexes between OMV phospholipids and ammonium ferrothiocyanate which 
produces a colorimetric readout.  
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Flow-cytometry is an alternative way to measure OMV yield and gain particle sizes, 
yet conventional machines can only measure particles larger than standard light 
wavelengths such as eukaryotic cells and bacterial cells. Previous studies have used 
highly sensitive nanoparticle flow cytometers to measure OMVs which have been 
dyed with a florescent dye such as FM-1 43, FITC and FM 4-64 in order to amply OMV 
signal (Cecil et al., 2016, van der Vlist et al., 2012). Yet standardisation with flow 
beads which are within OMV size distribution is essential as inappropriate sized beads 
can result in misrepresentative quantitative values (Cecil et al., 2016). Furthermore, 
florescent dyes can affect OMV stability, with protein and DNA staining dyes resulting 
in increased OMV breakdown. Nevertheless, some lipid-based dyes do not affect 
OMV stability, therefore, the dye which is used to label OMVs needs to be considered 
prior to measuring OMVs via flow cytometry. 
 
Previously, studies have suggested that protein contaminants from rich bacterial 
growth medium may be purified along with OMVs (Cecil et al., 2016). In this study, 
through SDS-PAGE analysis and DLS examination it was verified that medium-derived 
contaminants were not present when sterile LB medium and SCEM were treated with 
the established OMV isolation procedure. Nevertheless, in this study it was 
concluded that supplemented cell culture medium (DMEM, high glucose) could not 
be used as protein contaminants are also purified, consequently obscuring Omp 
densitometry. BSA may be one of the main protein contaminants as it is one of the 
major components of FBS with a molecular weight of 66 kDa. In contrast, no 
contaminants were present when non-supplemented EHEC cultures were treated for 
OMV isolation. Likewise, Bradford protein assay detected a significantly higher 
protein content in OMV samples from supplemented DMEM EHEC cultures compared 
to non-supplemented DMEM EHEC cultures. Thus, to examine the effect of human 
cells on OMV production, subsequent cultures were made in non-supplemented cell 






3.3.2 OMV production is dependent on bacterial growth phase 
 
After the establishment of an OMV isolation protocol, the growth phase to achieve 
optimal OMV yield was determined. Here, EHEC OMV yield was highest after a 24-
hour growth period i.e., stationary phase, as determined by both Bradford protein 
assay and densitometric quantification of Omp proteins. While late growth phases 
might provide higher OMV yields, after a long growth period bacterial lysis may result 
in membrane fragmentation and self-assembly into microvesicles known as outer-
inner membrane vesicles and explosive outer-membrane vesicles (Pérez-Cruz et al., 
2013, Devos et al., 2017, Turnbull et al., 2016). Such vesicles may carry cytoplasmic 
contents and lead to potential protein contaminations when analysing OMV protein 
patterns. Here it is assumed that OMVs isolated from 24-hour cultures do not contain 
the aforementioned vesicles formed from membrane fragments, as the protein 
patterns between OMVs isolated after 24-hour cultures were similar to those of 
cultures grown for a shorter period.  
 
These results are in agreement with a study undertaken with non-pathogenic E. coli, 
which also demonstrated that it is during the stationary growth phase that OMV 
production and release is at its optimum level, with similar protein composition 
between OMVs isolated at different growth phases (Manabe et al., 2013). Similarly, 
the highest OMV yields are produced from stationary growth phase cultures of 
Pseudomonas aeruginosa and Francisella novicida, yet OMV protein contents 
differed between different growth phases (Tashiro et al., 2010, McCaig et al., 2013, 
Bauman and Kuehn, 2006). Using NTA, it has also been determined that the highest 
OMVs yields produced by Neisseria meningitidis occurs during stationary phase 
(Gerritzen et al., 2017).  
 
Strikingly, the OD600 values attained from EHEC cultures harvested for OMV isolation 
were significantly lower compared to those previously recorded for the construction 
of EHEC growth curves (Fig S1). This may be due to frequent opening of Falcon tubes 
during growth curve analysis which might have provided the growing culture with 
more oxygen compared to end-point cultures for OMV isolation. In the presence of 
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oxygen, E. coli can carry out aerobic respiration which generates more energy and 
allows faster growth compared to anaerobic respiration or mixed-acid fermentation 
which is used at low oxygen concentrations (Yasid et al., 2016, Zhu et al., 2011).  
 
For safety reasons, Stx-positive EHEC cultures were grown in T75 flasks which allowed 
better aeration of cultures than Falcon tubes. This was reflected in higher optical 
densities of LB cultures achieved by EDL933 compared to the EDL933 derivative TUV 
93-0 strain (OD600 1.85 vs 3.16). As EDL933 cultures were grown differently than those 
of TUV 93-0 (rocking flasks vs. shaking tubes), OMV production could not be directly 
compared. No studies have been undertaken to determine whether there is a 
difference in OMV vesiculation between wild type EHEC strains and mutant Δstx 
strains. Whether Stx or other virulence factors affect EHEC OMV vesiculation remains 
to be deduced.  
 
 
3.3.3 Medium composition can affect EHEC OMV yield and composition 
 
To determine whether EHEC growth in different medium affected OMV yield and 
composition, LB and Tryptic Soy broth (TSB) cultures of EHEC strains 85-170 and TUV 
93-0 were compared. Unlike LB, TSB contains a ready to use carbon source, in the 
form of dextrose. In LB, catabolic amino acids are the main carbon sources, which 
first needs to be converted to usable carbon sources by EHEC enzymes. 
Consequently, this means that more energy is used in order for EHEC to grow in LB 
compared to media which has readily available carbon sources (Sezonov et al., 2007). 
Final bacterial cell counts and OD600 values were similar between both media, 
however both Bradford protein assay and densitometric measurements of Omps 
indicated that OMV yields were higher when EHEC strains were grown in TSB. OMV 
protein profiles between isolated samples did not show major differences, suggesting 
that the different composition of LB and TSB does not affect OMV composition.  
 
Differences in OMV yields have been observed in different bacterial species when 
grown in different media. When OMV yield was compared between Pseudomonas 
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putida cultures in LB and minimal medium, the highest yield was been attained from 
LB cultures grown (Choi et al., 2014). Increased OMV production has also been 
detected by Vibrio harveyi cultures when grown in nutritional rich Luria marine 
medium compared to minimal autoinducer bioassay medium (Brameyer et al., 2018). 
Nevertheless, bacterial growth in rich medium does not always increase OMV yield, 
as studies have shown that growth of Lysobacter sp. in limited nutritional broth 
produced higher OMV yields than cultures in nutritionally rich medium (Vasilyeva et 
al., 2009). 
 
The effect of DMEM/F-12 medium on two clinically relevant Stx-producing EHEC 
strains; EDL933 and 86-24 was examined. DMEM/F-12 medium contains glucose, 
amino acids, vitamins and inorganic salts and has been shown to support the growth 
of other E. coli pathotypes such as EAEC (Ellis et al., 2020). Indeed, this medium is 
mainly used to grow mammalian cells, yet supplementation with FBS is needed as the 
medium does not contain growth hormones. In this study, the growth between the 
two EHEC strains in DMEM/F-12 medium was similar to that of LB cultures. Regarding 
OMV production, no statistical differences were attained between yields for both 
EHEC strains when cultured in DMEM/F-12 medium, however it may be possible that 
more replicates would make differences significant. The different protein pattern 
produced between OMVs isolated from cultures grown in different medium, implied 
that in different media, different proteins were expressed. 
 
A weak Stx2 signal was detected by Western blots which is in contrast to other studies 
which have demonstrated Stx release within OMVs (Kolling and Matthews, 1999). It 
is speculated that this is due to the insufficient sensitivity of the antibody, as the 
presence of Stx was confirmed by immunofluorescence imaging when studying OMV 





3.3.4 EHEC OMV production is not significantly affected by the presence of 5% 
carbon dioxide  
 
Using an electronic gas sensing capsule, CO2 levels in colonic liquid has been 
measured to be from 5% to 30% of the total gas profile in the colon (Kalantar-Zadeh 
et al., 2018). Therefore, in this investigation the effect of 5% CO2 on EHEC OMV 
production was evaluated. CO2 becomes present in the gastrointestinal tract through 
various ways including (i) the swallowing of air, (ii) as a result of hydrogen ions 
present in gastric acid reacting with bicarbonate produced by cells, and (iii) as a by-
product following bacterial fermentation.   
 
In this study, supplementation of EHEC cultures with 5% CO2 significantly increased 
viable cell counts and OD600 measurements for both EHEC TUV 93-0 and 85-170. This 
is comparable to findings from earlier studies which showed that the growth rate of 
E. coli increases with a 0.3% CO2 supplementation, compared to normal atmospheric 
CO2 concentrations of 0.03% (Repaske and Clayton, 1978). Furthermore, a previous 
study has demonstrated that optimal growth rate is obtained by E. coli in anaerobic 
conditions when supplemented with 5% CO2, therefore emphasising the growth 
benefits of CO2 for E. coli (Lacoursiere et al., 1986). In contrast, another study 
suggests that in 5% CO2, E. coli growth is inhibited yet this study only evaluated 
growth after 4- and 8-hour incubation periods (Eklund, 1984).  
 
E. coli can utilize CO2 in order to produce bicarbonate molecules which are needed 
for nucleotide base synthesis, fatty acid synthesis and carboxylation reactions 
(Holms, 1996, Merlin et al., 2003). Due to the relatively low levels of CO2 in normal 
atmospheric conditions and rapid diffusion of CO2 from cells, E. coli possesses 
carbonic anhydrases to converts CO2 to bicarbonate and maintain intracellular levels 
of bicarbonate (Merlin et al., 2003, Capasso and Supuran, 2015). In solution, CO2 and 
bicarbonate spontaneously equilibrate, and it may be due to the higher levels of 
bicarbonate in CO2 supplemented cultures that significantly higher growth levels 
arise in this investigation. Indeed, studies have shown that CO2 supplementation 
permits the growth of mutant E. coli strains deficient of functional carbonic 
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anhydrases (Merlin et al., 2003). For EHEC, bicarbonate levels can also influence the 
expression of virulence genes through RscB and GrvA proteins (Morgan et al., 2013, 
Morgan et al., 2016). In acidic environments, RscB can form a heterodimer with GadE 
and activate the glutamate-dependent acid resistance pathway, which represses the 
expression of LEE. However, when sensing bicarbonate through GrvA, the glutamate-
dependent acid resistance pathway is repressed and expression of the TTSS is 
induced (Morgan et al., 2016, Abe et al., 2002).   
 
In contrast to enhanced EHEC growth, the presence of 5% CO2 did not result in 
significant increases in OMV yields. To the best of my knowledge, no studies have 
been performed to evaluate the effect of CO2 on OMV production in other bacterial 
species. Speculatively, since EHEC growth is augmented in 5% CO2, it is unlikely that 
EHEC undergoes major external stresses. This would correlate with the reduced OMV 
yields, since increased vesiculation has been associated with increased bacterial 
stresses (Maredia et al., 2012, MacDonald and Kuehn, 2013, McBroom and Kuehn, 
2007, Schwechheimer et al., 2013, Baumgarten et al., 2012, McBroom et al., 2006, 
Orench-Rivera and Kuehn, 2016, Bauwens et al., 2017a, Bauwens et al., 2017b).  
 
 
3.3.5 The presence of human cell lines does not significantly affect OMV yields 
 
To determine the effect of host cells on EHEC OMV production, EHEC was cultured in 
the presence of cervical HeLa cells generally used to investigate EHEC A/E lesion 
formation (Knutton et al., 1989) and the more biologically relevant Gb3-negative 
colon carcinoma cell line T84 (Schuller et al., 2004). Here, bacteria and cells were also 
cultured alone in non-supplemented cell culture medium to serve as controls. Like 
the intestinal epithelium, T84 cells can synthesise antimicrobial peptides such as 
lysozyme and cationic human beta-defensins (hBD; O'Neil et al., 1999, Ou et al., 2009, 
Bernet-Camard et al., 1996). Studies have also demonstrated that upon EHEC 
infection the expression of hBD2 by T84 cells is induced (Lewis et al., 2016). Thus, it 
was anticipated that EHEC growth would be affected when grown in the presence of 
T84 cells due to the antimicrobial abilities of hBD2 produced by T84 cells (Mathew 
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and Nagaraj, 2017). Here there was no significant difference in bacterial growth in 
the presence of cell monolayers compared to the absence of host cells. 
 
Interestingly, distinct protein bands were produced on polyacrylamide gels when 
non-infected medium samples from both HeLa and T84 cells were treated for OMV 
isolation and then evaluated. The presence of proteins in cell-derived samples, was 
also supported by Bradford protein assay. It is likely that these proteins are derived 
from extracellular vesicles such as exosomes. Like OMVs, exosomes can be purified 
by ultrafiltration and ultracentrifugation as they are similar in size (30 to 150nm; 
Doyle and Wang, 2019, Nath Neerukonda et al., 2019). Furthermore, exosomes 
contain cell-derived proteins and genetic material (Kowal et al., 2016). Notably, it has 
been shown that T84 cells can secrete exosomes which can interact with dendritic 
cells and instigate and immune response (Mallegol et al., 2007). 
 
Due to the presence of proteins in host cell-derived OMV preparations, Bradford 
protein assay was unsuitable for OMV quantification as it does not distinguish 
between EHEC- and host cell-derived proteins. In contrast, densitometric analysis of 
Omps was not affected by the presence of exosomes as these contained negligible 
amounts of proteins in the 32 kDa range. Densitometry results indicated similar EHEC 
OMV yields between the presence and absence of cell monolayers. It was predicted 
that lower OMV yields would be attained in the presence of host cells as it may have 
been possible that OMV internalisation by host cells occurs. To prevent OMV 
internalisation, uptake inhibitors such as dynasore and nystatin, could have been 
used. However, these drugs have an effect on cellular lipid rafts, cholesterol and actin 
which can impede the host response of T84 cells to EHEC and thereby artificially 
affect EHEC OMV production (Preta et al., 2015). Nevertheless, subsequent 
experiments in this thesis concluded that such internalisation is unlikely for T84 cells 
as results from internalisation experiments demonstrate that EHEC OMV uptake by 
this cell line was negligible (Chapter 4, Fig. 4. 29, Fig. 4. 30 and Fig. 4. 31).  
 
Another approach used to examine the influence of host cells on OMV production 
without the possibility of OMV internalisation by host cells has been used by Bauwens 
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et al. (2017), where EHEC was cultured in medium supplemented with lysates from 
Caco-2 cells. In contrast to results presented here, the presence of cell lysates 
augments EHEC OMV production (Bauwens et al., 2017b). However, these results 
should be interpreted with caution as cell lysates contain intracellular proteins to 
which EHEC is not normally exposed to during infection. Different investigations have 
demonstrated that in the presence of membrane damaging AMPs such as polymyxin 
and human a-defensin 5, E. coli OMV yields increase which correlates with enhanced 
bacterial survival (Manning and Kuehn, 2011, Bauwens et al., 2017a, Kulkarni et al., 
2015, Urashima et al., 2017). Since OMV yields did not increase in this study, it is 
speculated that the level of AMPs produced by T84 cells in this investigation does not 
affect EHEC growth of OMV vesiculation.  
 
 
3.3.6 Simulated colonic environment medium and bile salts stimulate the 
production of EHEC OMVs 
 
In this study, simulated colonic environment medium (SCEM) was used to examine 
the effect of the abiotic parameters of the colon on EHEC OMV production as it 
exhibits physiologically relevant pH, osmotic concentrations and the presence of bile 
salts (Beumer et al., 1992). Previous studies have confirmed that EHEC growth in 
SCEM induces the expression of proteins involved in nucleotide and amino acid 
synthesis, virulence and stress response (Polzin et al., 2013, Müsken et al., 2008). 
Another important requirement for intestinal colonisation is the adaption of bacterial 
cells to bile salts as such molecules can damage the bacterial outer membrane and 
DNA (Begley et al., 2005). Previous investigations have verified that incubation of 
EHEC in medium containing bile salts decreases the expression of OmpF resulting in 
reduced outer membrane permeability (Hamner et al., 2013). In addition, the 
expression of the AcrAB efflux pump is upregulated at 100µM of bile salts which 
actively exports bile salts from the bacterium and renders them resistant to bile salt 
exposure (Rosenberg et al., 2003). This resistance is reflected in the growth curve 
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produced in this study which revealed that EHEC strains 85-170 and TUV 93-0 have 
similar growth kinetics in SCEM with or without bile salts.  
 
Curiously, when OMVs were harvested from 18-hour SCEM EHEC cultures, a 3-fold 
decrease in viable cell counts was detected for both strains in the presence of bile 
salts compared to SCEM without bile salts. In addition, EHEC viable cell counts were 
lower in SCEM cultures lacking bile salts than in LB cultures. This is in agreement with 
data presented in Bauwens et al. (2017) which revealed that EHEC viable cell counts 
in SCEM with bile salts were lower than that of LB cultures. Likewise, OD600 
measurements in this study differed for both strains between constructed growth 
curves and endpoint cultures grown for OMV isolation. As initial growth curves did 
not detect a difference between EHEC growth in SCEM with or without bile salts, it is 
speculated that oxygen availability may explain these contradictory results. While 
growth curve analysis was carried out by frequently opening flasks, cultures for OMV 
isolation were not provided with hourly doses of air. Bile salts are known to function 
as oxygen carriers and antioxidants, and thus may lead to restriction of oxygen levels 
and aerobic respiration during EHEC growth in closed containers, therefore inhibiting 
the rate of EHEC growth (Feroci et al., 2007).  
 
In addition to attenuating EHEC growth, culture in SCEM also affected OMV 
production for both strains, compared to LB cultures. Higher yields were attained 
from SCEM cultures versus LB cultures, with a further increase in yield from cultures 
grown in the presence of bile salts. This is consistent with results from Bauwens et al. 
(2017), which demonstrated enhanced EHEC OMV production in SCEM with bile salts 
versus LB medium. Nevertheless, while densitometric measurements in Bauwens et 
al. (2017), detected a 39-fold increase in OMV yield in SCEM cultures with bile salts 
compared to LB cultures, densitometric measurements in this study suggest an 18- 
and 15-fold increase in OMV yield for EHEC strains TUV 93-0 and 85-170, respectively. 
In contrast to this investigation which used OD600 for OMV yield normalisation, 
Bauwens et al. (2017) normalised OMV yields by using viable bacterial counts. While 
bile salts reduced EHEC viable cell counts to a bigger extent than OD600 
measurements, this would consequently lead to higher adjusted OMV yields which 
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would explain the observed discrepancy. Interestingly, data attained through NTA did 
not suggest a significant increase in OMV particles, nevertheless with more replicates 
it may be possible that results are significant as data in this investigation shows 
increased trends when EHEC is grown in SCEM, with higher yields in medium 
supplemented with bile salts. 
 
The protein patterns differed between OMV samples isolated from cultures grown in 
different media. Notably, the densitometric analysis of Omps is likely to be affected 
due to downregulated expression of OmpF by bile salt exposure as described above. 
Therefore, the protein-independent nanoparticle analysis performed is likely to be 
more accurate in this case. Other studies have shown that the bile salt taurocholate 
(approximately 1.86mM) increases OMV production in Campylobacter jejuni and 
leads to changes in OMV protein composition resulting in increased proteolytic 
activity, cytotoxicity and immunogenicity to T84 cells (Elmi et al., 2018). NTA 
determined that EHEC cultures in SCEM without bile salts produced significantly 
smaller OMVs compared to EHEC cultures grown in LB and SCEM with bile salts. While 
Bauwens et al. (2017) did not analyse EHEC OMV production in SCEM without bile 
salts, OMV sizes gained in Bauwens et al. (2017) for EHEC LB and SCEM cultures were 
smaller compared to OMV sizes obtained in this investigation (LB: 115nm versus 
202nm and 225nm for EHEC TUV 93-0 and 85-170, respectively; SCEM containing bile 
salts: 115nm versus 205nm and 213nm for EHEC TUV 93-0 and 85-170, respectively).  
 
Antibiotics which activate the SOS response in EHEC have been associated with 
increased OMV production (Bauwens et al., 2017a). Similarly, when P. aeruginosa is 
exposed to DNA-damaging antibiotics, OMV vesiculation increases due to the 
activation of the SOS response which leads to antibiotic sequestration and bacterial 
protection (Maredia et al., 2012). As bile salts also induce an SOS response in E. coli, 
this might constitute a mechanism for enhanced OMV production under these 
conditions (Kandell and Bernstein, 1991, Begley et al., 2005). Yet, a recent study has 
revealed that the bile salt sodium taurocholate reduces the expression of genes 
which regulate the lipid asymmetry pathway in C. jejuni, resulting in increased OMV 
vesiculation (Davies et al., 2019). The lipid asymmetry pathway is highly conserved in 
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Gram-negatives and has been implicated as a general pathway that is involved in 
OMV biogenesis (Roier et al., 2016). Downregulation of the lipid asymmetry pathway 
leads to phospholipid accumulation on the outer leaflet of the bacterial outer 
membrane, consequently leading to asymmetric expansion and OMV formation. 
Mutants deficient of components involved in this pathway have demonstrated 
increased OMV productions. As E. coli OMV production can be regulated through the 
lipid asymmetry pathway, it is speculated that bile salts used in this study may 
increase OMV biogenesis this same pathway (Roier et al., 2016). Whether EHEC 
OMVs sequester bile salts and thereby provide protection remains to be deduced.  
  
SCEM contains 4.73 mM of bile salts composed of a 50:50 ratio of cholic and 
deoxycholic acid. Not only does this bile salt concentration exceeds physiological 
colonic levels but the concentration of the primary bile salt cholic acid far exceeds 
what is physiologically found in the colon. Due to the chemical diversity of bile salts 
and molecular complexity of biological matter such as bile and stool, the 
development of sensitive and accurate analytical methods to quantify bile salt 
concentrations in vivo is challenging (Sarafian et al., 2015). In the duodenum, it is 
estimated that bile salt concentrations can range from 4mM (starved state) to 10mM 
(fed state; Riethorst et al., 2016). Levels start to decrease in the small intestines, due 
to active absorption in the terminal ileum, with an estimated 5% of bile salts passing 
into the colon. Primary bile salts which enter the colon are subsequently transformed 
(through dihydroxylation and deconjugation reactions) into secondary bile salts such 
as deoxycholic acid and lithocholic acid (Ridlon et al., 2006). Autopsy studies 
conducted on 24 hours post-mortem cadavers have detected approximately 600 µM 
of bile salts in the cecum, with deoxycholic acid and lithocholic acid making up 34% 
(204 µM) and 26% (156 µM) of the total bile salt pool, respectively (Hamilton et al., 
2007). Nevertheless, these estimates may not be accurate due to the influence of 
post-mortem changes and patient antibiotic intake prior to death. Recent studies 
have measured bile salt concentration in healthy faecal samples to be 500 µM to 
3mM, with deoxycholic acid and lithocholic acid making up 60% and 38% of the total 
bile salt pool, respectively (Peleman et al., 2017). Since the bile salt concentrations 
used for SCEM far exceeds physiological levels, the fold increase in OMV production 
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suggested in this study may be overestimated to what occurs in vivo. Nevertheless, 
as OMV integrity was not affected by the augmented bile salt levels used in SCEM 
this study suggests that colonic levels of bile salts do not destroy EHEC OMVs.  
 
 
3.3.7 Summary  
 
Here, it has been demonstrated that the rate of EHEC vesiculation can be affected by 
different colonic conditions in distinctive ways. Firstly, this study determined that 
OMV production is growth phase-dependent, with stationary phase EHEC bacteria 
producing the highest OMV yield. Likewise, it has been demonstrated that different 
medium compositions can affect OMV vesiculation as significantly higher OMV yields 
were attained when EHEC was grown in TSB medium compared to LB medium, but 
similar yields were attained between LB and DMEM/F-12 EHEC cultures. This study 
also demonstrated that EHEC cultures in SCEM, which emulates various colonic 
abiotic factors, produced higher OMVs yields compared to LB cultures. Moreover, the 
addition of bile salts in SCEM further augmented OMV yield. In contrast, the 
supplementation of 5% CO2 to EHEC cultures and the presence of human colonic cells 
did not affect EHEC OMV production, suggesting not all colonic cues affect OMV 
production.  
 
Due to the loss of containment level 3 laboratory access, further work on Stx-
producing EHEC strains could not continue. However, due to the use of derivate Stx-
producing EHEC, it is anticipated that the effect different conditions have on such 
strains will be similar to Stx-producing EHEC. Coupled with the data presented here, 
it can be speculated that upon the ingestion, EHEC OMV vesiculation initially 
increases during EHEC passage in the gut lumen, aiding nutrient acquisition and 
providing protection against harsh conditions such as bile salts. Yet, once EHEC 
interacts with colonic cells, OMV vesiculation decreases with some OMVs possibly 
being internalised by colonic cells.  
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4 Chapter Four: The interaction between 



































EHEC infections can progress into haemorrhagic colitis and haemolytic uraemic 
syndrome (HUS; Karmali et al., 1983a, Riley et al., 1983, Tarr et al., 2005). Upon 
colonisation of the colonic epithelium, two virulence strategies are implemented by 
EHEC: (i) the formation of A/E lesions, and (ii) the production of Stx (Kaper et al., 
2004). The development of HUS is associated with the release of Stx which targets 
Gb3-expressing cells located throughout the vasculature, the central nervous system 
and the kidneys (Obata et al., 2008, Obrig, 2010). Soluble Stx is released by EHEC 
through the activation of the phage lytic cycle resulting in bacterial cell lysis (Neely 
and Friedman, 1998). Given that cells in the human intestinal epithelium do not 
express Gb3 receptors, it is not fully understood how the translocation of soluble Stx 
across the colonic epithelia into the vascular system occurs (Schuller et al., 2004, 
Kovbasnjuk et al., 2005). 
 
Various trafficking pathways have been proposed to explain how soluble Stx crosses 
the epithelia, including a macropinocytosis-mediated internalisation and subsequent 
translocation by colonocytes, and neutrophil-mediated disruption of the intestinal 
barrier which consequently allows paracellular trafficking of soluble Stx into the 
vascular system (Hurley et al., 2001, Malyukova et al., 2009, Lukyanenko et al., 2011, 
In et al., 2013). Yet, Stx has also been detected within EHEC OMVs, hence providing 
an alternative pathway for Stx release and interaction with host cells (Kolling and 
Matthews, 1999). Moreover, Yokoyoma et al. (2000), elucidated that under low 
oxygen conditions, akin to those found in the colon, Stx is mainly released via OMVs.   
 
Previous studies have demonstrated that OMVs contribute to bacterial pathogenesis 
by delivering virulence factors into host cells. OMVs produced by V. cholerae carry 
virulence factors including cholera toxin and PrtV metalloprotease, which are 
involved in inducing diarrhoea and degrading substrate proteins such as fibronectin 
in tissues, respectively (Chatterjee and Chaudhuri, 2011, Elluri et al., 2014, 
Rompikuntal et al., 2015). Similarly, LT can be encapsulated by OMVs produced by 
ETEC, which can cause increased cAMP production in target cells, leading to 
 133 
diarrhoea in the host during ETEC infections (Horstman and Kuehn, 2000, Kesty et al., 
2004). Typhoid toxin can also be encapsulated by OMVs produced by Salmonella 
enterica, which can result in DNA damage and the activation of the host DNA damage 
response in target cells (Guidi et al., 2013). 
 
The biological relevance of EHEC OMVs was confirmed in murine investigation, where 
intraperitoneal injections of EHEC OMVs resulted in the development of disease and 
renal cell damage (Kim et al., 2011). Along with Stx, other virulence factors which can 
be released via EHEC OMVs include haemolysin (Hly), flagellin, cytolethal distending 
toxin V (CdtV) and Shigella enterotoxin 1 (Kolling and Matthews, 1999, Yokoyama et 
al., 2000, Bielaszewska et al., 2013, Kunsmann et al., 2015). Using colonic-derived 
non-polarised Caco-2 cells and human microvascular endothelial cells, EHEC OMV 
internalisation has been demonstrated to be mediated by dynamin-dependent (and 
partially clathrin-mediated) endocytosis (Bielaszewska et al., 2017). It has also been 
demonstrated that upon OMV transportation to late endosomes, Stx2, CdtV and Hly 
are separated from OMVs and are trafficked to ribosomes, nucleus and mitochondria, 
respectively, consequently leading to cell apoptosis (Bielaszewska et al., 2017).  
 
To determine OMV trafficking and the trafficking of OMV-associated virulence 
factors, non-polarised Caco-2 cells were used. Yet, the use of non-polarised Caco-2 
cells to study what arises in vivo may not be appropriate. Physiologically, the 
intestinal epithelium is arranged in a polarised manner and expresses intercellular 
junctions such as tight junctions, which prevent paracellular trafficking of luminal 
contents and separating the apical and basolateral cell surfaces (Zihni et al., 2016, 
Schneeberger et al., 2018, Furness et al., 1999). Accordingly, the distribution of 
surface proteins and cytoskeletal components differs between the basal and apical 
cell membranes (van der Wouden et al., 2003, Weisz and Rodriguez-Boulan, 2009). 
The use of Caco-2 cells may also be questioned as mature Caco-2 cells are akin to 
small intestinal enterocytes due to their comparatively long microvilli and expression 
of brush boarder hydrolases unique to the small intestine (Devriese et al., 2017). 
Furthermore, due to the expression of the Gb3 receptor by Caco-2 cells, the use of 
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this cell line may not be truly reflective of what occurs in vivo, therefore questioning 
the reliability of these results (Schuller et al., 2004, Kovbasnjuk et al., 2005). 
 
In order to address these limitations, physiologically relevant colonic and renal cell 
lines were utilised in this investigation so to study the interaction between OMVs and 
the host, at both the site of bacterial infection (colon) and the main Stx target site 
(kidneys). In this investigation, to mimic the colon, the interaction between OMVs 
and polarised colonic cells was examined. Furthermore, the interaction between 
colonic T84 cells and OMVs was investigated as these crypt-like cells do not express 
Gb3 in the fully differentiated state (Schuller et al., 2004). To evaluate whether the 
results achieved by using cell monocultures fully represents what occurs in vivo, the 
interaction between EHEC OMVs and two-dimensional human-derived colonoid was 
also studied, as differentiated colonoids contain similar cell compositions as that of 
the colonic epithelium.  
 
By elucidating whether EHEC OMVs are internalised by polarised cells and 
determining the subsequent trafficking, this study will address whether OMVs 
provide a potential mechanism for Stx translocation across the colonic epithelium. As 
previous investigations have demonstrated the internalisation of EHEC OMV by non-
polarised Caco-2 cells and microvasculature cells, it is hypothesised that EHEC OMV 
internalisation can occur in the colon, with subsequent translocation in polarised 
cells.  
 
The objectives of this study were to:    
1. Determine whether OMVs can be internalised by the colon by using various 
models such as Caco-2 cells, T84 cells and human colonoid models.  
2. Investigate the intracellular trafficking of OMVs in non-polarised and 
polarised colonic models. 
3. Elucidate whether EHEC OMVs can translocate across polarised colonic 
monolayers. 
4. Evaluate if renal cells can internalise EHEC OMVs and elucidate the 




4.2.1 Optimisation of EHEC O157 OMV internalisation and detection assay 
 
EHEC infections can lead to the development of HUS, which entails kidney damage 
due to the action of Stx (Karmali et al., 1983a, Obrig, 2010). As previous studies have 
demonstrated the encapsulation of Stx within EHEC OMVs, Stx transportation from 
the colonic lumen to the kidneys may involve OMVs during infection (Kolling and 
Matthews, 1999, Bielaszewska et al., 2017). To evaluate the interaction between 
OMVs and OMV-associated Stx2 with the kidneys, African green monkey renal Vero 
cells were used as such cells readily internalise soluble Stx due to the expression of 
Gb3. They have also been used in previous studies to determine the intracellular 
trafficking of soluble Stx (Konowalchuk et al., 1977, Lingwood et al., 1987).  
 
To study OMV internalisation, previous studies have utilised lipophilic dyes to label 
OMV membranes, thus allowing OMV uptake and trafficking to be studied by 
fluorescence microscopy (Parker et al., 2010, Bielaszewska et al., 2013, Kunsmann et 
al., 2015, Jones et al., 2020). Therefore, in the first part of this investigation OMVs 
isolated from EHEC strains were labelled with lipophilic DiO dye (DiO-OMVs). 
 
To deduce whether renal Vero cells can internalise EHEC OMVs, cells were seeded 
onto coverslip and cultured for 5 days until full confluency was reached. To determine 
whether starvation was required for OMV internalisation, Vero cells were incubated 
in supplemented DMEM or in non-supplemented DMEM 24 hours prior to OMV 
inoculation. Pathophysiological EHEC OMV concentrations in the colon and kidneys 
during infection is unknown, thus the use of arbitrary OMV concentrations may lead 
to artificial results. Nevertheless, it was decided that the amount of OMVs used in 
this investigation would be similar to those used by previous studies so that some 
comparisons can be achieved (Bielaszewska et al., 2013, Bielaszewska et al., 2017). 
After quantifying OMV protein content through Bradford protein assay, Vero cell 
monolayers were incubated for 5 and 24 hours with 10µg of DiO-dyed OMVs (DiO-
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OMVs) protein isolated from LB cultures of EHEC 85-170, and monolayers were 
subsequently visualised by fluorescence microscopy. 
 
As shown in Fig. 4.1, confluent Vero cell monolayers interacted with DiO-OMVs 
isolated from EHEC strain 85-170 after 5-hours of incubation. Furthermore, 
examination of monolayers incubated with DiO-OMVs for 24 hours showed a similar 
staining pattern. Starved Vero cell monolayers exhibited fragmentation; however, 
this was probably due to the lack of nutrients in the non-supplemented DMEM as 
non-treated control monolayers showed a similar phenotype. Therefore, to study 
OMV internalisation and trafficking, subsequent experiments were performed using 
10µg of EHEC OMVs in non-supplemented cell medium without prior starvation. 
 
The use of lipophilic dyes may produce misleading results as the possibility of free 
dye interacting with host cells may arise due to insufficient washing of the lipophilic 
dyed OMV sample (Mulcahy et al., 2014, O'Donoghue and Krachler, 2016). In 
addition, previous studies have demonstrated that dye molecules can alter OMV 
membranes and may affect OMV function and intracellular trafficking (Lulevich et al., 
2009). Another possible drawback of the use of lipophilic dyes is the leaching of 
fluorescent molecules onto cellular membranes, resulting in a fluorescence pattern 
which arises due to dyed membranes rather than OMV trafficking. To confirm that 
the stained pattern produced by intracellular DiO label was not a result of 
internalisation of free dye molecules or leached dye molecules staining organelle 
membranes, an E. coli specific anti-LPS antibody was used to detect OMVs. This 
antibody was chosen as it has been shown to label EHEC OMVs in previous studies 
(Bielaszewska et al., 2017).  
 
Confluent Vero cell monolayers were incubated with DiO-OMVs or DiI-dyed OMVs 
(DiI-OMVs) for 5 hours and then immunostained. As shown in Fig. 4.2 little colocalised 
staining was exhibited. Colocalisation was quantified by Manders colocalisation 
coefficients (Fig 4.3), with a M1 value (% of red fluorophore colocalising with green 
fluorophore) and a M2 value (% of green fluorophore colocalising with red 
fluorophore) of 36.5% and 11.68% being detected, respectively, between DiO-OMV 
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signal and LPS signal. Similar colocalisation values were attained between LPS signal 
and DiI-OMVs with a M1 value of 7.4% and M2 value of 40.54%. Interestingly, a higher 
proportion of LPS signal overlaps with the lipophilic dye signal for both dyes than 
lipophilic dye with LPS signal, suggesting that some intracellular OMVs retain the dye 
molecules, yet some dye molecules may also leach onto intracellular membranes. To 
verify that free dye molecules are not present in dyed OMV samples, Vero cell 
monolayers were incubated with the flow-through attained from the last wash step 
after the OMV staining procedure with lipophilic dyes. As shown in Fig. 4.2, Vero cells 
lack staining, therefore confirming the absence of soluble dye molecules in lipophilic 
stained OMVs and suggesting the leaching of dye molecules onto organelle 




Figure 4.1: Starvation is not needed for DiO-OMVs isolated from LB cultures of EHEC 85-170 to interact with Vero cells. Vero cells were incubated with 
supplemented (non-starved) or non-supplemented (starved) DMEM, 24 hours prior to OMV incubation. Monolayers were subsequently incubated for 5 and 24 hours 
with 10µg of DiO-OMVs (green). Cell nuclei were labelled with DAPI (blue). Images are representative of three independent experiments, performed in duplicate. 
Images were produced at a resolution as close to the optimal resolution permitted by the system. Images were attained by using a Zeiss Axio imager M2 widefield 
microscope fitted with a 10x objective (EC Plan-Neofluar, NA = 0.30, Zeiss). Scale bars = 50µm. 
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Figure 4.2: DiO and DiI molecules leach onto intracellular membranes in Vero cells. Confluent Vero cell monolayers were incubated for 5 hours with 10µg of DiO-
OMVs (green) or DiI-OMVs (red) isolated from LB cultures of EHEC 85-170. Cells were also incubated with flow-through from the final wash step after staining OMVs 
with the lipophilic dyes. OMVs were detected with E. coli specific anti-LPS (red in cells incubated with DiO-OMVs and green in cells incubated with DiI-OMVs) and cell 
nuclei were labelled with DAPI (blue). Images are representative of more than three independent experiments, performed in duplicate. The main image represents 
merged images from three separate channels, with channels representing the red and green channels shown individually in the side panels. The percentage of 
colocalisation (M1, % of red fluorophore overlapping with green fluorophore; and M2, % of green fluorophore overlapping with red fluorophore) are indicated by 
the white numbers. Images were produced at a resolution as close to the optimal resolution permitted by the system. Images were attained by using a Zeiss LSM800 












Figure 4.3: Quantification of signal colocalisation between DiO or DiI molecules and OMV-LPS 
signals in Fig. 4.2. M1 = % of red fluorophores which colocalised with green fluorophores, M2 = % of 
green fluorophores which colocalised with red fluorophores. Data is shown as the means of 
colocalisation ± SD of five different cells. 
 
 
4.2.2 Upon the internalisation of OMVs isolated from EHEC by renal Vero cells, OMV-
associated Stx splits and follows a different trafficking pathway 
 
Having established that EHEC OMVs can interact with Vero cells, the interaction 
between Vero cells and OMV-associated Stx2 isolated from LB cultures of EHEC strain 
EDL933 was examined. Even though both Stx1 and Stx2 are encapsulated within OMVs 
produced by EHEC (Kolling and Matthews, 1999), the intracellular trafficking of Stx2 was 
chosen as Stx2 is associated with the development of severe disease (Werber et al., 
2003, Orth et al., 2007, Kawano et al., 2008, Byrne et al., 2015). 
 
To establish a protocol for immunofluorescence detection of Stx2, confluent Vero cell 
monolayers were incubated with 1.25µg of purified Stx2 for 5 hours and immunostained 
using a polyclonal anti-Stx2 antibody. As shown in Fig. 4.4, Stx2 labelling was localised 
to the perinuclear region. To confirm that this staining was specific for internalised Stx2, 
cells were subsequently immunostained for the endoplasmic reticulum (ER), since 
soluble Stx is known to be retrogradely trafficked to the ER (Sandvig et al., 1992). 
Colocalisation of the two markers was observed (Fig. 4.5) and quantified (Fig 4.6 A and 







































of the total Stx2 signal colocalised with the ER (Fig. 4.6A), and a M2 rate of 34.72% 
suggesting that only 34.72% of the ER compartment contained Stx2 (Fig 4.6B). Overall, 
these results suggest Stx2 is being trafficked to the ER which is consistent with previous 
results (Sandvig et al., 1992). 
 
Following these results, DiO-OMVs isolated from LB cultures of Stx-producing EHEC 
strain EDL933 were incubated with confluent Vero cell monolayers for 3 and 5 hours 
and were subsequently stained for Stx2. As shown in Fig. 4.7, Vero cells internalised DiO-
OMVs after a 3-hour incubation period, with DiO fluorescence being retained after 5 
hours. Stx2 was also detected within cells after being incubated with the same DiO-
OMVs for 3- and 5-hours, yet the intracellular localisation of DiO dye and Stx2 differed. 
This difference in location, suggests that upon OMV internalisation, OMV-associated 
Stx2 is freed and follows a different intracellular trafficking pathway to that of OMVs or 
DiO molecules. Colocalisation rate were quantified and confirmed the different 
intracellular locations, as low M1 and M2 values were obtained after both 3- and 5-hour 
incubation periods (Fig. 4.8A and B, respectively). Interestingly, not all cells which 
internalised DiO-OMVs exhibited intracellular Stx2, suggesting not all OMVs produced 









Figure 4.4: Soluble Stx2 are internalised by Vero cells after a 5-hour incubation period. Cells were 
immunostained for Stx2 (red), and cell nuclei were labelled with DAPI (blue). Images are 
representative of more than three independent experiments performed in duplicate. Images were 
produced at a resolution as close to the optimal resolution permitted by the system. Images were 
attained by using a Zeiss Axio imager M2 widefield microscope fitted with a 63x oil immersion 
objective (Plan-Apochromat, NA = 1.4, Zeiss). Scale bars = 10µm.  
 
 
Figure 4.5: Some colocalisation occurs between internalised soluble Stx2 and the ER in Vero cells 
after a 5-hour incubation period. Cells were immunostained for the ER (green) and Stx2 (red), and 
cell nuclei were labelled with DAPI (blue). Images are representative of two independent 
experiments performed in duplicate. The main image represents merged images from three 
separate channels, with the red and green channels shown individually in the side panels. The 
percentage of colocalisation (M1 = % of Stx2 signal colocalising with the ER, M2 = % of ER 
compartment containing Stx2 signal) are indicated by the white numbers. Images were produced at 
a resolution as close to the optimal resolution permitted by the system. Images were attained by 
using a Zeiss Axio imager M2 widefield microscope fitted with a 100x oil immersion objective (EC 
Plan-Neofluar, NA = 1.3, Zeiss). Scale bars = 10µm.  
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Figure 4.6: Quantification of signal colocalisation between internalised soluble Stx2 and the ER in 
Fig. 4.5. A) Graphical presentation of the mean percentage of Stx2 signal colocalising with ER signal 
± SD of five representative cells (M1). B) Graphical presentation of the mean percentage of the ER 






































































Figure 4.7: Internalised EHEC OMVs and OMV-associated Stx2 follow different intracellular trafficking pathways in Vero cells. After 3- and 5-hour incubation 
periods with 10µg of DiO-OMVs (green) isolated from LB cultures of EHEC EDL933, Vero cells were immunostained for Stx2 (red), and cell nuclei were labelled with 
DAPI (blue). Images are representative of three independent experiments, performed in duplicate. The main image represents merged images from three separate 
channels, with the red and green channels shown individually in the side panels. The percentage of colocalisation (M1 = % of Stx2 signal colocalising with DiO, M2 = 
% of DiO containing Stx2 signal) are indicated by the white numbers. Images were produced at a resolution as close to the optimal resolution permitted by the 
system. Images were attained by using a Zeiss Axio imager M2 widefield microscope fitted with a 63x oil immersion objective (Plan-Apochromat, NA = 1.4, Zeiss). 
Scale bars = 10µm.
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Figure 4.8: Quantification and statistical analysis of signal colocalisation between DiO-OMVs and 
Stx2 in Fig. 4.7. A) Graphical presentation of the mean percentage of Stx2 signal colocalising with 
DiO signal ± SD of five representative cells (M1). B) Graphical presentation of the mean percentage 
of DiO signal colocalising with Stx2 signal ± SD of five representative cells (M2). ** = P < 0.01. 
 
 
4.2.3 OMV-associated Stx2 from EHEC O157 is trafficked to the Golgi apparatus and 
subsequently the ER in renal Vero cells 
 
To elucidate the intracellular trafficking of OMV-associated Stx2 in Vero cells, confluent 
Vero cell monolayers were incubated with OMVs isolated from EHEC strain EDL933 for 
1, 3 and 5 hours and subsequently immunostained for Stx2 and either the Golgi 
apparatus or the ER as these are the main organelles involved in the intracellular 
trafficking of soluble Stx (Sandvig et al., 1992, Falguieres et al., 2001).   
 
As shown in Fig. 4.9, Stx2 colocalisation with the Golgi apparatus and the ER was time 
dependent. After an hour of incubation, OMV-derived Stx2 was internalised and 
colocalised with the Golgi apparatus, with longer incubation times reducing 
colocalisation. The colocalisation rates of Stx2 signal with that of the Golgi apparatus 
(M1) were measured to be 62.92%, 9.66% and 10.86% after 1-, 3- and 5-hour 
incubations, respectively (Fig 4.10A), with the initial decrease being significant (P < 
0.01). Furthermore, after 1-, 3- and 5-hour incubations, 89.76%, 90.12% and 90.86% of 
the Golgi apparatus compartment was detected to have Stx2 signal (Fig 4.10B). These 
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results suggest that after initial transportation to the Golgi apparatus, Stx2 is 
subsequently transported to another organelle. Stx2 colocalisation with the ER 
significantly increased over time (P < 0.05), with colocalisation rates of 21.22%, 61.28% 
and 82% after 1-, 3- and 5-hour incubations, respectively (Fig. 4.10A). Similarly, the level 
of the ER compartment containing Stx2 signal significantly increased overtime (P < 0.01), 
with colocalisation rates of 10.72%, 45.54% and 80.3% after 1-, 3- and 5-hour 
incubations, respectively (Fig 4.10B). These results indicate that after OMV 
internalisation, OMV-associated Stx2 follows a retrograde transport via the Golgi 






















Figure 4.9: Upon the internalisation of EHEC OMVs, OMV-associated Stx2 follows retrograde trafficking to the ER via the Golgi apparatus in Vero cells. Confluent 
Vero cell monolayers were incubated for 1, 3 and 5 hours with 10µg of OMVs isolated from LB cultures of EHEC EDL933. Cells were immunostained for Stx2 (red) and 
either the Golgi apparatus (green) or ER (green) and cell nuclei were labelled with DAPI (blue). Images are representative of more than three independent 
experiments, performed in duplicate. The main image represents merged images from three separate channels, with the red and green channels shown individually 
in the side panels. The percentage of colocalisation (M1, % of Stx2 overlapping with organelle compartments; and M2, % of organelle compartment containing Stx2 
signal) are indicated by the white numbers. Images were produced at a resolution as close to the optimal resolution permitted by the system. Images were attained 


















Figure 4.10: Quantification and statistical analysis of colocalisation between Stx2 and the Golgi 
apparatus or ER shown in Fig. 4.9. A) Graphical presentation of the mean percentage of Stx2 signal 
colocalising with organelle compartment signal ± SD of five representative cells (M1). B) Graphical 
presentation of the mean percentage of organelle compartment signal containing Stx2 signal ± SD 
of five representative cells (M2). * = P < 0.05, ** = P < 0.01, *** = P < 0.001. 
 
 
4.2.4 EHEC O157 OMVs are trafficked to the late endosomes/lysosomal 
compartments upon internalisation into Vero cells. 
 
Having demonstrated intracellular transportation of OMV-associated Stx to the Golgi 
apparatus and the ER, the intracellular destination of the respective OMVs was 
determined. To deduce this, confluent Vero cell monolayers were incubated with OMVs 
isolated from EHEC strain EDL933 for 1, 3 and 5 hours and subsequently stained for 
OMVs using the E. coli specific LPS targeting antibody (hereafter termed OMV-LPS) and 
either the Golgi apparatus or the ER (Fig. 4.11). Weak colocalisation was detected as low 
M1 and M2 colocalisation values were attained at all time points (Fig. 4.12A and B, 
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Since previous studies have demonstrated that EHEC OMVs are transported to the 
lysosomes in human brain endothelial cells, the trafficking of OMVs to late endosomal/ 
lysosomal compartments in Vero cells was investigated (Bielaszewska et al., 2017).  
 
Unfortunately, due to the move of the Schüller group to the UEA in 2019, access to 
containment level 3 laboratories at the Quadram Institute was no longer available. 
Therefore, studies were continued using OMVs from the Stx-negative EHEC strain 85-
170 and TUV 93-0 (derivate of Stx producing 84-289 and EDL933 EHEC strains). 
Confluent Vero cell monolayers were inoculated with OMVs isolated from both EHEC 
strains for 3 and 5 hours. As demonstrated in Fig. 4.13, OMV-LPS staining colocalised 
with late endosomal/lysosomal compartment signal after 3-hour incubation periods for 
both EHEC strains. Colocalisation rates between signals were quantified and suggested 
that 48.84% and 63.5% of all OMV-LPS staining colocalising with late 
endosomal/lysosomal compartments for OMVs isolated from EHEC strains 85-170 and 
TUV 9-30, respectively (Fig 4.14A). Statistical testing also detected a significant 
difference (P < 0.05) between the two strains, implying more OMVs from EHEC TUV 93-
0 are trafficked to the late endosomal/lysosomal compartment after 3-hour incubation 
periods than OMVs from EHEC 85-170. Colocalisation rates for both strains significantly 
increased after a 5-hour incubation (P < 0.01), to 79.48% and 86.18% for strains 85-170 
and TUV 9-30, respectively. The different values between the OMVs from both EHEC 
strains were not statistically significantly. It was also determined that 58.88% and 61.5% 
of total lysosomal compartments contained OMV-LPS signal when incubated with OMVs 
isolated from EHEC stains 85-170 and TUV 9-30 after 3-hour incubation periods, 
respectively (Fig. 4.14B). Furthermore after 5-hour incubation periods, 70.34% and 
75.46% of total late endosomal/lysosomal compartments contained OMV-LPS signal for 
OMVs isolated from EHEC stains 85-170 and TUV 9-30, respectively. 
 
Overall, these results indicate that unlike internalised OMV-associated Stx2, EHEC OMVs 
are trafficked to the late endosomal/lysosomal compartments in Vero cells after 3-hour 
incubation period.
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Figure 4.11: Internalised EHEC OMVs are not trafficked to the Golgi apparatus nor the ER in Vero cells.  Confluent Vero cell monolayers were incubated for 1, 3 and 
5 hours with 10µg of OMVs isolated from LB cultures of EDL933. Cells were immunostained for OMVs using E. coli specific anti-LPS (red) and either the Golgi apparatus 
(green) of the ER (green), and cell nuclei were labelled with DAPI (blue). Images are representative of more than three independent experiments, performed in 
duplicates. The main image represents merged images from three separate channels, with channels representing the red and green channels shown individually in 
the side panels. The percentage of colocalisation (M1 = % of OMV-LPS signal colocalising with organelle compartment signal, M2 = % of organelle compartment signal 
containing OMV-LPS signal) are indicated by the white numbers. Images were produced at a resolution as close to the optimal resolution permitted by the system. 
Images were attained by using a Zeiss Axio imager M2 widefield microscope fitted with a 63x oil objective (Plan-Apochromat, NA = 1.4, Zeiss) to assess OMV trafficking 
to the Golgi apparatus, or using a Leica DM6000 B widefield microscope fitted with a 63x oil objective (HCX PL S - APO, NA = 1.30, Leica) to assess OMV trafficking to 























Figure 4.12: Quantification and statistical analysis of signal colocalisation between OMVs and the 
Golgi apparatus or ER shown in Fig. 4.11. A) Graphical presentation of the mean percentage of OMV 
signal colocalising with organelle signal ± SD of five representative cells (M1). B) Graphical 
presentation of the mean percentage of organelle compartment signal containing OMV signal ± SD 
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Figure 4.13: EHEC OMVs are trafficked to late endosomal/lysosomal compartments in Vero cells. Confluent Vero cell monolayers were incubated for 3 and 5 hours 
with 10µg of OMVs isolated from LB cultures EHEC 85-170 and TUV 93-0. Cells were immunostained for OMVs using E. coli specific anti-LPS (red) and late 
endosomal/lysosomal compartments (green), and cell nuclei were labelled with DAPI (blue). Images are representative of more than three independent experiments, 
performed in duplicates. The main image represents merged images from three separate channels, with channels representing the red and green channels shown 
individually in the side panels. The percentage of colocalisation (M1 = % of OMV-LPS signal colocalising with late endosomal/lysosomal signal, M2 = % of late 
endosomal/ lysosomal signal containing OMV-LPS signal) are indicated by the numbers in white. Images were produced at a resolution as close to the optimal 
resolution permitted by the system. Images were attained by using a Zeiss Axio imager M2 widefield microscope fitted with a 63x oil objective (Plan-Apochromat, 















Figure 4.14: Quantification and statistical analysis of signal colocalisation between OMVs isolated 
from EHEC strains 85-170 or TUV 93-0 and late endosomal/lysosomal compartments in Fig. 4.13. 
A) Graphical presentation of the mean percentage of OMV signal colocalising with late 
endosomal/lysosomal compartment signal ± SD of five representative cells (M1). B) Graphical 
presentation of the mean percentage of late endosomal/lysosomal compartment signal colocalising 
with OMV signal ± SD of five representative cells (M2). * = P < 0.05, ** = P < 0.01. 
 
 
4.2.5 OMVs from EHEC O157 are internalised and trafficked to late 
endosomal/lysosomal compartments in non-polarised colonic-derived Caco-2 
cells. 
 
Upon ingestion, EHEC colonises the colonic epithelium (Lewis et al., 2015). To determine 
EHEC OMV internalisation and trafficking in the colonic epithelium, the colonic-derived 
Caco-2 cell line was used. OMVs isolated from EHEC strain 85-170 were used for 
subsequent work as OMV yield from EHEC cultures of strain 85-170 was slightly higher 
compared to strain TUV 93-0 when grown in CO2 supplement (Chapter 3, Fig 3.17). 
 
To determine whether EHEC OMVs are internalised, once confluent monolayers of 
Caco-2 cells were grown on coverslips, monolayers were incubated with DiO-OMVs or 
DiI-OMVs for 3 and 5 hours. Cells were subsequently immunostained for OMVs using E. 
coli specific anti-LPS to determine if the dye would remain associated with OMVs within 
Caco-2 cells. Confocal laser microscopy showed that OMVs interacted with Caco-2 cells 
as both lipophilic dyes signals were detected (Fig. 4.15). Little colocalisation was 






























































































detected between the dyes and anti-LPS signals after 3-hour incubations, with 
colocalisation reducing after 5 hours (table 4.1). Some 5-hour colocalisation values were 
lower than the colocalisation values attained using Vero cells (Fig. S2A and B; DiO M1 P 
< 0.0001, DiI M2 P < 0.01).  
 
Table 4.1: Manders coefficient values measuring colocalisation between DiO or DiI molecules and 
OMV-LPS signals in Caco-2 cells. M1 = % of red fluorophores which colocalised with green 
fluorophores, M2 = % of green fluorophores which colocalised with red fluorophores. Data is shown 
as the means of colocalisation ± SD of ten different cells. 
 
Since both dyes produced a staining pattern similar to that of the ER, Caco-2 cells were 
incubated with EHEC DiI-OMVs or DiO-OMVs for 5-hours and immunostained for the ER. 
As shown in Fig. 4.16, little colocalisation between the dye molecules and ER signal was 
detected. Colocalisation was quantified, with Manders values of 11.59% (M1) and 
23.34% (M2) being attained between DiO signal and the ER, and 31.87% (M1) and 8.18% 
(M2) being attained between DiI and the ER (Fig. 4.17), suggesting that some dye 
molecules may be leaching onto the ER.  
 
Since these experiments indicate that lipophilic dye potentially leaches and integrate 
onto membrane bound organelles, the E. coli specific anti-LPS antibody was used to 
verify EHEC OMV internalisation into Caco-2 cells and to examine sequential 
intercellular trafficking of EHEC OMVs. To verify EHEC OMV internalisation by Caco-2 
cells, monolayers were immunostained for EHEC OMVs and actin. As shown in Fig. 4.18, 
 Colocalisation between DiO 
(green) and OMV-LPS signal (red) 
Colocalisation between DiI (red) 
and OMV-LPS signal (green) 
M1, % of LPS 
signal 
colocalising 
with DiO signal 
M2, % of DiO 
signal 
colocalising 
with LPS signal 
M1, % of DiI 
signal 
colocalising 
with LPS signal 




3 hours 20.98% ± 12.66 20.42% ± 8.6 21.5% ± 10.6 17.06% ± 5.74 
5 hours 10.58% ± 2.98 20.15% ± 19.23 11.14% ± 8.25 15.42% ± 7.39 
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internalised EHEC OMVs were detected within Caco-2 cells after 3 hours, with a similar 
staining pattern being produced after 5 hours. 
 
Having demonstrated EHEC OMV transportation to late endosomal/lysosomal 
compartments in Vero cells, it was determined whether EHEC OMVs would also be 
trafficked to the same compartments in Caco-2 cells. Representative images shown on 
Fig. 4.19, indicate that OMVs colocalised with late endosomal/lysosomal compartments 
after 3- and 5-hour incubation periods. Colocalisation between signals was quantified 
and it was determined that 13.76% and 40.12% of the total OMV-LPS signal colocalised 
with late endosomal/lysosomal compartments after 3- and 5- hours, respectively (Fig. 
4.20A). Low colocalisation rates were attained between OMV-LPS signal and both the 
Golgi apparatus and the ER after both incubation periods. These were significantly lower 
to rates attained with late endosomal/lysosomal compartments (Fig. 4.20A, P < 0.01 and 
P < 0.05 after 3 hours for the Golgi apparatus and ER, respectively, and P < 0.0001 after 
5 hours), suggesting OMVs are not trafficked to the Golgi apparatus nor the ER. In 
addition, after 3-hour incubation periods, 24.42% of late endosomal/lysosomal 
compartments colocalised with OMV-LPS signal and increased to 40.7% after 5-hour, 
however this increase was not statistically significant (Fig 4.20B). Significantly lower 
values were attained when examining the percentage of organelles compartments 
containing OMV-LPS signal for both the Golgi and ER (P < 0.001 for Golgi and ER vs. late 
endosomal/lysosomal compartments after 3 hours and 5 hours). 
 
Compared to Vero cells, significantly lower levels of OMVs colocalised with late 
endosomal/lysosomal compartments for both time points in Caco-2 cells (P < 0.0001, 
Fig. S3A) suggesting OMV trafficking to these compartments is slower in Caco-2 cells 
than in Vero cells. In addition, a significantly higher proportion of late endosomal/ 
lysosomal compartments contained OMV signals in Vero cells, compared to Caco-2 cells 
(P < 0.0001, Fig S3B). 
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Figure 4.15: Little colocalisation is exhibited between internalised DiO or DiI molecules and OMV-LPS in Caco-2 cells. Confluent Caco-2 cell monolayers were 
incubated for 3- and 5-hours with 10µg of DiO-OMVs (green) and DiI-OMVs (red) isolated from LB cultures of EHEC 85-170. Cells were immunostained for OMVs 
using E. coli specific anti-LPS (red in cells incubated with DiO-OMVs and green in cells incubated with DiI-OMVs) and cell nuclei were labelled with DAPI (blue). Images 
are representative of more than two independent experiments performed in duplicate. The main image represents merged images from three separate channels, 
with channels representing the red and green channels shown individually in the side panels. The percentage of colocalisation (M1 = % of red fluorophore overlapping 
with green fluorophore; M2 = % of green fluorophore overlapping with red fluorophore) are indicated by the white numbers. Images were produced at a resolution 
as close to the optimal resolution permitted by the system. Images were attained by using a Zeiss LSM800 confocal microscope fitted with a 63x water immersion 
objective (C-apochromat, NA = 1.2, Zeiss). Scale bars = 10µm.
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Figure 4.16: Similar colocalisation rates are attained in Caco-2 cells between internalised DiO or 
DiI molecules and the ER, compared to internalised dye molecules and OMV-LPS signals. Confluent 
Caco-2 cell monolayers were incubated for 5 hours with 10µg of DiO-OMVs (green) and DiI-OMVs 
(red) isolated from LB cultures EHEC 85-170. Cells were immunostained for the ER (red in cells 
incubated with DiO-OMVs and green in cells incubated with DiI-OMVs) and cell nuclei were labelled 
with DAPI (blue). Images are representative of two independent experiments, performed in 
duplicate. The main image represents merged images from separate channels, with channels 
representing the red and green channels shown individually in the side panels. The percentage of 
colocalisation (M1 = % of red fluorophore overlapping with green fluorophore; and M2 = % of green 
fluorophore overlapping with red fluorophore) are indicated by the white numbers. Images were 
produced at a resolution as close to the optimal resolution permitted by the system. Images were 
attained by using a Zeiss LSM800 confocal microscope fitted with a 63x water immersion objective 








Figure 4.17: Quantification of signal colocalisation between DiO or DiI molecules and the ER in Fig. 
4.16. M1= % of red fluorophores which colocalised with green fluorophores, M2 = % of green 
fluorophores which colocalised with red fluorophores. Data is shown as the means of colocalisation 



































Figure 4.18: EHEC OMVs are internalised by non-polarised Caco-2 cells. Confluent Caco-2 cell monolayers were incubated for 3 and 5 hours with 10µg of OMVs 
isolated from LB cultures of EHEC 85-170. Cells were immunostained for OMVs using E. coli specific anti-LPS (red), actin (green, FITC-phalloidin) and cell nuclei were 
labelled with DAPI (blue). Images are representative of three independent experiments, performed in duplicate. The main image represents merged images from 
three separate channels, with the red and green channels shown individually in the side panels. Images were produced at a resolution as close to the optimal 
resolution permitted by the system. Images were attained by using a Zeiss LSM800 confocal microscope fitted with a 63x water immersion objective (C-apochromat, 
































Figure 4.19: Internalised EHEC OMVs are trafficked to late endosomal/lysosomal compartments in 
non-polarised Caco-2 cells. Confluent Caco-2 cell monolayers were incubated for 3 and 5 hours with 
10µg of OMVs isolated from LB cultures of EHEC 85-170. Cells were immunostained for OMVs using 
E. coli specific anti-LPS (red) and either the Golgi apparatus (green), ER (green), or late 
endosomal/lysosomal compartments (green), and cell nuclei were labelled with DAPI (blue). Images 
are representative of three independent experiments, performed in duplicate. The main image 
represents merged images from three separate channels, with the red and green channels shown 
individually in the side panels. The percentage of colocalisation (M1 = % of OMV-LPS signal 
colocalising with organelle compartment signal, M2 = % of organelle compartment signal containing 
OMV-LPS signal) are indicated by the white numbers. Images were produced at a resolution as close 
to the optimal resolution permitted by the system. Images were attained by using a Zeiss LSM800 
confocal microscope fitted with a 63x water immersion objective (C-apochromat, NA = 1.2, Zeiss). 




















Figure 4.20: Quantification and statistical analysis of signal colocalisation between EHEC OMVs 
and either the Golgi apparatus, ER or late endosomal/lysosomal compartments in Fig. 4.19. A) 
Graphical presentation of the mean percentage of OMV signal colocalising with organelle signal ± SD 
of five representative cells (M1). B) Graphical presentation of the mean percentage of organelle 
compartment signal containing OMV signal ± SD of five representative cells (M2). * = P < 0.05, ** = 
P < 0.01, *** = P < 0.001, **** = P < 0.0001. 
 
To confirm OMV trafficking to late endosomal/lysosomal compartments within 
confluent Caco-2 cells, these experiments were repeated with OMVs isolated from Stx-
producing strain EDL933. As shown in Fig. 4.21, OMV-LPS staining colocalised with late 
endosomal/lysosomal compartments both after 3- and 5-hours incubation periods, with 
colocalisation rates of 21.1% after 3-hour incubations and significantly increasing to 
38.4% after 5-hours (Fig 4. 22A, P < 0.01). Likewise, after 3-hour incubation periods 
18.86% of late endosomal/lysosomal compartments contained OMV-LPS signal, with a 
































































































significantly higher rate of 40.92% of late endosomal/lysosomal compartments 
containing OMV-LPS signal after 5-hour incubation periods (Fig 4.22B, P < 0.01). 
Comparatively, these values are similar to those attained from Caco-2 cells incubated 
with OMVs isolated from EHEC 85-170 (Fig S4A and B).  
 
Since OMV-associated Stx2 was trafficked to the ER in Vero cells by 5 hours, it was 
anticipated that OMV-associated Stx2 would also colocalise with the ER by 5 hours. 
Subsequent immunostaining of Stx2 and the ER showed little signal overlap, with 
Manders colocalisation quantifying 12.86% of the total Stx2 signal colocalising with ER 
staining, which was statically lower between the signals Vero cells at the same time 
point (Fig S5A; 82%, P < 0.0001). Likewise, 11.62% of the total ER staining contained Stx2 
signal, which was statically lower than that in Vero cells (Fig S5B, 80.3%, P < 0.0001). 




Figure 4.21: Fluorescence microscopy images of Caco-2 cells incubated with OMVs isolated from LB cultures of EHEC EDL933. Confluent Caco-2 cell monolayers 
were incubated for 3 and 5 hours with 10µg of OMVs isolated from LB cultures of EHEC EDL933. Cells were immunostained for either OMVs using E. coli specific anti-
LPS (red) or Stx2 (red) and either late endosomal/lysosomal compartments (green) or the ER (green) and cell nuclei were labelled with DAPI (blue). Images are 
representative of two independent experiments, performed in duplicate. The main image represents merged images from three separate channels, with channels 
representing the red and green channels shown individually in the side panels. The percentage of colocalisation (M1 = % of red fluorophore overlapping with green 
fluorophore; and M2 = % of green fluorophore overlapping with red fluorophore) are indicated by the white numbers. Images were produced at a resolution as close 
to the optimal resolution permitted by the system. Images were attained by using a Zeiss LSM800 confocal microscope fitted with a 63x water immersion objective 
















Figure 4.22: Quantification and statistical analysis of signal colocalisation between EHEC OMVs 
and late endosomal/lysosomal compartments in Fig. 4.21. A) Graphical presentation of the mean 
percentage of OMV colocalising with late endosome/lysosome signal ± SD of five representative cells 
(M1). B) Graphical presentation of the mean percentage of late endosome/lysosome compartment 
containing OMV signal ± SD of five representative cells (M2). ** = P < 0.01, *** = P < 0.001. 
 
 
4.2.6 EHEC OMVs trafficking in polarised colonic-derived Caco-2 cells 
 
Cells which make up the intestinal epithelium are arranged in a polarised manner and 
express intercellular junctions such as tight junctions, which prevent paracellular 
trafficking of luminal contents, and separate apical and basolateral cell surfaces (Zihni 
et al., 2016, Schneeberger et al., 2018). Cell polarisation also instigates the distribution 
and expression of surface proteins, and cytoskeletal components to differs between the 
basal and apical cell membranes (van der Wouden et al., 2003, Weisz and Rodriguez-
Boulan, 2009). Therefore, it was determined whether Caco-2 cells in this physiologically 
relevant arrangement could also internalise EHEC OMVs, and whether the intracellular 
trafficking pathways of OMVs would be the same.  
 
To support polarisation, Caco-2 cells were grown on collagen-coated Transwell 
membrane inserts and polarisation was monitored by measuring the transepithelial 
electrical resistance (TEER; Fig. 4.23A; Madara et al., 1987). Monolayers were used after 
TEER readings reached 1500 Ω x cm2, which is regarded as an indicator of polarisation 
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(Lu et al., 1996). This was confirmed by confocal microscopy which demonstrated the 
formation of columnar-shaped cells with an apical actin-rich brush border (Fig. 4.23B 











Figure 4.23: Characteristics of polarised Caco-2 cells. Cells were grown on Transwell inserts for 18 
days. (A) Transepithelial electrical resistance (TEER) was monitored from 5 days post-seeding. Data 
is shown as means ± SD of three independent experiments performed in triplicates. (B) Confluent 
cells were stained with FITC-phalloidin (actin) and DAPI (nucleus). Immunofluorescence image shows 
the formation of a confluent polarised monolayer and the apical brush border. (C) The confocal XZ 
scan image of actin-stained cells (FITC-phalloidin, green) shows the column-shaped morphology of 
the cells. Images are representative of five independent experiments. Images were produced at a 
resolution as close to the optimal resolution permitted by the system. Images were attained by using 
a Zeiss LSM800 confocal microscope fitted with a 63x water immersion objective (C-apochromat, NA 
= 1.2, Zeiss). Scale bars = 10µm (B) and 20µm (C).  
 
To determine whether EHEC OMVs disrupt the epithelial barrier, polarised Caco-2 
epithelia were incubated with OMVs from LB cultures of EHEC 85-170 for 24 hours. TEER 
readings were recorded hourly for the first 5 hours and at the end of 24-hour incubation 
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periods. As shown in Fig. 4.24, compared to control samples, incubations with EHEC 
OMVs did not affect epithelial barrier function.  
 
To deduce whether OMVs could be internalised by polarised Caco-2 cells, after an 
incubation period of 3, 5 and 24 hours with OMVs, monolayers were stained for OMVs 
and actin using the anti-LPS antibody and FITC-phalloidin, respectively. As shown in Fig 
4.25, intracellular OMVs were detected within Caco-2 cells after 3 hours, with increased 
OMV signal observed after longer incubations periods.  
 
Since EHEC OMVs were trafficked to late endosomes/lysosomes in non-polarised Caco-
2 cells, it was determined whether EHEC OMVs were also trafficked to the same 
organelles. As shown in Fig 4.26, some colocalisation between EHEC OMVs and late 
endosomes/lysosomes was detected. Quantification of colocalisation indicated that 
11.96%, 15.72% and 28.04% of the total OMV-LPS signal colocalised with the late 
endosomal/lysosomal compartments after 3-, 5- and 24-hour incubation periods, 
respectively (Fig. 4.27A). In addition, little colocalisation between OMV-LPS signal with 
the Golgi apparatus and the ER was detected at the different time points. Statistical 
analysis detected a significantly lower colocalisation rate between OMV-LPS signal and 
both the ER and the Golgi apparatus compared to OMV-LPS and late 
endosomal/lysosomal compartments after 24-hour incubation periods (Fig 4.27A, P < 
0.01 and P < 0.001, respectively). Likewise, it was measured that 10.38%, 25.26% and 
27.08% of late endosomal/lysosomal compartments contained OMV-LPS signal, with 
other organelle compartments containing significantly lower colocalisation rates for 
each time point (Fig 4.27B, P < 0.0001).  
 
Comparatively, colocalisation rates between OMV-LPS and late endosomal/lysosomal 
compartments in non-polarised and polarised Caco-2 cells were similar after 3-hour 
incubations, however total OMV-LPS signal colocalisation with the late 
endosomal/lysosomal compartments after 5-hour incubation periods were significant 
lower in polarised Caco-2 cells than in non-polarised cells (P < 0.0001, Fig. S6A). 
 
 168 
Given the low colocalisation of OMVs in late endosomes/lysosomes, the possibility of 
OMV translocation across the epithelium was examined. To this aim, the basolateral 
medium was collected from the Caco-2 Transwells, concentrated and added to 
confluent Vero cell monolayers for 24 hours. Subsequent immunostaining with anti-LPS 
and microscopy examination confirmed the presence of OMVs in the basolateral 
medium as early as 3 hours, indicating OMV translocation across polarised Caco-2 cells 
(Fig. 4.28). Since EHEC OMVs did not affect epithelial barrier function, this would 
indicate that OMV translocation via the transcellular route occurred.  
 
Taken together, these results indicate that polarised Caco-2 cells internalise EHEC OMVs 
without any consequential disruption of the epithelial barrier. Furthermore, OMVs may 
have two distinct intracellular trafficking pathways including transport to late 




Figure 4.24: EHEC OMVs do not affect the epithelial barrier function of polarised Caco-2 cell 
monolayers. Caco-2 transwell inserts were incubated with EHEC OMV isolated from LB cultures of 
EHEC 85-170 for 24 hours. Data is shown as a mean percentage of the TEER compared to TEER 
measured at time ‘0’ ± SD four independent experiments performed in triplicate




















Figure 4.25: EHEC OMVs are internalised by polarised Caco-2 cells. Confluent Caco-2 cell monolayers were incubated for 3, 5 and 24 hours with 10µg of OMVs 
isolated from LB cultures of EHEC 85-170. Cells were immunostained for OMVs using E. coli specific anti-LPS (red), actin (green, FITC-phalloidin) and cell nuclei were 
labelled with DAPI (blue). Images are representative of three independent experiments, performed in duplicate. The main image represents merged images from 
three separate channels, with the red and green channels shown individually in the side panels. Images were produced at a resolution as close to the optimal 
resolution permitted by the system. Images were attained by using a Zeiss LSM800 confocal microscope fitted with a 63x water immersion objective (C-apochromat, 






























Figure 4.26: Fluorescence micrographs depicting intracellular trafficking of EHEC OMVs in 
polarised Caco-2 cell monolayers. Confluent polarised Caco-2 cell monolayers were incubated for 3, 
5 and 24 hours with 10µg of OMVs isolated from LB cultures of EHEC 85-170. Cells were 
immunostained for OMVs using E. coli specific anti-LPS (red) and either late endosomal/lysosomal 
compartments (green), the Golgi apparatus (green) or the ER (green), and cell nuclei were labelled 
with DAPI (blue). Images are representative of three independent experiments, performed in 
duplicate. The main image represents merged images from three separate channels, with the red 
and green channels shown individually in the side panels. The percentage of colocalisation (M1 = % 
of OMV-LPS signal colocalising with organelle compartment signal, M2 = % of organelle 
compartment signal containing OMV-LPS signal) are indicated by the white numbers. Images were 
produced at a resolution as close to the optimal resolution permitted by the system. Images were 
attained by using a Zeiss LSM800 confocal microscope fitted with a 63x water immersion objective 





















Figure 4.27: Quantification and statistical analysis of signal colocalisation between OMVs isolated 
from EHEC 85-170 and either the Golgi apparatus, ER or late endosomal/lysosomal compartments 
in Fig. 4.26. A) Graphical presentation of the mean percentage of OMV signal colocalising with 
organelle signal ± SD of five representative cells (M1). B) Graphical presentation of the mean 
percentage of organelle compartment signal containing OMV signal ± SD of five representative cells 






































































































Figure 4.28: Basolateral medium collected from polarised Caco-2 grown on Transwells contain 
OMVs, indicating OMV translocation. Basolateral medium was collected from Transwells after 3-, 
5- and 24-hour apical incubation periods with OMVs. Medium was concentrated and subsequently 
incubated with confluent Vero cell monolayers for 24 hours. Vero cells were immunostained for 
OMVs using E. coli specific anti-LPS (red) and cell nuclei were labelled with DAPI (blue). Images are 
representative of more than three independent experiments. Images were produced at a resolution 
as close to the optimal resolution permitted by the system. Images were attained by using a Zeiss 
LSM800 confocal microscope fitted with a 63x water immersion objective (C-apochromat, NA = 1.2, 
Zeiss). Scale bars = 10µm. 
 
 
4.2.7 Colonic T84 cells exhibits minimal uptake of EHEC OMVs  
 
Although Caco-2 cells originate from the colon, they morphologically resemble 
enterocytes from the small intestine as they have comparatively long microvilli when 
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polarised and express brush boarder hydrolases (Devriese et al., 2017). Furthermore, 
Caco-2 cells express the Stx receptor Gb3, which is not usually present in the colon 
(Jacewicz et al., 1995, Schuller et al., 2004). In contrast, T84 cell more closely resembles 
the morphology of colonocytes and do not express Gb3, therefore making this cell line 
a more physiologically relevant model to study EHEC infections in the colon than Caco-
2 cells (Schuller et al., 2004, Kovbasnjuk et al., 2005, Devriese et al., 2017).  
 
To examine whether EHEC OMVs can interact with T84 cells, semi-confluent cell 
monolayers were incubated with DiO-OMVs isolated from EHEC 85-170 for 5 and 24 
hours. As shown in Fig. 4.29, EHEC OMVs only associated with T84 cells located on the 
edges of cell islands after 5 hours. Unlike previous results achieved with Vero and Caco-
2 cells, an increase in OMV uptake was not observed with longer incubation periods. To 
validate that the DiO signals were OMVs, monolayers were immunostained with E. coli 
specific anti-LPS. The attained images showed colocalisation between the dye and the 
anti-LPS signal (Fig 4.29), with Manders colocalisation analysis confirming colocalisation 




5 hours 62.49% ± 26.85 61.4% ± 18.04 
24 hours 60.57% ± 15.92 45.72% ± 14.66 
Table 4.2: Manders coefficient values measuring colocalisation between DiO signals and OMV-LPS 
signals in T84 cells. M1= % of LPS signal colocalising with DiO signal, M2 = % of DiO signal colocalising 




Figure 4.29: Colocalisation of DiO molecules and OMV-LPS signal arises in T84 cells. Semi-confluent T84 cells were incubated for 5 and 24 hours with 10µg of DiO-
OMVs (green) isolated from LB cultures of EHEC 85-170. OMVs were detected using E. coli specific anti-LPS (red) and cell nuclei were labelled with DAPI (blue). Images 
are representative of three independent experiments, performed in duplicate. The main image represents merged images from three separate channels, with 
channels representing the red and green channels shown individually in the side panels. The percentage of colocalisation (M1= % of OMV-LPS signal colocalising with 
DiO signal, M2 = % DiO signal colocalising with OMV-LPS signal) are indicated by the numbers in white. Images were produced at a resolution as close to the optimal 
resolution permitted by the system. Images were attained by using a Zeiss Axio imager M2 widefield microscope fitted with a 40x water immersion objective (EC 
Plan-Neofluar, NA = 0.75, Zeiss). Scale bars = 20µm.  
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As cells only located in the peripheries of growing cell islands exhibited interaction DiO-
OMVs, it was subsequently tested whether confluent T84 cell monolayers needed to be 
starved for OMV internalisation. This was carried out by incubating confluent 
monolayers in supplemented or non-supplemented DMEM/F-12 medium 24 hours prior 
to EHEC OMV inoculation. Following this, DiO-OMVs were added to confluent 
monolayers and incubated for 5 hours. As shown in Fig 4.30, the interaction between 
DiO-OMVs isolated from EHEC strain 85-170 and T84 cells was similar under both 
conditions, suggesting that little OMV interaction occurs irrespective of nutrient 
starvation in T84 cells.  
 
 
Figure 4.30: Little OMV interaction occurs with T84 cells. T84 cells were incubated with 
supplemented (non-starved) or non-supplemented (starved) DMEM/F-12 medium for 24 hours prior 
to OMV inoculation. After a 5-hour incubation period with DiO-OMVs (green) isolated from LB 
cultures of EHEC 85-170, cell nuclei were labelled with DAPI (blue). Images were produced at a 
resolution as close to the optimal resolution permitted by the system. Images are representative of 
three independent experiments performed in duplicate. Images were attained by using a Zeiss Axio 
M2 widefield microscopy fitted with a 20x objective (EC Plan-Neofluar, NA = 0.50, Zeiss). Scale bars 
= 50µm.  
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To determine whether a higher OMV amount would increase OMV interaction with T84 
cells, increasing amounts of DiO-OMVs isolated from EHEC strain 85-170 were added to 
confluent T84 cell monolayers and incubated for 24 hours. As shown in Fig. 4.31, very 
little uptake was observed and higher doses of DiO-OMVs (12µg - 48µg of OMV protein) 
did not result in an increased level of association with EHEC OMV. 
 
To evaluate whether T84 cells could internalise OMV-associated Stx without OMV 
internalisation, DiI-OMVs from Stx-producing EHEC strain EDL933 and soluble Stx2 
(control) were incubated with T84 and Vero cells (positive control) for 5 and 24 hours. 
As shown in Fig. 4.32, only a few T84 cells located at the margins of cell islands exhibited 
any association with OMVs, whereas all Vero cells exhibited OMV uptake after 5-hour 
incubation periods with OMVs. Internalised Stx2 derived from EHEC OMVs was rarely 
detected in T84 cell monolayers, yet cells which contained Stx2 showed colocalisation 
with internalised DiI. This was confirmed using Manders colocalisation analysis (M1), 
which detected a colocalisation rate of 71.89% (Fig 4.33A). Unlike T84 cells, many Vero 
cells contained internalised Stx2 with comparatively significantly lower colocalisation 
rates with the dye (Fig. 4.33A, 7.24%, P < 0.0001). Limited OMV internalisation was also 
exhibited in confluent T84 cell monolayers after 24 hours, with a colocalisation rate 
(M1) of 91.48% between Stx2 and dye, suggesting Stx2 retention within OMVs. 
However, after incubation for the same time period, the integrity of the Vero cell 
monolayer was disrupted due to cell death, with the remaining cells containing OMVs 
and Stx2, with an 8.54% colocalisation rate (M1) between the two signals (Fig. 4.33A). 
Similar colocalisation rates were also attained when the level of Stx2 colocalisation with 
DiI signal was examined (M2) for both T84 cells and Vero cells, with significantly lower 
colocalisation rates being attained with Vero cells (Fig. 4.33B, P < 0.001).  
 
Overall, the results obtained from semi-confluent and confluent T84 cell monolayers 
showed that T84 cell association with OMVs was limited to peripheral cells. 








Figure 4.31: Higher OMV doses do not exhibit increased OMV association with confluent T84 
monolayers. DiO-OMVs (green) isolated from LB cultures of EHEC 85-170 for were administered at 
different doses (12µg - 48µg OMV protein) and incubated for 24 hours. Cell nuclei were labelled with 
DAPI (blue). Images were produced at a resolution as close to the optimal resolution permitted by 
the system. Images are representative of more than two independent experiments performed in 
duplicate. Images were attained by using a Zeiss Axio imager M2 widefield microscope fitted with a 
10x objective (EC Plan-Neofluar, NA = 0.30, Zeiss). Scale bars = 100µm.  
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Figure 4.32: Fluorescence microscopy images of T84 and Vero cells incubated with DiI-OMVs 
isolated from LB cultures of EHEC EDL933 or with soluble Stx2, for 5 and 24 hours. Cell monolayers 
were incubated with DiI-OMVs (red), immunostained for Stx2 (green) and cell nuclei were labelled 
with DAPI (blue). Images are representative of more than three independent experiments, 
performed in duplicate. The main image represents merged images from three separate channels, 
with the red and green channels shown individually in the side panels. The percentage of 
colocalisation (M1 = % of DiI signal colocalising with Stx2 signal, M2 = % of Stx2 signal containing DiI 
signal) are indicated by the white numbers. Images were produced at a resolution as close to the 
optimal resolution permitted by the system. Images were attained by using a Leica DM6000 B 



























   
Figure 4.33: Quantification and statistical analysis of signal colocalisation between DiI signal and 
Stx2 signal in Fig. 4.32. A) Graphical presentation of the mean percentage of DiI signal colocalising 
with Stx2 signal ± SD of five representative cells (M1). B) Graphical presentation of the mean 
percentage of Stx2 signal colocalising with DiI signal ± SD of five representative cells (M2). * = P < 
0.05, *** = P < 0.001, **** = P < 0.0001. 
 
 
4.2.8 Differentiated human colonoids internalise EHEC OMVs 
 
In this study, the interaction of OMVs with colonic derived Caco-2 and T84 cell lines 
differed. While results obtained with Caco-2 cells showed OMV internalisation by non-
polarised and polarised cells, and subsequent transcellular translocation to the 
basolateral membrane, T84 cells exhibited limited interaction with OMVs. Due to the 
discrepant results, the interaction between OMVs and human-derived two-dimensional 
colonoid models was investigated.  
 
This two-dimensional model was used so as to reproduce the heterogenous absorptive 
and secretory cell types found in the colon, thus providing results which more accurately 
reflect the in vivo interactions with OMVs compared to immortalised colonic cell lines 
(Furness et al., 1999, In et al., 2016b). To elucidate whether OMV internalisation occurs 
in native human colonic epithelium, colonoids derived from healthy endoscopic biopsy 
tissue were seeded out on Transwell inserts and differentiated into two-dimensional 
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Epithelial barrier function was monitored by TEER, with differentiated two-dimensional 
colonoids exhibiting TEER values of >300 Ω x cm2. Resulting two-dimensional colonoids 
would be made up of columnar intestinal mucin-producing goblet cells, 
enteroendocrine cells and epithelial cells with an actin-rich brush border on the apical 
cell surface.  
 
To determine whether OMV internalisation would occur, differentiated two-
dimensional colonoid monolayers were incubated with OMVs isolated from EHEC 85-
170 for 5 and 24 hours. As shown in Fig. 4.34, EHEC OMVs did not affect TEER values, 
suggesting that the barrier remained intact throughout the 24-hour incubation period. 
Subsequent immunostaining of two-dimensional colonoids for OMVs, actin and the 
mucin glycoprotein MUC2 (to label goblet cells), showed that only colonocytes exhibited 
the ability to internalise OMVs after 5- and 24-hour incubation periods (Fig. 4.35).   
 
Furthermore, OMV translocation was examined by collecting the basolateral medium 
from confluent differentiated colonoids grown on Transwells inserts incubated with 
apically applied OMVs for 24 hours and incubating the concentrated basolateral 
medium with Vero cells for 24 hours. Immunofluorescence examination of Vero cells 
confirmed the presence of OMVs, indicating the translocation of OMVs across two-
dimensional colonoids (Fig. 3.36).  
 
Taken together, these results indicate that two-dimensional colonoids can internalise 











Figure 4.34: EHEC OMVs do not affect the barrier function of polarised two-dimensional colonoids. 
Colonoid transwell inserts were incubated for 24 hours with OMVs isolated from LB cultures of EHEC 
85-170. Data is shown as a percentage of the TEER compared to TEER taken at time ‘0’ ± SD of 







Figure 4.35: OMVs are internalised by polarised two-dimensional colonoids. Differentiated 
colonoids were incubated for 5 and 24 hours with OMVs isolated from LB cultures of EHEC 85-170. 
Cells were immunostained for OMVs using E. coli specific anti-LPS (red), actin (green) and mucin 
glycoprotein MUC2 (white), and cell nuclei were labelled with DAPI (blue). Images are representative 
of an independent experiment performed in duplicates. Images were produced at a resolution as 
close to the optimal resolution permitted by the system. Images were attained by using a Zeiss 
LSM800 confocal microscope fitted with a 40x water objective (LD C-apochromat, NA = 1.1, Zeiss). 
Scale bars = 20µm.  
 




























Figure 4.36: Fluorescence micrographs of Vero cells incubated with basal medium collected from 
polarised two-dimensional colonoids after 24-hour incubation periods with OMVs. Basolateral 
medium was collected from Transwells incubating with apically applied OMVs and incubated for 24 
hours. Medium was concentrated and incubated with Vero cells for 24 hours. Cells were 
immunostained for OMVs using E. coli specific anti-LPS (red) and cell nuclei were stained with DAPI 
(blue). Images are representative of more than two independent experiments. Images were 
produced at a resolution as close to the optimal resolution permitted by the system. Images were 
attained by using a Zeiss LSM800 confocal microscope fitted with a 63x water objective (Objective 
C-apochromat, NA = 1.2, Zeiss). Scale bars = 10µm.
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4.3 Discussion  
 
The development of HUS occurs due to the action of Stx released by infecting EHEC. 
Soluble Stx is not actively secreted by a bacterial secretion system but is released 
after bacterial lysis following the activation of the phage lytic cycle. Stx has cytotoxic 
effects on Gb3-expressing endothelial cells, neurons and various renal cells such as 
podocytes and mesangial cells (Obata et al., 2008, Obrig, 2010). To reach these cells 
Stx needs to cross the human colonic epithelium, yet due to the absence of Gb3 
receptors in the colon, the mechanism of how this process occurs remains unclear 
(Schuller et al., 2004, Kovbasnjuk et al., 2005, Schüller, 2011).  
 
It has been proposed that soluble Stx can cross the colonic barrier through a 
paracellular pathway which arises due to the disruption of tight junctions (Philpott et 
al., 1998, Hurley et al., 2001). Previous studies have demonstrated that through the 
TTSS which EHEC possesses, effector proteins such as EspFu, EspF, EspG and Map 
enter host cells and reorganise the distribution of tight junction proteins N-WASP, 
ZO-1, ZO-2, occludin and claudin, thereby causing a leaky barrier (Philpott et al., 1998, 
Viswanathan et al., 2004). This process can be further enhanced by paracellular 
transmigration of neutrophils into the gut lumen, which is a key feature during EHEC 
infections, as evidenced by elevated neutrophil levels in stool samples (Klein et al., 
2002, Bielaszewska and Karch, 2005). Interestingly, neutrophils can induce Stx2 
synthesis, therefore contributing to the development of disease in vivo (Wagner et 
al., 2001). Macropinocytosis has also been proposed as another route for Stx2 
transmigration across the human colonic epithelium. Investigations have 
demonstrated that EHEC infection can stimulate macropinocytosis in colonic cells 
including Gb3 deficient cells which can cause the translocation of Stxs (Lukyanenko 
et al., 2011).   
 
OMVs secreted by EHEC can encapsulate Stx (Kolling and Matthews, 1999, 
Bielaszewska et al., 2017) and thus may provide a means of toxin transport across 
the intestinal epithelial barrier. Previous studies have demonstrated that EHEC OMV 
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can interact and be internalised by human cells including the colonic derived Caco-2 
cell line (Bielaszewska et al., 2013, Bielaszewska et al., 2017). However, the 
physiological relevance of this cell line is debatable since it is physiologically similar 
to cells which line the small intestine rather than the colon (Devriese et al., 2017). In 
addition, the aforementioned trafficking studies have only been made using non-
polarised cells, which contrasts with the morphology of cells which line the intestinal 
epithelium as such cells are polarised and have distinct apical and basolateral surface 
membranes separated by tight junctions. 
 
Thus, in this study to deduce whether the colonic epithelium can internalise EHEC 
OMVs, colonic derived Caco-2 and T84 cell lines were used, as well as human derived 
two-dimensional colonoid monolayers. To further mimic the colonic epithelium, the 
ability of EHEC OMVs to translocate across polarised cell monolayers was examined 
in colonic cells which exhibited EHEC OMV internalisation. Furthermore, the 




4.3.1 OMV labelling 
 
Previous investigations have used various methods to label OMVs. In this 
investigation, to study OMV internalisation, OMVs were labelled using the lipophilic 
dyes DiO and DiI as previous studies have used such dyes to examine OMV 
internalisation and trafficking (Parker et al., 2010, Bielaszewska et al., 2013, 
Kunsmann et al., 2015, Jones et al., 2020). This relatively easy method allows the user 
to label the entire OMV population and examine OMV internalisation by eukaryotic 
cells using florescence microscopy. 
 
In this study, EHEC DiO- and DiI-OMVs were internalised by renal Vero cells after 5-
hour incubation periods with similar staining after 24-hours incubation periods. 
Similar results were also attained with lipophilic dyed OMVs were incubated with 
Caco-2 cells after 3-hour incubation periods. Confirmation of OMV internalisation 
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was demonstrated by both Vero and Caco-2 cells by examination of XZ-stacking 
achieved in confocal imaging which showed lipophilic dye within cells. These results 
are in agreement with previous studies which utilised lipophilic dye DiO and 
rhodamine B isothiocyanate labelled OMVs isolated from EHEC O103:H2 strain 8033 
or EHEC O157:H7 strain 5791/99 and demonstrated internalisation by non-polarised 
Caco-2 cells and by human brain microvasculature endothelial cells (HBMEC) within 
4 hours (Bielaszewska et al., 2013, Bielaszewska et al., 2017).  
 
A disadvantage of using lipophilic dyes is the possibility that due to insufficient 
washing, excess dye will lead to labelling of host membranes (Mulcahy et al., 2014). 
Moreover, it may be possible that internalised dye molecules can leach from OMVs 
and onto various membrane bound organelles, subsequently spreading dye 
molecules within cells and leading to artificial trafficking results. It may also be 
possible that dye molecules can form aggregates and enriched domains, 
consequently altering the mobility and rigidity of the OMV lipid bilayer (Lulevich et 
al., 2009). Such membrane alterations may also affect the function and intracellular 
trafficking of OMVs. To confirm the specificity of lipophilic OMV staining, co-staining 
was performed using an antibody specific for E. coli LPS (US Biological, Polyclonal) 
which has been confirmed to specifically label EHEC OMVs (Bielaszewska et al., 2017).  
 
In Vero cells, low colocalisation values were attained between lipophilic dye and 
OMV-LPS signal when both DiO- and DiI-OMVs were utilised for 5-hour incubation 
periods. Similarly, low rates were attained between DiO or DiI signal and OMV-LPS 
signal in Caco-2 cells after 3- and 5-hours incubation periods. In contrast, high 
colocalisation rates between lipophilic DiO dye and OMV-LPS signal was achieved 
when colocalisation was examined in T84 cells with M1 values (% of red signal 
overlapping green signal) of 62.49% and 60.57%, and M2 values (% of green signal 
overlapping red signal) of 61.4% and 45.72% after 5- and 24-hour incubation periods, 
respectively. Low colocalisation values achieved in Vero and Caco-2 cells suggest the 
dissociation of dye molecules from OMVs and labelling of host cell membranes. 
Interestingly, examination of fluorescence images from other studies which use DiO-
OMVs from other E. coli strains and other bacterial species demonstrate similar 
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labelling patterns of host membranes and a lack of vesicular patterns which would 
be expected for vesicles (Tyrer et al., 2014, Svennerholm et al., 2017, Ling et al., 2019, 
Jones et al., 2020).  
 
In non-polarised Caco-2 cells, similar colocalisation values were achieved between 
the ER and internalised lipophilic dye (via labelled OMVs) to that between dye and 
LPS signals. This suggests that dye molecules may leach and spread to membrane-
bound organelles. Due to the suspected leaching of the dye onto host membrane, 
antibody-mediated detection of OMVs was used to investigate the intracellular 
trafficking of OMVs.   
 
 
4.3.2 EHEC OMV internalisation and intracellular transport 
 
Previous studies have demonstrated EHEC OMV internalisation by Gb3-positive 
human colonic-derived Caco-2 cells, and human renal and brain endothelial 
microvasculature cells (HRMEC and HBMEC, respectively), through clathrin-mediated 
endocytosis (Bielaszewska et al., 2013, Bielaszewska et al., 2017).   
 
In this study, OMV uptake by non-polarised Caco-2 cells was confirmed by XZ confocal 
scans of actin and OMV-LPS stained cells. However, unpolarised Caco-2 cells differ 
from native intestinal epithelium which is composed of columnar-shaped 
differentiated epithelial cells with distinct apical and basolateral surface membranes 
separated by tight junctions (Furness et al., 1999, Giepmans and van Ijzendoorn, 
2009, Marchiando et al., 2010). Therefore, Caco-2 cells were grown on Transwell 
inserts which results in the formation of differentiated columnar shaped enterocyte-
like cells (Lu et al., 1996, Madara et al., 1987, Devriese et al., 2017). XZ confocal scans 
confirmed the internalisation of EHEC OMVs into polarised Caco-2 cell monolayers 
after 3-hour incubation periods. The OMV staining patterns at different time points 
were similar to that of non-polarised Caco-2 cells. 
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The fate of internalised cargo via endocytic vesicles is decided in common endosomal 
compartments (Brown et al., 2000, Garcia-Castillo et al., 2017). It is known that upon 
internalisation, cargoes can be trafficked (i) back to the plasma membrane via 
recycling endosomes, (ii) sorted to the lysosomes, or (iii) sent to the trans-Golgi 
network (Saimani and Kim, 2017). Previous studies have demonstrated the 
intracellular trafficking of bacterial OMVs to lysosomes. OMVs from P. gingivalis 
which are internalised by human gingival epithelial cells first localise in endosomes 
and are subsequently trafficked to lysosomes (Furuta et al., 2009). In addition, OMVs 
from commensal E. coli strains have been demonstrated to be trafficked along the 
endosomal-lysosomal pathway in polarised colonic-derived HT29 cells (Cañas et al., 
2016). A similar pathway has also been confirmed for (i) OMVs from EHEC O157:H7 
strain 5791/99 in HBMEC, (ii) OMVs from EHEC O103:H2 strain 8033 in non-polarised 
Caco-2 cells and (iii) EHEC O157:H7 strain EDL933 in non-polarised DLD-1 intestinal 
cells (Bielaszewska et al., 2013, Bielaszewska et al., 2017). In agreement with this, the 
work presented in this study confirmed intracellular trafficking of OMVs isolated from 
EHEC O157 to late endosomal/lysosomal compartments in non-polarised and 
polarised Caco-2 cells. OMV trafficking to late endosomes/lysosomes was observed 
for OMVs from both Stx-positive and negative EHEC strains, suggesting that 
intracellular trafficking of OMVs does not rely on the encapsulation of Stx. Similarly, 
using non-polarised colonic DLD-1 cells, Bielaszewska et al. (2017) demonstrated that 
OMVs are transported to the lysosomes irrespective of the encapsulation of both 
Stx2a and Stx1a. Nevertheless, different colocalisation rates were quantified 
between OMVs and late endosomal/lysosomal compartments between polarised 
and non-polarised monolayers, with significantly lower colocalisation values in non-
polarised cells after 5 hours (P < 0.0001) suggesting that polarised Caco-2 cells have 
a slower trafficking system and/or have an additional intracellular route for 
internalised EHEC OMVs. 
 
In addition to Caco-2 cells, EHEC OMV transport was examined in Vero cells which 
are of renal origin and therefore reflect the ultimate target of systemically released 
Stx (Konowalchuk et al., 1977, Lingwood et al., 1987). The colocalisation rate 
between OMVs for EHEC 85-170 and TUV 93-0 and late endosomal/lysosomal 
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compartments reached 49% and 64% in Vero cells after 3 hours, which is comparable 
to the colocalisation rate of 60% after 90 minutes between EHEC OMVs and 
lysosomal compartments in HBMEC presented in Bielaszewska et al. (2017). 
Comparatively, colocalisation rates between OMVs from 85-170 and late 
endosomal/lysosomal compartments were lower in non-polarised Caco-2 cells than 
Vero cells after 3- and 5-hour incubation periods (P < 0.0001), suggesting Caco-2 cells 
have a slower intracellular trafficking kinetics than Vero cells. Since widefield 
microscopy was used to image the intracellular trafficking of OMVs in Vero cells, it 
may be argued that colocalisation values are overestimated due to out-of-focus and 
background fluorescence associated with this microscopy technique. However, due 
to the flatness of Vero cells this may not be a huge issue. In this study, confocal 
microscopy was used to examine colocalisation of OMVs and late 
endosomes/lysosomes in Caco-2 cells, suggesting that OMVs accumulate in late 
endosomal/lysosomal compartments, which can range from 100nm to 1500nm (Xu 
and Ren, 2015). It is likely that the colocalisation manifestations are true due to the 
confocal microscope being fitted with appropriate objectives being used. 
 
T84 cells are considered to be more physiologically relevant than Caco-2 cells to 
simulate colonocytes, as polarized T84 cells are phenotypically similar to colonic crypt 
cells due to their short microvilli, whereas polarized Caco-2 cells express brush border 
hydrolases and long microvilli similar to a mid-villous small intestinal epithelial cell 
(Devriese et al., 2017). Furthermore, similarly to the colonic epithelium, T84 cells lack 
Gb3 expression whereas Caco-2 cells express Gb3 (Schuller et al., 2004, Kovbasnjuk 
et al., 2005). Thus, the ability of T84 cells to internalise EHEC OMVs was examined. 
Unlike Caco-2 cells, confluent T84 cell monolayers exhibited little internalisation of 
EHEC OMVs. Moreover, EHEC OMV internalisation was observed in semi-confluent 
monolayers by T84 cells located on the edge of cell islands. As little internalisation of 
EHEC OMVs was exhibited in confluent non-polarised T84 cell monolayers, the 
interaction between EHEC OMVs and polarised T84 cells was not examined. To date, 
very little work has been made to study the interaction of T84 cells with OMVs 
derived from other enteric pathogens. Despite extensive literature review, no 
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microscopic studies have reported OMV internalisation from any bacterial species by 
T84 cells.  
 
The discrepant results achieved between Caco-2 cells and T84 cells did not clarify 
whether OMV internalisation by the colonic epithelium occurred. Due to the 
physiological relevance of T84 cells, results attained with this cell line may appear 
more reliable, and the immediate conclusion might be that very little EHEC OMV 
internalisation occurs in the colon. However, a weakness of using cell culture models 
is that immortalised cell lines derive from cancer cells have accumulated various 
mutations and therefore are different from normal cells. Furthermore, cell culture 
models lack the presence of a mucus layer and the cell mixture present in the normal 
intestinal epithelia such as goblet cells and neuroendocrine cells (Furness et al., 1999, 
In et al., 2016b).  
 
To overcome these shortcomings, experiments were performed in this study using 
human colonic organoids, known as colonoids (In et al., 2016a, In et al., 2019, Clevers, 
2013, Sato et al., 2009, Sato and Clevers, 2013). Colonoids are derived from human 
adult intestinal stem cells located in the crypts of endoscopic biopsy samples and cells 
can differentiate into one of the three major colonic cell types including colonocytes, 
goblet and neuroendocrine cells (In et al., 2016b, Grün et al., 2015, Sato et al., 2009). 
During growth in Matrigel, colonoids form three-dimensional closed spheres, with 
the apical surface facing inwards (Sato et al., 2009, Foulke-Abel et al., 2016). Thus, to 
enable EHEC OMV internalisation and translocation studies, colonoids were grown 
on collagen-coated Transwell filters resulting in the formation of two-dimension 
polarised monolayers (In et al., 2016a).  
 
Unlike T84 cells, EHEC OMVs were readily internalised into colonoid monolayers with 
predominant uptake by colonocytes but not by goblet cells. However, compared to 
polarised Caco-2 cells, polarised colonoid monolayers exhibited lower internalisation 
of EHEC OMVs. This in turn would suggest that EHEC OMVs are internalised in the 
intestinal epithelium, however the rate of internalisation is slower in vivo than that 
exhibited by polarised Caco-2 cells. So far, only one study has shown OMV 
 191 
internalisation by intestinal organoids using murine caecal organoids to evaluate 
interaction with OMVs from B. thetaiotaomicron (Jones et al., 2020). Therefore, this 
investigation is the first study to show that human intestinal organoids can be 
employed as a model system to study OMV uptake in the gut.  
 
 
4.3.3 EHEC OMV-associated Stx2 trafficking in cell models 
 
While EHEC OMVs undergo lysosomal degradation, several associated virulence 
factors are freed during OMV trafficking in the endosomal network and consequently 
follows different intracellular trafficking routes to their respective targets. 
Bielaszewska et al. (2017) has shown that OMVs from EHEC O157:H7 strain 5791/99 
contain Stx2a, haemolysin (Hly) and cytolethal distending toxin V (cdtV). Using 
HBMEC, it has been demonstrated that Stx2a separates from OMVs in endosomes 
due to a drop in pH and follows retrograde transport via the Golgi apparatus to the 
ER, from where the A1 fragment is translocated to the cytosol. Interestingly, the 
expression of Gb3 is a prerequisite for sequential retrograde transport of Stx2 as 
investigations showed that OMV-associated Stx2 trafficked to the lysosome rather 
than the ER in intestinal epithelial DLD-1 cells which are Gb3-negative. Similarly, the 
B-subunit of cdtV, the DNase-like component of CdtV, follows retrograde transport 
to the Golgi apparatus and the ER but is ultimately trafficked to the nucleus. 
Furthermore, using the HBMEC it has been demonstrated that Hly separates from 
OMVs in the lysosomes, and is transported to mitochondria.  
 
This study confirmed that OMV-associated Stx2 produced by EHEC strain EDL933 are 
transported to the Golgi apparatus and the ER in Gb3 positive Vero cells. 
Interestingly, not all cells which internalised DiO-OMVs exhibited Stx2 staining, 
suggesting that not all OMVs produced by EDL933 contain Stx2. Fluorescence 
microscopy demonstrated Stx2 separation from OMVs and trafficking to the Golgi 
apparatus after an hour of incubation with subsequent transport to the ER after 3 
hours; with cell death by a 24-hour period. This is similar to studies made by 
Bielaszewska et al. (2017), which incubated HBMEC with OMV-associated Stx2a from 
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EHEC O157:H7 strain 5791/99 and demonstrated trafficking of Stx2a to the Golgi 
apparatus within 30 minutes and to the ER by 4 hours.  
 
In this study, to deduce the intracellular trafficking of OMV-associated Stx, widefield 
microscopy was utilised. Even though such microscopic techniques provide a fast 
means to attain results, colocalisation values attained here may be overemphasised 
due to background noise. This study did not examine the overlap between the Golgi 
apparatus and the ER. As it may be possible that the two compartments overlap, it 
may be possible that colocalisation values may be overemphasised.  
 
Different results were obtained for non-polarised Caco-2 cells, where confocal 
microscopy was utilised. Very little colocalisation values were attained between Stx2 
with the ER after 5 hours of incubation. This is in contrast to Vero cells, suggesting 
slower kinetics and/or a different intracellular trafficking route, yet due to the use of 
widefield microscopy to analyse Stx2 trafficking in Vero cells, this cannot be 
concluded.  
 
In contrast to Caco-2 and Vero cells, little OMV and Stx2 internalisation was detected 
in Gb3 negative T84 monolayers. However, co-localization of DiO-OMVs with Stx2 
signal was high, suggesting a lack of Stx2 dissociation from OMV upon interaction by 
T84 cells. This is in agreement with previous investigations which concluded that 
retrograde transport of OMV-associated Stx2 is Gb3-dependent as OMVs incubation 
with colonic Gb3-negative DLD-1 cells resulted in OMVs and Stx2 being trafficked to 
the lysosomes, and a lack of cytotoxicity (Bielaszewska et al., 2017). Results obtained 
in this study suggest that OMVs and Stx are trafficked to similar intracellular 
destinations in T84 cells. Speculatively, it is suspected that both entities are trafficked 
to the late endosome/lysosome, but this will need to be confirmed. T84 cells were 
also inoculated with soluble Stx2 to serve as a control. Microscopy demonstrated the 
internalisation of soluble Stx2 by T84 cells but a lack of cytotoxic effects. This is 
coherent with results from another study which used the same amount of free Stx2 
and demonstrated transportation to the ER after 6 hours, without any cytotoxic 
consequences in T84 cells (Schuller et al., 2004).  
 193 
In conclusion, the findings presented in this study suggest that intracellular trafficking 
of OMV-associated Stx2 in Vero cells is similar to that of soluble Stx2 resulting in 
retrograde transport in the ER with subsequent cell death. This process seems to be 
dependent on the expression of Gb3, as T84 cells did not support retrograde toxin 
trafficking and cytotoxicity. Nevertheless, it may be possible that Gb3-negative 
intestinal epithelium allows transcytosis of OMV-associated Stx which could 
subsequently damage Gb3-expressing microvascular cells in the lamina propria.  
 
 
4.3.4 OMV translocation 
 
Translocation of OMVs across the intestinal epithelium may occur via a transcellular 
or paracellular routes. The latter mechanism is supported by work on OMVs from C. 
jejuni which has demonstrated a reduction of the T84 cell barrier function due to 
degradation of tight junction proteins such as occludin and E-cadherin by the action 
of OMV-associated high temperature requirement A protease and Cj1365c proteases 
(Elmi et al., 2016). Interestingly, protease activity was enhanced when OMVs were 
isolated from C. jejuni cultures grown in the presence of bile salts (Elmi et al., 2018). 
OMVs isolated from P. gingivalis have also demonstrated the ability to compromise 
tight junctions between lung epithelial cells (He et al., 2020). It is speculated that this 
degradation is mediated by the protease gingipain, which would allow paracellular 
OMV transport into deeper tissue. In contrast, the opposite effect has been observed 
for OMVs from probiotic and commensal E. coli strains, where such OMVs strengthen 
the epithelial barrier of Caco-2 and T84 cells by promoting expression of tight junction 
proteins (Alvarez et al., 2016, Cañas et al., 2016, Alvarez et al., 2019). Furthermore, 
the integrity of the epithelial barrier was maintained when monolayers were infected 
with barrier disrupting EPEC and OMVs isolated from probiotic and commensal E. coli 
(Alvarez et al., 2019).  
 
In this study, the application of EHEC OMVs for 24 hours did not affect the epithelial 
barrier function of polarised Caco-2 cells nor of colonoid monolayers suggesting a 
lack of cytotoxic effect or tight junction degradation. Nevertheless, results attained 
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in this investigation suggest that EHEC OMVs are trafficked across polarised Caco-2 
and colonoid monolayers as evidenced by the application of sampled basal medium 
to Vero cells for 24 hours and subsequent imaging of internalised EHEC OMVs. EHEC 
OMV translocation across Caco-2 and colonoid monolayers was detected after 3 and 
24 hours of incubation, respectively. Given the maintenance of epithelial resistance, 
these results suggest that EHEC OMVs can penetrate the colonic epithelium via a 
transcellular pathway, which does not involve the Golgi apparatus or the ER. Here, it 
is speculated that EHEC OMV translocation across polarised epithelial may involve 
recycling endosomes. Recycling endosomes are involved in recycling internalised 
proteins and lipids back to the plasma membrane (Stoops and Caplan, 2014, He and 
Guo, 2009, Cramm-Behrens et al., 2008, Garcia-Castillo et al., 2017). Examples of 
compounds which are known to be trafficked across polarised cell via recycling 
endosomes include antibodies and cholera toxin (Saslowsky et al., 2013, Brown et al., 
2000). Furthermore, intracellular pathogens such as P. gingivalis exploit such 
intracellular vesicles to exit from host cells (Takeuchi et al., 2011).  
 
In conclusion, these findings suggest that EHEC OMVs are endocytosed by colonic 
epithelia cells and translocate across the epithelium, with little intracellular 
trafficking to host cell late endosome/lysosomes. When considering the in vivo 
situation, the evidence gathered implies that OMVs allow Stx2 to cross the colonic 





In this investigation, it has been demonstrated that EHEC OMVs can cross the colonic 
epithelium. First, it was confirmed that non-polarised and polarised Caco-2 
monolayers internalised EHEC OMVs. Nevertheless, very little OMV internalisation 
was detected in confluent non-polarised T84 monolayers. This questioned the 
reliability of the results attained by the Caco-2 cell line as T84 cells are regarded as a 
more physiological relevant cell line than Caco-2 cell. In order to determine whether 
OMVs are internalised by the colonic epithelium, a two-dimensional colonoid models 
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were used. In this model, OMV internalisation was achieved without comprise of the 
barrier integrity.  
 
EHEC OMV internalisation was also achieved in renal Vero cells, and it was 
demonstrated that upon OMV internalisation, Stx2 is freed and follows retrograde 
transportation to the Golgi apparatus and then the ER. Similarly, Stx2 disassociation 
from OMVs was demonstrated in non-polarised Caco-2 cells. In both Vero and Caco-
2 cells, OMVs are transported to the late endosomal/lysosomal compartments, yet 
there was a lower colocalisation rate in polarised Caco-2 cell monolayers.  
 
Following this, it was elucidated by using polarised Caco-2 cells and colonoid 
monolayers that OMVs can cross the epithelial barrier without compromising the 
epithelial barrier, therefore suggesting a transcellular trafficking pathway.  
 
In summary, the results achieved in this investigation suggest that EHEC OMVs can 
cross the intestinal epithelium. Furthermore, the trafficking of OMV-associated Stx in 
renal cells is similar to soluble Stx, which ultimately results in cell lysis. Additionally, 
due to the discrepancies gained in OMV trafficking using different cell lines, the 
importance of using appropriate physiological cell models to study in vivo 














































The aim of this PhD project was to elucidate how EHEC OMVs may contribute to the 
development of diseases upon EHEC infection in the intestines. The first part of the 
study evaluated how the colonic milieu influences EHEC OMV production. This was 
achieved by examining the effects of different settings mimicking the colonic 
environment on EHEC OMV yields. The secondary part of this project examined how 
EHEC OMVs interact with host cells including colonic epithelial cells, and to deduce 
whether OMV translocation across the colonic epithelium could arise. In this section, 
the main outcomes from this investigation are summarised and the potential future 
work which can arise from this study will be proposed.  
 
 
5.1 Summary of key findings 
 
The gastrointestinal tract is a hostile milieu for colonising EHEC. In order to 
successfully establish in the colon, infecting EHEC has a variety of mechanisms to 
overcome these stresses, including the release of OMVs. OMVs have been identified 
as a bacterial stress response, enabling survival in harsh environments (McBroom and 
Kuehn, 2007, Sampath et al., 2018, Bauwens et al., 2017a, Bauwens et al., 2017b, 
Urashima et al., 2017). Therefore, in the first part of this investigation the effect 
different colonic cues have on EHEC OMV vesiculation was examined.  
 
This investigation builds on studies which have demonstrated that different intestinal 
conditions such as gastric pH and microaerobic conditions, increase EHEC 
vesiculation (Bauwens et al., 2017b). In this investigation, it was first deduced that 
the highest OMV yields were attained by stationary phase cultures. By comparing 
EHEC OMV yields attained from LB cultures to TSB or DMEM/F-12 cultures, it was 
confirmed that different conditions can influence OMV vesiculation. In agreement 
with Bauwens et al. (2017b), this study confirms that simulated colonic 
environmental medium (SCEM) increases the rate of OMV vesiculation. In context to 
bacterial pathogenesis, this suggests that EHEC upregulates OMV vesiculation in the 
colonic lumen due to the presence of stressors such as bile salts. In addition, this 
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study confirmed that bile salts do not disrupt the integrity of OMVs, suggesting their 
ability to remain viable in the host intestine. This investigation also concluded that 
the presence of colonic CO2 levels and the presence of colonic epithelial T84 cells do 
not significantly affect EHEC OMV vesiculation, indicating not all factors in the colon 
augment EHEC OMV production. 
 
Previous work has demonstrated that EHEC OMVs can be internalised by human 
epithelial and endothelial cells and thereby act as a vehicle for the delivery of 
virulence factors (Bielaszewska et al., 2017). In this study, OMV uptake and trafficking 
in human colonic cells was investigated. Although absolute quantification is lacking, 
results in this study show that OMV internalisation into Gb3-positive Caco-2 cells was 
higher compared to Gb3-negative T84 cells. Moreover, internalisation into 
colonocytes in two-dimensional colonoid monolayers was achieved, suggesting 
internalisation occurs in vivo. In addition, OMVs translocation across polarised Caco-
2 cells and colonoids without compromise of epithelial barrier function was achieved.  
 
This work provides evidence that OMV translocation across the intestinal epithelium 
occurs via a transcellular route. Speculatively, OMVs may play a relevant role in the 
delivery of virulence proteins including Stx across the colonic epithelium. This 
investigation provides evidence that EHEC OMVs may contribute to HUS 
development as OMV-associated Stx follows the same retrograde pathway in Gb3 
expressing cells and causes cell death. Lastly, this work highlights the effectiveness of 
organoids to study OMV uptake in the gut due to discrepancies between different 
colonic cells.  
 
 
5.2 Future experiments 
 
The increase in OMV vesiculation in the presence of bile salts suggests that OMVs 
may have a defensive role, protecting EHEC from the lethal effects of bile salts. To 
deduce whether this occurs, growth of E. coli mutants lacking bile salt resistance 
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genes (e.g., efflux pump acrA and acrB) in lethal bile salt levels can be carried out 
with and without the addition of OMVs isolated from wild type EHEC strains grown 
in SCEM containing bile salts. If growth is not affected with the addition of OMVs, this 
would indicate that OMVs sequester bile salts and protect growing bacterial cells.  
 
Throughout this study, it was noted that different OMV protein profiles were attained 
when EHEC cultures were grown in different conditions. It would be of interest to 
elucidate the proteins which are expressed under different conditions through mass 
spectrometry. Furthermore, it would be of interest to elucidate whether different 
virulence factors are encapsulated by OMVs in certain conditions. Indeed, previous 
studies have shown that in the presence of bile salts, OMVs produced by C. jejuni 
increase protease ability which degrade tight junction proteins and corrupt the 
integrity of the epithelial barrier (Elmi et al., 2018). Subsequently, it would be 
beneficial to deduce whether OMVs isolated from EHEC SCEM cultures compromise 
the epithelial barrier through a similar mechanism.  
 
Furthermore, the internalisation capabilities of OMVs with different protein profiles 
may differ. It is possible that OMVs isolated from growth conditions different to the 
one used in this study (LB medium, 5% CO2/air), may show increased OMV 
internalisation in cells, including T84 cells. OMVs from bacteria in close contact with 
the colonic epithelium are most likely to interact with host cells, therefore, it would 
be of interest to examine the interaction between OMVs isolated from EHEC-T84 cell 
co-cultures with colonic cells. To study the rate of OMV internalisation, previous 
studies have utilised fluorescently labelled OMVs to measure the rate of 
internalisation into host cells (Bielaszewska et al., 2013, Bielaszewska et al., 2017). 
This same method could be used to determine whether OMVs isolated from different 
conditions affects OMV uptake by host cells. 
 
Another parameter which needs to be considered is the mucus layer which lines the 
colonic epithelium. The mucus layer protects the epithelium from bacteria and 
foreign antigens. Around 300µm thick, the mucus layer is made up of mucin 
glycoproteins which are secreted by goblet cells (Johansson et al., 2008, McGuckin et 
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al., 2011, Johansson et al., 2014). Due to its complex structure, the mucus layer may 
inhibit the ability of OMVs to interact with host cells. Here, the effect of the mucus 
layer was not taken into consideration when studying the interaction between OMVs 
and polarised Caco-2 cells which do not secrete mucus. In addition, despite the 
presence of MUC2-producing goblet cells in colonoid monolayers, a mucus layer was 
absent. It would be of interest to evaluate the ability of OMVs to be internalised by 
cells which are covered by a mucus layer. Furthermore, the ability of EHEC OMVs to 
penetrate and cross mucus complexes can be evaluated by preparing simulating 
mucus layers and loading them into make-shift columns or cell culture insert. Such 
penetration assays have been used to examine the ability of antibiotics and bacteria 
including enteroaggregative E. coli to penetrate through mucus (Saggers and Lawson, 
1966, Sheikh et al., 2002, Kajikawa et al., 2018). The ability of OMVs from non-
pathogenic E. coli strains to diffuse across the mucin layer produced by polarised 
mucus-producing HT29-MTX cells has been reported (Cañas et al., 2016). However, 
this study reports the internalisation of fluorescently labelled OMVs by detecting 
fluorescence intensity changes in wells containing mucus-producing cells over time 
and no images are provided. Thus, this brings into question whether OMVs are being 
internalised or are trapped in the mucus layer, consequently trapping OMVs and 
increasing fluorescence intensity. Nevertheless, the relevance of a mucus layer 
during EHEC infections is debatable as previous studies on human colonic biopsies 
and colonoids have demonstrated that EHEC degrades and permeates the mucus 
layer (In et al., 2016a, Hews et al., 2017). 
 
Another aspect which should be considered when examining how OMVs interact with 
human colonic epithelium, is the microaerobic environment at the mucosal surface 
(He et al., 1999, Marteyn et al., 2011, Kalantar-Zadeh et al., 2018). Earlier work has 
determined that Stx translocation across polarised T84 monolayers can be enhanced 
during EHEC infection under microaerobic conditions compared to aerobic conditions 
(Tran et al., 2014). Speculatively, this may be due to actions of the TTSS and its 
effectors, since the expression of the TTSS is enhanced under low oxygen levels 
(Schuller and Phillips, 2010, Müsken et al., 2008). Likewise, it is possible that due to 
the presence of EHEC, the rate of OMV internalisation changes due to the ability of 
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adhered EHEC to alter host cell signalling and modulate actin-based host-cell 
cytoskeleton (Wong et al., 2011, Alto et al., 2007, In et al., 2013). Previous studies 
have shown that secreted EHEC proteins are sufficient to manipulate host cell 
cytoskeleton and increase transcellular trafficking of Stx1 (In et al., 2013). This was 
achieved by incubating host cells with Stx1 and lysates of transformed E. coli K-12 
cultures expressing EHEC EspP. Therefore, to test whether EHEC proteins can affect 
OMV internalisation, the same approach can be carried out using cell monolayers and 
evaluating OMV internalisation by microscopy. The endocytic abilities of host cells 
may also be influenced under microaerobic environments, therefore OMV 
internalisation may be affected by such conditions (Tran et al., 2014).  
 
In this investigation, the impact of EHEC OMVs on the innate immune response by 
colonic epithelial cells was not studied. EHEC OMVs are known to stimulate IL-8 
secretion in Caco-2 cells, suggesting neutrophils recruitment and activation at the site 
of OMV internalisation (Bielaszewska et al., 2018). Neutrophil recruitment will 
consequently lead to the disruption of the intestinal barrier, thus potentially 
permitting the paracellular transmigration of OMVs. To test this, colonic cells can be 
grown on inverted Transwells inserts. Upon reaching confluence, EHEC OMVs can be 
applied in the basolateral medium and neutrophils isolated from healthy volunteers 
can be applied in to apical medium. If paracellular migration of neutrophils arises due 
to OMVs, TEER reading will drop, and neutrophils can be isolated from basolateral 
medium. Moreover, to examine OMV translocation, apical medium can be collected 
and incubated with Vero cells, with immunostaining for EHEC OMVs subsequently 
performed.  
 
The interaction between OMVs and immunological cells should also be evaluated in 
order to deduce whether or not OMVs are cleared. If OMVs are cleared, this would 
suggest that OMVs may not have a role in renal and neuronal damage during EHEC 
infection. Fluorescence microscopy can be used to analyse whether EHEC OMVs may 
be internalised and degraded by immune cells. However, if not degraded by 
immunological cells, such cells may provide a means of systemic spread within the 
host. 
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The effect of EHEC OMVs on the host response of T84 cells would also be of particular 
interest due to minimal OMV internalisation in this cell line. Previous work has shown 
induced secretion of the pro-inflammatory cytokines IL-6, IL-8 and TNF-α as well as 
the antimicrobial peptide β-defensin by T84 cells when incubated with OMVs from C. 
jejuni (Elmi et al., 2012). In contrast, OMVs from V. cholerae dampen the expression 
of pro-inflammatory IL-8 and TNF-α in polarised T84 cells by increasing the expression 
of immunomodulatory microRNA (Bitar et al., 2019). To test whether EHEC OMVs 
elicit an immune response in T84 cells, purified OMVs (using density gradient 
centrifugation) need to be used in order to exclude the effect of soluble LPS and 
flagella. After host incubation with OMVs, cell medium can be collected and cytokines 
can be quantified using ELISAs. 
 
In this investigation, OMVs from non-Stx producing EHEC were demonstrated to 
translocate across polarised Caco-2 cells and colonoids. The precise route of 
transcellular trafficking has not been elucidated but it is speculated that recycling 
endosomes may be involved as they offer transcellular trafficking of toxins and 
antibodies (Müller et al., 2017, Garcia-Castillo et al., 2017, Saslowsky et al., 2013, 
Brown et al., 2000). To elucidate whether OMVs are trafficked via recycling 
endosomes, Transwell experiments similar to those in this investigation can be 
carried out. After different incubation periods, monolayer immunostaining for 
recycling endosome markers using Rab11 and OMV-LPS antibody should be made, in 
order to evaluate colocalisation through florescence microscopy.  
 
In this study, widefield and confocal microscopy was utilised to determine the 
intracellular trafficking of EHEC OMVs and OMV-associated Stx. Even though 
colocalisation was quantified, the rate of overlap between different organelles (such 
as the Golgi apparatus and the ER) was not examined. It may be possible that 
colocalisation may be overemphasised due to the possibility of organelle overlap. 
Thus, the overlap between such organelles should be examined. Furthermore, in 
order to confirm the intracellular trafficking routes stated in this study, super-
resolution microscopy could be applied as such microscopes have a higher resolution 
than the microscopes used in this study, thus giving detailed and clearer images.  
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It would also be of interest to examine the effect OMVs produced by Stx-producing 
EHEC strains would have on polarised monolayers. Investigations have shown that 
following internalisation of OMVs containing Stx, cell death occurs in Gb3 positive 
cells. Since Caco-2 cells express Gb3, it is possible that OMVs from Stx-producing 
EHEC strains will cause cell death and comprise the integrity of the cell barrier. As 
Gb3 is likely not expressed in the colon, the outcome of this experiment may be 
disputed (Schuller et al., 2004). The colonoid model may be a better model to 
elucidate the effects of OMV-associated Stx on the integrity of the colonic epithelium 
and to determine whether Stx disassociates from OMVs or whether Stxs are 
translocated with OMVs. Thus far it is not known whether colonocytes in colonoids 
express Gb3, therefore this would need to be elucidated in order to understand the 
possible outcomes of such experiments.  
 
The ability of OMVs to damage renal cells has been demonstrated in this study. 
Indeed, it is likely that OMVs may damage Gb3-expressing endothelial cells, but it is 
not known whether OMVs can reach the kidneys. Intraperitoneal injected EHEC 
OMVs can cause HUS-like disease including kidney damage in mice, thus suggesting 
OMVs spread in host (Kim et al., 2011). The distribution of orally administrated OMVs 
isolated from B. thetaiotaomicron has also been demonstrated in mice (Jones et al., 
2020). In Jones et al. (2020), after the administration of lipophilic-dyed OMVs, OMVs 
were detected in various organs such as the liver by excising organs and measuring 
fluorescence. By carrying out similar studies, results can be indicative of whether 
OMVs can distribute throughout the body. 
 
 
5.3 Summary  
 
This PhD project has demonstrated that different colonic conditions can affect EHEC 
OMV vesiculation in different ways. Abiotic conditions of the colonic milieu replicated 
by SCEM increase OMV vesiculation with bile salts further augmenting vesiculation. 
In contrast, the presence of colonic relevant levels of CO2 and human cells resulted 
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in no significant changes. This project has also demonstrated that non-polarised and 
polarised Caco-2 cell monolayers and two-dimensional colonoids can internalise 
EHEC OMVs. Moreover, using polarised Caco-2 cells and colonoids, it was elucidated 
that OMVs can cross epithelial barriers via a transcellular route. This suggests that 
during infection, EHEC OMVs can cross the colonic epithelium and enter the vascular 
system. The cytotoxic ability of OMV-associated Stx2 was also verified using renal 
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Figure S1: Significantly lower OD600 measurements are attained from EHEC cultures when 
grown for OMV isolation compared to measurements attained from EHEC growth curves. 
Overnight cultures of EHEC strains TUV 93-0 and 85-170 were inoculated in LB medium (1:100) 
and grown shaking at 37oC for 4, 7 and 24 hours. Data is shown as means ± SD of three 
independent experiments, performed in duplicates. Statistical tests were only made between 
OD600 measurements of EHEC cultures attained after growing for the same amount of time. * = P 





Figure S2: Quantification and statistical analysis of signal colocalisation between DiO or DiI 
signals and OMV-LPS signal in Vero cells and non-polarised Caco-2 cells. A) Graphical 
presentation of the mean percentage of red fluorophores which colocalised with green 
fluorophores ± SD of five or ten representative cells (Vero cells and Caco-2 cells, respectively; 
M1). B) Graphical presentation of the mean percentage of green fluorophores which colocalised 
with red fluorophores. Data is shown as the means of colocalisation ± SD of five or ten 
representative cells (Vero cells and Caco-2 cells, respectively; M2). Statistical tests were only 
made between colocalisation measurements with the same lipophilic dye between Vero cells and 
























































































































Figure S3: Quantification and statistical analysis of signal colocalisation between OMVs isolated 
from EHEC strains 85-170 and late endosomal/lysosomal compartments in Vero and non-
polarised Caco-2 cells. A) Graphical presentation of the mean percentage of OMV signal 
colocalising with late endosomal/lysosomal compartment signal ± SD of five representative cells 
(M1). B) Graphical presentation of the mean percentage of late endosomal/lysosomal 
compartment signal colocalising with OMV signal ± SD of five representative cells (M2). Statistical 
tests were only made between colocalisation measurements attained for Vero cells and Caco-2 
cells after incubating with EHEC OMVs for the same time periods. **** = P < 0.0001.  
 
    
  
Figure S4: Quantification and statistical analysis of signal colocalisation between OMVs isolated 
from EHEC strains 85-170 or EDL933 and late endosomal/lysosomal compartments in non-
polarised Caco-2 cells. A) Graphical presentation of the mean percentage of OMV signal 
colocalising with late endosomal/lysosomal compartment signal ± SD of five representative cells 
(M1). B) Graphical presentation of the mean percentage of late endosomal/lysosomal 
compartment signal colocalising with OMV signal ± SD of five representative cells (M2). Statistical 
tests were only made between colocalisation measurements attained between EHEC OMVs 
isolated from EHEC strain 85-170 or EDL933 and late endosomal/lysosomal compartments after 
similar incubation periods.   
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Figure S5: Quantification and statistical analysis of colocalisation between Stx2 and ER in Vero 
cells and non-polarised Caco-2 cells. A) Graphical presentation of the mean percentage of Stx2 
signal colocalising with organelle compartment signal ± SD of five representative cells (M1). B) 
Graphical presentation of the mean percentage of organelle compartment signal containing Stx2 






Figure S6: Quantification and statistical analysis of signal colocalisation between OMVs isolated 
from EHEC strains 85-170 and late endosomal/lysosomal compartments in non-polarised (NP) 
and polarised (P) Caco-2 cells. A) Graphical presentation of the mean percentage of OMV signal 
colocalising with late endosomal/lysosomal compartment signal ± SD of five representative cells 
(M1). B) Graphical presentation of the mean percentage of late endosomal/lysosomal 
compartment signal colocalising with OMV signal ± SD of five representative cells (M2). Statistical 
tests were only made between colocalisation measurements attained for non-polarised and 
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